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“The living protoplasm […] is a liquid or rather a mixture of liquids in 
the form of a fine emulsion consisting of a continuous substance in 
which are suspended drops […] of different chemical nature.” 
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Transcription of protein-coding genes by RNA polymerase (Pol) II is a highly coordinated process. In 
metazoan cells, transcription is regulated both at the initiation step by recruitment of the Pol II machinery 
as well as during early elongation by promoter-proximal pausing.  
Prior to transcription initiation, Pol II forms short-lived clusters near active gene promoters, but the 
underlying molecular basis has remained unknown. Pol II possesses a disordered C-terminal heptad 
repeat domain (CTD) that is essential for factor recruitment during the transcription cycle. CTD length 
is organism-specific with 52 repeats in human and 26 repeats in yeast. In this work, we report that the 
human and yeast CTD can undergo concentration-dependent liquid-liquid phase separation in vitro, 
based on weak multivalent repeat-repeat interactions. We show that this behavior strongly correlates 
with the repeat number, as the shorter yeast CTD forms less-stable droplets. Shortening of the CTD in 
human cells to the length of the yeast CTD reduces Pol II clustering and chromatin-association, while 
artificial extension has the contrary effect. Repeat-repeat interactions are sensitive to CTD 
phosphorylation by the transcription factor IIH kinase CDK7, which dissolves CTD droplets in vitro. 
Together these results imply a model for gene activation that involves CTD-mediated clustering of 
initiation-competent Pol II and release through CTD phosphorylation upon transcription initiation. 
Heat shock causes the accumulation of the negative elongation factor (NELF) at chromatin, which 
stabilizes paused Pol II within the promoter-proximal region of downregulated target genes. In this 
work, we show that NELF clusters in nuclear puncta upon heat shock, which possess properties 
consistent with phase-separated condensates. In vitro, purified NELF complex self-interacts to form 
phase-separated droplets with liquid-like properties. We show that multivalent interactions between the 
disordered NELF tentacles are essential for NELF phase separation in vitro and stress-induced 
condensation in vivo. Phosphorylation by positive elongation factor b (P-TEFb) counteracts NELF 
phase separation in vitro and is prevented through the inactivation of P-TEFb upon heat shock in vivo. 
Sumoylation is further required for stress-induced NELF condensation, as NELF itself can be 
sumoylated in vitro and interacts with SUMO2/3 in a chain length-dependent manner. Together with 
published data, our results suggest a model that involves stress-induced sequestration of promoter-
proximal paused Pol II by NELF near downregulated gene promoters.  
Taken together, the findings presented in this work indicate that phase separation mechanisms regulate 
key steps of eukaryotic gene transcription and provide a basis to further analyze the role of phase 
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1.1 Key principles of eukaryotic gene transcription 
The eukaryotic cell nucleus contains the vast majority of an organism’s genetic information, 
which is stored in the form of the deoxyribonucleic acid (DNA) double helix2. In multicellular 
lifeforms, every cell contains the genetic blueprint to give rise to the entire organism3. Yet, cells 
can exhibit vast morphological and functional differences. Such variation arises through the 
activation of different genes in different cell types. The central dogma of molecular biology 
describes the directional flow of the genetic information4: All genetic information is encoded 
in the form of DNA, copied to the transient messenger ribonucleic acid (mRNA), and translated 
into a linear polypeptide chain that folds into a functional protein, the workhorse molecules of 
the cell that largely define its phenotype4. Thus, as the critical initial step, the regulated cell 
type-specific transcription of genes into RNA largely determines cellular identity5.  
Gene transcription is carried out by DNA-dependent RNA polymerases that utilize a  
DNA template to produce complementary single-stranded RNA molecules using nucleotide 
triphosphates as substrate6. While bacteria and archaea have only one type of RNA polymerase, 
transcription of the nuclear genome in eukaryotes requires up to five different RNA 
polymerases (Pol I-V), which synthesize functionally distinct transcripts7, 8. Pol I and Pol III 
catalyze the synthesis of ribosomal and transfer RNAs required for protein biosynthesis as well 
as some small non-coding RNAs9-11. The plant-specific enzymes Pol IV and Pol V produce 
small interfering RNAs (siRNAs) that are involved in gene silencing12. RNA polymerase II 
(Pol II) carries out the transcription of all protein-coding genes into precursor-messenger RNA 
(pre-mRNA)13, 14. Synthesized pre-mRNAs then undergo various co-transcriptional and post-
transcriptional processing steps before they can serve in their mature form as templates for 
ribosomal protein synthesis in the cytoplasm15, 16. Since the repertoire of functional protein 
molecules results from the set of assembled mRNA transcripts, Pol II transcription is the central 
determinant of the cellular proteome and shapes its identity.  
Pol II transcription can be divided into three key steps: Initiation, elongation and termination 









associate with Pol II in a transcription stage-dependent manner. The Pol II C-terminal domain 
(CTD), a unique tail-like C-terminal extension of the largest Pol II subunit RPB1, plays a 
pivotal role for the recruitment of many of these factors to the transcriptional machinery during 
the different phases of the transcription cycle. 
 
 
Figure 1.1 | Pol II transcription cycle.  
During transcription initiation, Pol II binds together with the general transcription factors to the core promoter in 
close proximity to the transcription start site (TSS). After opening of the promoter DNA and promoter escape, 
elongation factors bind to Pol II to form a productive elongation complex that extends the mRNA (blue) in a 
processive manner. At the end of the transcription unit, mRNA becomes cleaved after reaching the cleavage and 
polyadenylation (polyA) site. Pol II continues elongation before it gets destabilized through binding of termination 
factors and ultimately dissociates from the template. During recycling, released Pol II is then prepared to engage 
in a new round of transcription. Co-transcriptional modification with a 5’ cap structure and post-transcriptional 
modification with a polyA-tail (An) renders the produced RNA competent for nuclear export and translation.  
The Pol II C-terminal domain was omitted for clarity. Figure was adapted from Hantsche & Cramer (2016)17.  
 
1.1.1 RNA polymerase II carboxy-terminal domain (CTD)    
Early studies in the 1980s uncovered the presence of an ‘unusual’ repetitive amino acid 
sequence at the carboxy-terminal end of the largest Pol II subunit RPB1 that was not present in 
any other bacterial, archaeal or eukaryotic RNA polymerase18, 19. Later studies revealed that the 
C-terminal domain of the largest RNA Pol II subunit RPB1 is instrumental to coordinate the 
association of accessory factors with Pol II during the transcription cycle (reviewed in20-22).  
The Pol II CTD forms a tail-like extension near the RNA exit size and consists of multiple 









repeats within the CTD varies between species and roughly scales with the complexity of the 
organism23: While the CTD of the yeast S. cerevisiae contains 26 heptapeptide repeats, the 
human CTD is composed of 52 repeats (Fig. 1.2a). The human CTD can be divided in  
an N-terminal proximal half that consists largely of consensus repeats and closely resembles 
the yeast CTD, and a C-terminal distal half with many non-consensus heptads that diverge 
mostly at position 7 (Fig. 1.2a). Within the human CTD, Y1 and P6 show strongest conservation 
and are present in all 52 repeats. In addition, the tyrosine content is strongly conserved even 
between distantly related species (Fig. 1.2b). 
 
 
Figure 1.2 | The Pol II C-terminal domain.   
a, Comparison of human and yeast Pol II CTD sequences. The human CTD comprises 52 heptad repeats and can 
be divided into an N-terminal part that consists mostly of repeats with the consensus sequence Y1S2P3T4S5P6S7 
and closely resembles the CTD of the yeast S. cerevisiae and a C-terminal part that contains mostly divergent 
repeats. b, Tyrosine content within the CTDs of distantly related species. Despite great variation in length and 
repeat number, the abundance of tyrosine within the CTD is strongly conserved in all eukaryotes. The species are 
from left to right: Trichomonas vaginalis, Trypanosoma brucei, Leishmania donovani, Monoblepharis macrandra, 
Acanthamoeba castellanii, Plasmodium falciparum 3D7, Vairimorpha necatrix, Glaucosphaera vacuolata, 
Dictyostelium discoideum AX4, Nosema ceranae, Breviata anathema, Saccharomyces cerevisiae, 
Schizosaccharomyces pombe, Monosiga brevicollis, Arabidopsis thaliana, Caenorhabditis elegans, Drosophila 
melanogaster, Culex quinquefasciatus, Branchiostoma floridae, Strongylocentrotus purpuratus, Ixodes 
scapularis, Tribolium castaneum, Danio rerio, Mus musculus, Homo sapiens and Hydra magnipapillata. The red 
and blue bars correspond to S. cerevisiae and H. sapiens, respectively. c, Disorder prediction of the human CTD 
sequence using the PONDR tool24 (for details see Section 2.3.1.7). The CTD is predicted to be disordered over its 









While the CTD in its entirety is dispensable for templated Pol II transcription in vitro, it is 
essential for viability in vivo26, 27. However, CTD truncation is tolerated to a limited extent in 
vivo, suggesting that repeats possess largely redundant functions: Mutational studies in yeast 
have revealed that at least 8 repeats are required for viability, but resulted in a slow growth 
phenotype28. Thirteen repeats resulted in normal yeast growth, but the cells exhibited defects in 
stimulus-activated transcription29, 30. Similarly, in mammalian cells about half of the repeats 
were sufficient to support growth31, but reduced the responsiveness to enhancer-mediated 
transcriptional activation32.    
Despite its pivotal role during the transcription cycle, insights into the structure of the Pol II 
CTD have been limited. The CTD is absent from Pol II structures obtained by X-ray 
crystallography or cryo-electron microscopy (cryo-EM), indicating a large degree of inherent 
flexibility21. Consistent with this, computational algorithms predict the CTD to be disordered 
over its entire length (Fig. 1.2c). Disordered protein domains can assume various conformations 
that range from extended structures via a random coil to compact globules, depending on the 
degree of favorable intramolecular interactions that lead to chain compaction33, 34. Several lines 
of evidence indicate that the CTD assumes a rather compact conformation in dilute aqueous 
solutions21: The limited available space within the Pol II crystal lattice can only accommodate 
a compact CTD13. Moreover, negative stain electron microscopy analyses of wild-type and 
CTD-deficient Pol II measured a weak density difference of only ~100 Å in diameter35 and 
provided indirect evidence for a compact conformation of a recombinant CTD fusion protein 
in complex with a submodule of the transcriptional regulator Mediator36. In agreement with 
previous data, recent cryo-EM analysis of the Pol II pre-initiation complex with Mediator 
suggested that only a compact CTD globule can be accommodated within an open space 
between Pol II and Mediator37. In support of this hypothesis, a rather compact structure was 
also inferred from biophysical analysis of recombinant CTD from various species using size-
exclusion chromatography and small-angle X-ray scattering38. 
The Pol II CTD becomes extensively post-translationally modified during the transcription 
cycle22. Most prominently, all five CTD consensus amino acids that possess hydroxyl groups, 
Y1, S2, T4, S5, and S7, have been shown to undergo reversible phosphorylation
39-42.  
CTD phosphorylation marks are established through the dynamic interplay of transcriptional 









Specific phosphorylation patterns are recognized by CTD-binding factors that form binary 
interactions with short, 1-3 heptad comprising CTD segments and facilitate Pol II progression 
through the transcription cycle (see Section 1.1.2). The differential phosphorylation of up to  
5 repeat positions, the isomerization of proline43 as well as the methylation44 and acetylation44 
of lysine, and the methylation45 and citrullination46 of arginine residues in distal non-consensus 
repeats were thus proposed to give rise to an elaborate ‘CTD code’47. However, despite of the 
high conceivable complexity of such a code, recent mass spectrometric analyses of  
CTD phosphorylation in yeast and mammalian cells suggested that each heptad contains on 
average less than one phosphorylation and that S2 and S5 are the predominant phosphorylation 
sites in vivo48-50.  
Beyond its role in factor recruitment, CTD phosphorylation has also immediate effects on its 
structure. While the CTD assumes a rather compact conformation in the unphosphorylated state, 
its hydrodynamic radius increases upon phosphorylation resulting in a reduced electrophoretic 
mobility and elution volume in size-exclusion chromatography51. In agreement, this structural 
extension upon CTD phosphorylation leads also to an increased protease sensitivity52.   
 
1.1.2 The Pol II transcription cycle 
1.1.2.1 Transcription initiation 
In order to allow transcription initiation to take place, Pol II needs to obtain access to promoter 
DNA at the transcription start site of a gene. In vivo, DNA is compacted through binding to 
octameric histone complexes that act as spools53. Each histone octamer is composed of two 
copies of the histones H2A, H2B, H3, and H4, which together with 147 bp of encircling DNA 
form the nucleosome53, the fundamental building block of chromatin. The accessibility of the 
DNA template is strongly impaired by chromatinization54, 55, but can be regulated through 
chromatin remodelers that can slide or eject nucleosomes from the DNA56, 57. Promoters of 
active transcription units are generally located in nucleosome-depleted regions that provide 
access for the transcriptional machinery to the DNA. Transcription initiation involves the 
assembly of the pre-initiation complex (PIC) encompassing the general transcription factors 
(GTFs) TFIIA, TFIIB, TFIID, TFIIE, TFIIF, and TFIIH together with Pol II at the core 









promoter and enabling transcription start site (TSS) selection17, 59. TFIIH plays a key role in 
this process as it opens the double-stranded promoter DNA at the TSS through its  
ATP-dependent translocase activity (‘open PIC’). This allows the translocation of the template 
strand into the Pol II active site, and promotes the polymerization of a complementary  
RNA strand via a conserved catalytic mechanism (‘initially transcribing complex’)60-62. Once 
the transcript exceeds a critical length (12-13 nt), the growing RNA chain clashes with TFIIB, 
strongly destabilizing the PIC63-65. Concomitantly, the trimeric TFIIH kinase module containing 
the CDK7 kinase (Kin28 in yeast) phosphorylates the Pol II CTD at the heptad positions S5 and 
S7, which further facilitates PIC disassembly and promoter escape
37, 66-68.  
 
1.1.2.2 Transcription elongation 
Upon promoter escape, initiation factors disassemble and a processive transcription elongation 
complex forms, which becomes increasingly stabilized by the growing DNA-RNA hybrid69. 
S5-phosphorylated CTD recruits the capping enzyme that modifies the 5’-end of the nascent 
mRNA with a stabilizing methylated guanosine nucleotide70-72. In metazoans, the Pol II 
elongation complex temporarily pauses in the promoter-proximal region ~50 nt downstream of 
the TSS, representing a regulatory checkpoint for transcriptional control during elongation73 
(for details see Section 1.1.3.2). Pol II pausing is stabilized by the negative elongation factor 
(NELF) and DRB sensitivity-inducing factor (DSIF)74. Pause release by the CDK9 kinase 
subunit of the positive elongation factor b (P-TEFb) results in displacement of NELF by the 
elongation factor complex PAF, binding of the elongation factor SPT6, and S2-phosphorylation 
of the Pol II CTD22, 75-77. While pause sites are generally located upstream of the first (+1) 
nucleosome78, 79, further transcription of the gene body necessitates Pol II passage through 
nucleosomes80, 81. Recruitment of positive elongation factors like – among others82-84 –   
the histone chaperone SPT683, 85, or the H3K36 histone methyltransferase SET2 to the  
S2/S5-hyperphosphorylated CTD
86 can enable efficient nucleosome passage80, 87 to facilitate 
elongation velocities of up to ~60 bp/s88, 89. As transcription elongation proceeds through the 
gene body, the phosphorylated CTD coordinates co-transcriptional pre-mRNA maturation 










1.1.2.3 Transcription termination and recycling 
Close to the termination site, the predominantly S2-phophosphorylated CTD mediates 
interactions with the 3-end RNA processing machinery42, 94, 95. Concomitantly, other 
components of the 3’-end processing machinery bind to the emerging well-defined RNA 
cleavage and polyadenylation signal (5’-UUAUUU-3’) in the nascent RNA and trigger 
transcript cleavage96. Release of the RNA reduces the stability of the Pol II elongation complex, 
ultimately resulting in termination of Pol II transcription (Fig. 1.1). Two non-exclusive models 
have been proposed for eukaryotic transcription termination97, 98: In the torpedo model, an 
exonuclease that degrades the unprotected 5’-end of the cleaved transcript displaces Pol II from 
the template strand98-100. In the allosteric model, transcription termination results from the 
indirect destabilization of the Pol II elongation complex through binding of 3’-end processing 
factors, transcript cleavage and sequences that induce Pol II pausing101, 102. After release from 
the template, CTD dephosphorylation renders Pol II competent for re-initiation103, 104. 
 
1.1.3 Regulation of the Pol II transcription cycle 
The core transcriptional machinery is functionally well conserved across eukaryotes, although 
the mechanisms that underlie transcriptional regulation differ substantially between yeast and 
human105. While Pol II transcription in yeast is mostly regulated at the level of transcription 
initiation (Fig. 1.3a), elaborate mechanisms of elongation control have additionally evolved in 
metazoan organisms (Fig. 1.3b)106.  
 
1.1.3.1 Transcriptional activation through Pol II recruitment  
Transcription initiation is largely regulated through the recruitment of the transcriptional 
machinery to gene promoters107 (Fig. 1.3a). While most of the GTFs represent the minimal set 
that is sufficient to reconstitute transcription in vitro108, in vivo gene transcription necessitates 
additional factors109.  
Transcriptional factors that can recruit the transcriptional machinery are essential for robust 
gene activation110, 111. Such transcriptional activators possess intrinsically disordered 









coactivators to stimulate transcription initiation112. Transcription factors also contain  
DNA-binding domains, with which they bind in a sequence-specific manner to regulatory  
DNA elements that can be either located proximal or distal to the core promoter113. In yeast, 
short upstream activating sequences adjacent to the promoter harbor few closely spaced 
transcription factor-binding sites114, 115. Besides having similar proximal regulatory sequences, 
metazoans possess additional extended distal enhancer elements that can be localized spatially 
uncoupled, upstream or downstream from the target promoter (often >100 kb apart)116-118, 
contain multiple transcription factor binding sites118, 119, and can contact the core promoter 
through gene looping116, 120, 121. As a consequence, enhancer-promoter interactions are not 
mutually exclusive and multiple enhancers can activate transcription on a single promoter or 
single enhancers can co-activate transcription on multiple promoters simultaneously122-125.  
The frequency of enhancer-promoter contacts determines the transcriptional output122, 126  
and is highly controlled by the local genome organization within topologically-associated 
domains116, 127. For enhancer activity, transcriptional coactivators are required that interact with 
transcription factors and provide a functional link to translate activator binding into 
transcriptional activity128. Some coactivators possess chromatin-remodeling or histone-
modifying activities that increase promoter accessibility. Others, such as the multi-subunit  
co-activator Mediator129, additionally transiently interact with the gene promoter, serving as a 
functional and architectural bridge130-132. Association of Pol II with the PIC requires the 
disordered CTD in an unphosphorylated state133. CTD truncation in yeast29 and CTD deletion 
in human cells32 strongly diminished transcription at activated gene promoters, suggesting that 
the CTD is required for Pol II recruitment in vivo. Weak interactions of the CTD with 
transactivation domains of transcription factors134, 135, mediator subunits36, 136, other 
transcriptional co-activators137, and general transcription factors138 are reported. The transient 
nature and ill-defined stoichiometry of multi-protein assemblies that underlie gene activation 










Figure 1.3 | Mechanisms of transcriptional regulation in higher eukaryotes.  
a, Initiation regulation. Transcription initiation is largely regulated through the recruitment of the transcriptional 
machinery to gene promoters. Recruitment of the transcriptional machinery is facilitated by cis-regulatory 
elements such as enhancers. b, Elongation regulation. After transcription initiation, Pol II pauses 30-80 bp 
downstream of the transcription start site (TSS) through binding of negative elongation factor (NELF) and  
DRB sensitivity inducing factor (DSIF), which stabilize a tilted DNA-RNA hybrid conformation within the active 
site of Pol II. Pause release requires the positive elongation factor b (P-TEFb), which phosphorylates NELF, DISF 
and the Pol II CTD (omitted in the scheme for clarity). P-TEFb phosphorylation converts DSIF into a positive 
elongation factor, leads to the replacement of NELF by the PAF complex and binding of the histone  
chaperone SPT6, which facilitates Pol II transcription through chromatin. Figure is adapted from Hantsche &  
Cramer (2016)17. 
 
1.1.3.2 Promoter-proximal pausing and the role of negative elongation factor 
(NELF) 
Early studies of transcriptional regulation in the model organism S. cerevisiae led to the notion 
that gene transcription is predominantly regulated through Pol II recruitment at the level of 
initiation107. However, the study of metazoan model systems revealed an additional previously 
unappreciated level of transcriptional regulation during early elongation, after Pol II 
commences transcription. Promoter-proximal pausing of Pol II was initially discovered at the 
HSP70 locus in the fruit fly Drosophila melanogaster141, 142 (Fig. 1.3b). However, with the 
advent of approaches that map transcriptionally-engaged Pol II genome-wide, promoter-
proximal pausing was readily appreciated as a widespread phenomenon and integral step of the 
transcription cycle in metazoan organisms78, 88, 143, 144 (reviewed in73).  
Many of the molecular determinants that lead to promoter-proximal pausing have been 
uncovered in the recent years, although their individual contribution is still part of on-going 









downstream sequence89, 145, 146. It was thus suggested that the high stability of the DNA-RNA 
hybrid reduces Pol II elongation rate and processivity73, 145, 146. Stable pausing, however, 
additionally requires binding of DSIF and NELF to the Pol II elongation complex147, 148.  
The emerging nascent transcript promotes the association of DSIF149, a heterodimer composed 
of the conserved elongation factor SPT5 and the eukaryote-specific subunit SPT4150, through 
contacts with RNA and the Pol II core151, 152. Similar to the Pol II CTD, SPT5 contains a  
C-terminal repeat (CTR) domain that contributes to factor recruitment during transcription 
elongation153 (such as the PAF1 complex in yeast154). Binding of DSIF might then aid the 
recruitment of NELF147, 152. The metazoan-specific NELF complex is composed of  
four subunits74, NELFA, NELFB, NELFC (or the nine amino acid shorter isoform NELFD) and 
NELFE, and is considered an essential facilitator of Pol II pausing74, 76, 147. While the DSIF 
subunit SPT5 underlies strong evolutionary conservation from bacteria to human, no NELF 
orthologs are present in yeast, nematodes, and plants, consistent with the absence of promoter-
proximal pausing in these organisms147, 155.  NELFA and –C as well as NELFB and –E form 
heterodimeric subcomplexes156 that associate and form a three-lobed structure76. In addition, 
the NELFA and NELFE subunits possess large disordered C-terminal regions that were termed 
‘tentacles’ due to their inherent flexibility76.  Recent structural analysis of paused Pol II 
revealed that binding of NELF and DSIF allosterically stabilizes a tilted DNA-RNA hybrid 
conformation within the active site76. The tilted conformation of the DNA-RNA hybrid 
represents a non-productive state for nucleotide addition, as canonical base pairing of the next 
incoming nucleotide triphosphate with the template DNA is impaired76. Consequently, further 
extension of the pre-mRNA chain cannot occur, resulting in Pol II stalling. NELF additionally 
contacts the Pol II trigger loop76, a mobile domain that facilitates nucleotide selection and 
catalysis157, and restricts Pol II movement required to escape the paused state76, 158.  
The half-life of paused Pol II is often in the order of minutes, but can greatly vary between 
different transcription units89, 159, 160 and under different developmental78, 161 and 
environmental162, 163 conditions.  
Pause release requires the positive elongation factor b (P-TEFb) containing the CDK9 kinase 
together with a T-type cyclin, mainly T1164-166. P-TEFb triggers pause release through extensive 
phosphorylation of DSIF, NELF, the Pol II CTD and the CTD linker75, 153, 167. NELF becomes 









tentacle which contributes to pause stabilization76, 87. P-TEFb phosphorylation weakens the 
interaction of NELF with Pol II and promotes NELF displacement by the competitively binding 
elongation factor complex PAF87. Additionally, phosphorylation of the CTR helps to overcome 
the repressive effect of DSIF on transcription elongation and CTD linker phosphorylation 
results in recruitment of the histone chaperone SPT6. Thus, pause release involves the exchange 
of pausing factors by elongation factors (such as histone chaperones and remodelers) that enable 
Pol II transcription through chromatin (Fig. 1.3b).  
While active in its free form, P-TEFb becomes inactivated by incorporation into the 7SK small 
nuclear ribonucleoprotein particle (snRNP)168, 169. P-TEFb sequestration involves the 
interaction with HEXIM1/2 (hexamethylene bisacetamide-inducible protein 1/2) and the non-
coding 7SK RNA together with the stabilizing factors LARP7 (La-related protein 7) and 
MEPCE (methylphosphate capping enzyme)170, 171. Although the exact molecular mechanisms 
remain elusive, cells can tightly control P-TEFb activity by tuning the equilibrium between both 
forms in response to stimuli168, 169, 172.  
 
1.1.3.3 Transcriptional regulation in response to heat shock  
In order to survive and thrive, cells need to rapidly sense and adapt to the ever-changing 
environmental conditions. Such adaptation involves an extensive gene-specific regulation of 
the transcription cycle. During heat stress, eukaryotic cells mount a rapid and conserved 
genome-wide response that involves the coordinated redistribution of the transcriptional 
machinery173, 174. It results in the upregulation of hundreds of genes, which encode pro-survival 
factors such as heat shock proteins (HSPs) and chaperones, and simultaneous downregulation 
of thousands of genes involved in anabolic processes162, 175, 176.  
Transcriptional upregulation upon heat shock in eukaryotic cells is mainly mediated through 
heat shock factor 1 (HSF1) (reviewed in177, 178). HSF1 binds as master regulator to conserved 
sequence elements within heat shock-activated gene promoters179-181 and triggers gene 
activation by recruitment of the transcriptional machinery182, 183 (Fig. 1.3a). The rapid 
transcriptional response at HSF1 target genes is facilitated through engaged, but 
transcriptionally paused Pol II, which maintains an open chromatin structure at the  









elongation factors such as P-TEFb182 or SPT6186, and chromatin remodelers187 that can undergo 
local recycling to mediate efficient gene activation188 (see also Section 1.2).   
Transcriptional downregulation of genes involved in metabolism, protein synthesis and cell 
cycle is the prevalent consequence of heat stress, and by far outnumbers the upregulated  
genes162, 175, 189. It is accompanied by an enhanced recruitment of negative elongation factors 
such as NELF to chromatin that accumulate near repressed gene promoters175. Consistently, 
paused Pol II becomes stabilized within the promoter-proximal region of these genes upon 
stress, resulting in increased pause duration162, 163, 189 (Fig. 1.3b). Since the presence of paused 
Pol II prevents new transcription initiation, enhanced Pol II pausing can facilitate swift 
transcriptional repression89, 190. But at the same time, it might keep the transcriptional 
machinery in a competent state that allows rapid reactivation after the heat stress ceases176. In 
contrast to stress-induced activation, the molecular mechanisms that cause genome-wide 
transcriptional downregulation upon heat shock are far less well understood175.  
 
1.2 Spatiotemporal organization of Pol II transcription 
Each human diploid cell contains 23 pairs of chromosomes that encompass together about  
six billion base pairs DNA with a total length of ~2 m. To accommodate the genetic information 
in the cell nucleus that is about five orders of magnitude smaller, the DNA is highly packaged 
at multiple levels. This degree of compaction is equivalent to accommodating a DNA strand 
encircling the earth for >6000 times inside a chicken egg191. Given this highly crowded nuclear 
environment the question arises how the manifold factors involved in Pol II transcription can 
efficiently encounter each other in a spatiotemporally controlled manner. In the middle of  
the 1990s this puzzling question was first addressed in pioneering studies by Peter Cook and 
colleagues who observed that Bromo-UTP labelled nascent transcripts in fixed human cells 
were not evenly distributed throughout the entire nucleus, but localized to distinct focal sites 
that they termed ‘transcription factories’192. Several follow-up studies reported similar 
observations using different nucleotide analogs and electron microscopy, and detected the  
co-localization of Pol II with labelled nascent transcripts in foci193-195. About 2400 of such foci 
were detected, each estimated to contain on average about 30 engaged polymerases195. Using 









colocalize with Pol II foci, which in turn colocalized with fluorescence in situ hybridization 
signals from the produced transcripts196. Correspondingly, these and other197-199 early studies 
led to the concept that stable pre-assembled transcription factories, dedicated nuclear sites for 
RNA synthesis with high concentrations of transcriptional components such as Pol II, exist,  
to which genes must translocate in order to become transcribed200-203 (Fig. 1.4a). However, it 
was argued at the same time that results obtained in these studies could have been affected by 
intrinsic methodological limitations. For example, it was criticized that chemical cell fixation 
might have introduced artificial aggregation artefacts204. Similarly, the number of Pol II 
molecules might be overestimated through indirect Pol II immunolabeling with antibodies 
targeting the repetitive CTD as multiple antibody molecules bind a single Pol II enzyme205. 
Importantly, the dynamics of (dis-)assembly of the detected transcription factories could not be 
explored due to cell fixation, impeding conclusions regarding their stability. Subsequent 
attempts to detect stable clusters of transcriptionally active Pol II in living mammalian cells 
using GFP-tagged Pol II and confocal microscopy were not successful206, 207. Rather, initiating 
and elongating forms of Pol II were observed to possess a distinct but adjacent nuclear 
localization204. More recent single-molecule super-resolution microscopy approaches suggest 
that the majority of Pol II molecules are solitary and spaced on average >200 nm away from 
each other205, arguing against the predominant occurrence of Pol II in large stable transcription 
factories. 
Using an elegant super-resolution microscopy approach that focuses on transiently (~50 ms) 
immobile Pol II molecules, Cisse et al. (2013) showed that a small fraction of Pol II molecules 
indeed forms transient clusters in live human cells208. For these experiments, the authors used 
a stable human cell line encoding RPB1 that was N-terminally tagged with the photo-switchable 
fluorescent protein Dendra2. Successive cycles of photoactivation and localization allowed 
time-resolved counting of detections used then for pair-correlation analysis208-210. Interestingly, 
the detected Pol II clusters possessed highly transient lifetimes of only few seconds  
(5.1 ± 0.4 s in208, 8.3 ± 0.2 s in211, and 12.9 ± 1.4 s in212) and average sizes below the diffraction 
limit, representing potential reasons why they could not be detected in previous studies.  
As estimated in fixed cells, an average cluster contains ~80 Pol II molecules211. Live-cell two-
color imaging of Pol II and mRNA produced from the β-actin locus revealed that transient Pol II 









lifetimes after inhibition of transcription elongation208, 211. Together, these findings provided 
compelling evidence that small populations of Pol II transiently form high local concentrations 
in close proximity to gene promoters prior to transcription initiation (Fig. 1.4b).  
 
 
Figure 1.4 | Models for the spatiotemporal organization of gene transcription.  
a, Gene transcription requires the translocation into static pre-assembled transcription factories containing high 
concentrations of relevant factors (i.e. RNA Pol II). b, Nucleoplasmic pool of Pol II surrounds the gene and 
dynamically forms high concentration clusters upon transcriptional activation. Figure concept was adapted from 
Buckley & Lis (2016)200. 
 
 
The rapid Pol II clustering kinetics also match residence times observed for several 
transcription factors (TFs) on their target sites remarkably well: FRAP and recent single-
molecule tracking experiments showed that the large majority of TF molecules occupy fast-
diffusing states213-216 and that just a small percentage of molecules is bound at specific target 
sites. At the same time each binding event persists for only few seconds216. Consistent with the 
kinetics of Pol II clustering, the coactivator complex Mediator also forms transient clusters at 
enhancer elements with average lifetimes of 11.1 ± 0.9 s212. In agreement with the transient 
assembly/disassembly of Pol II and co-activator clusters, recent analysis of transcription in 
single-cells revealed that transcription initiation is not a constant continuous process, but occurs 









bursts generate convoys of closely spaced Pol IIs, which transcribe the gene body220. Bursts are 
triggered when enhancer elements come in close proximity to gene promoters through DNA 
looping116, 117, 120, 121.   
Cellular stress such as heat shock causes the dynamic nuclear redistribution of the Pol II 
machinery. The heat shock response has been extensively studied on Drosophila polytene 
chromosomes, where heat shock stress causes local chromatin decondensation at 
transcriptionally active loci called puffs221. Because of the naturally amplified HSP70 gene 
cluster at polytene chromosomes it is possible to image transcriptional activation at high signal-
to-noise using diffraction-limited fluorescence microscopy203, 222. Heat stress-induced 
transcriptional activation caused the sequential accumulation of heat shock factor HSF1, Pol II 
and other positive transcription elongation factors (i.e. P-TEFb, SPT6, and chromatin 
remodelers) at the HSP70 locus185, 188, 223. Prolonged gene activation resulted in sustained 
recruitment of Pol II and elongation factors beyond the amount that can bind to the transcription 
unit and the ADP-ribosylation-dependent compartmentalization of the locus185 that facilitated 
the local recycling of these factors over the time of activation185, 188.  
Taken together, these insights into the spatiotemporal organization of transcription in living 
cells suggests a very dynamic regulation involving transient high local concentrations of Pol II 
and relevant cofactors during gene activation in steady state and upon stress. While these studies 
suggest the functional importance of transient macromolecular assemblies encompassing Pol II, 
a mechanistic understanding of the molecular principles that govern such factor concentration 
only begins to emerge. 
 
1.3 Intrinsic disorder in Pol II transcription 
Which mechanisms might underlie the formation of such transient macromolecular assemblies? 
Proteome-wide computational analyses revealed that factors involved in eukaryotic gene 
transcription contain a high proportion of intrinsically disordered protein regions (IDRs) 
(Fig. 1.5). Such protein domains exist as a heterogeneous ensemble of rapidly interconverting 
conformations34. Because IDRs do not fold into stable three-dimensional structures, they are 
generally devoid of hydrophobic amino acids that drive the higher-order folding of proteins. 









threonine (T), and glutamine (N)) and charged amino acids (arginine (R), lysine (K), aspartic 
acid (D), and glutamic acid (E))224, 225. In addition, disordered regions often appear to contain 
interspersed aromatic amino acids (in particular tyrosine (Y) and phenylalanine (F)) and have 
sometimes a high proline (P) content224, 225. Since the biased amino acid composition and the 
strong overrepresentation of certain amino acids is often indicative of disorder, many IDRs are 




Figure 1.5 | Intrinsic disorder in gene transcription.  
The cumulative proportion of proteins is shown in dependence on the fraction of amino acids in disordered protein 
regions for the entire proteome (black line) or proteins involved in gene transcription (blue line; GO:0006351, 
DNA-templated transcription) for S. cerevisiae. While only 32% of proteins in the entire proteome (n =8610) 
possess more than 20% of the residues in disordered regions, over 63% of the proteins involved in gene 
transcription (n=528) possess more than 20% disorder. Figure was plotted based on the data presented in  
Herzel et al. (2017)90.  
 
 
From early on, the importance of disordered regions was recognized for transcriptional 
activation140. Transcription factors often possess extended disordered transactivation domains 
that promote transcription initiation through ill-defined intermolecular interactions and were 
thus referred to as ‘negative noodles’140. The human proteome comprises over 1,600 
transcription factors113, with many of them containing disordered transactivation domains227. 
Pol II itself contains an extended disordered C-terminal domain, which comprises over 350 
residues with a molecular mass of ~40 kDa in mammals. Being composed almost exclusively 
of the four amino acids Y, S, P, and T, the CTD is certainly one of the most prominent low-









regulate Pol II progression through the transcription cycle possess substantial disorder46, 228, 229,  
230. One such example is the pausing factor NELF that contains two large unstructured ‘tentacle 
regions’, which are in part required for stabilization of Pol II pausing in vitro76.  
 
1.4 Liquid-liquid phase separation 
The emerging concept of liquid-liquid phase separation can provide a mechanistic basis how 
intrinsically disordered regions can mediate the local concentration of proteins in so-called 
membraneless organelles or biomolecular condensates225, 231. The underlying concepts are 
based on fundamental physical properties of polymers232, 233: Molecules are soluble in solution 
until their concentration reaches a solubility threshold. At concentrations above the solubility 
limit, some of the molecules cannot remain dissolved in solution and distribute into a distinct 
separate phase232, 233. Hyman and colleagues were the first to recognize that identical principles 
also apply to biological polymers such as proteins in aqueous solutions, which then can give 
rise to two liquid phases with different properties234. Such liquid-liquid phase separation of 
proteins has subsequently emerged as a fundamental principle of intracellular organization in 
the absence of bounding membranes225, 231. 
 
1.4.1 Physical basis of liquid-liquid phase separation 
Liquid-liquid phase separation (LLPS) is a concentration-dependent process and results above 
the polymer saturation concentration csat in the demixing of a homogeneous solution into a 
condensed, polymer-rich phase with liquid-like properties that co-exists with a dilute (polymer-
poor) phase (Fig. 1.6a)225, 231, 235-237. Phase separation results from governing thermodynamic 
principles by which a system strives to reach the lowest energy state possible237. On a molecular 
level, different polymers possess varying tendencies to interact with solvent molecules as well 
as with other polymer molecules. Such interactions between biological polymer molecules are 
typically low-affine but multivalent231, 235, 238. The solubility of a polymer results from the 
balance between polymer-solvent and polymer-polymer interactions. If polymer-solvent 
interactions are stronger than the tendency of polymer molecules to interact with each other, 
then the polymer molecules remain soluble in solution, independent of their concentration231. 









maximize the entropy of the system. If, on the other hand, polymer-polymer interactions are 
stronger than polymer-solvent interactions, polymer solubility decreases and the propensity of 
phase separation increases. Such a system can undergo phase separation when favorable 
polymer-polymer interactions become more and more likely with increasing concentration until 
their energetic contribution overcomes the entropic tendency of the system to stay uniformly 
mixed. Under these conditions phase separation into two phases is thermodynamically 
favorable as the sum of the free energy of both phases is smaller than the free energy of the 
single (mixed) phase (Fig 1.6b). Since in the two-phase regime polymer-polymer and solvent-
solvent interactions are energetically more favorable, the condensed phase assumes a droplet-
like structure to minimize unfavorable polymer-solvent interactions. The formation of such 
droplets can be analyzed using differential contrast interference or fluorescence microscopy 
methods239. Importantly, liquid-like droplets possess similar characteristics as known from 
ideal liquids and can coalesce and fuse (Fig 1.6c). Since the nature of the interactions within 
the condensed phase is weak, molecules can diffuse dynamically and are in constant exchange 
with the dilute phase (Fig 1.6d). 
On the basis of the previous considerations, it follows that the breadth of interaction between 
polymer molecules crucially determines whether a polymer undergoes phase separation at a 
given concentration. In this regard, Rosen and colleagues were the first to provide experimental 
evidence that multivalency – the ability of a single molecule to engage in interactions with 
multiple other molecules – is a key parameter that promotes phase separation240. IDRs that do 
not fold into well-defined three-dimensional structures but possess conformational 
heterogeneity can provide the underlying basis for such multivalent intermolecular interactions. 
While it is not well understood on a molecular level how IDRs can promote LLPS of the protein 
they are attached to241, a ‘stickers and spacers model’ that was developed from polymer 
theory242, 243 by Pappu and colleagues244, 245 has proven helpful in this regard. The model 
predicts the existence of distributed associative motifs called ‘stickers’ that can promote LLPS 
through intermolecular sticker-sticker interactions and are interspersed by inert ‘spacers’  
(Fig. 1.7a). Sticker motifs appear to interact through three key types of molecular interactions 
which are combined/arranged in various patterns224, 225, 246: Electrostatic interactions between 
blocks of oppositely charged amino acids247-251, cation-π interactions between basic amino acids 









aromatic groups134, 135, 253 (Fig. 1.7b). Interactions between polar amino acids are generally 
considered to have only minimal direct effect on phase separation. Instead, polar amino acids 
often appear to occupy spacer regions that enhance solubility and determine flexibility of sticker 
motifs224, 244, 245 (Fig. 1.7a). Aliphatic amino acids are generally depleted in IDRs, yet proline 
constitutes a notable exception: Although proline-rich domains were reported to decrease the 
saturation concentration for LLPS in a few cases254-256, an important reason for the 
overrepresentation of proline might be its ability to suppress the formation of regularly 
structured elements together with the accompanying increase in the conformational flexibility 
of the peptide backbone257, 258.  
 
 
Figure 1.6 | Thermodynamic basis of liquid-liquid phase separation and emerging properties.  
a, Biological polymers such as proteins can undergo liquid-liquid phase separation in aqueous solutions if their 
concentration exceeds the solubility limit (csat), also sometimes referred to as the critical concentration. Above csat, 
the solution demixes into two liquid phases: A condensed polymer-rich phase co-exists with a dilute phase with 
the concentration csat. At a polymer concentration that is equal or higher to the concentration inside the droplets 
(cin), the system returns to the one-phase regime. b, Free energy as a function of the protein concentration. Above 
the saturation concentration (csat), polymer-polymer and solvent-solvent interactions are more favorable than 
polymer-solvent interactions and drive phase separation. Demixing happens when the sum of the free energy of 
both phases (head of blue arrow) is smaller than the free energy of the mixed phase (base of blue arrow). The 
figure was kindly provided by Dr. Johannes Soeding (MPI for Biophysical Chemistry, Göttingen) and adapted 
based on Soeding et al. (2019)236. c, Droplet fusion. Droplets formed by liquid-liquid phase separation have 
properties known from ideal liquids and coalesce upon contact. d, Condensed polymers in liquid-like droplets are 
in constant exchange with the surrounding solution. Photobleaching of material in the condensed phase using 









1.4.2 Regulation of phase separation 
The ability of cells to inducibly and rapidly alter the chemical properties of amino acids through 
post-translational modifications (PTMs) and thereby modulate interactions between IDRs has 
emerged as a key mechanism to regulate phase separation236, 259, 260. PTMs can affect phase 
separation in various ways through the modulation of sticker-sticker interactions. For example, 
direct post-translational modification of sticker motifs can prevent IDR-IDR interactions with 
other sticker motifs251, 261, 262. In other cases, PTMs can also create new sticker motifs resulting 
in novel interactions that promote phase separation247, 263, 264. Similarly, the ability of different 
sticker motifs to interact can be sterically influenced through post-translational modifications 
of spacer sequences265. Phosphorylation of serine, threonine, and tyrosine residues is the most 
common PTM in eukaryotes targeting about half of all human proteins266. Interestingly, most 
of the phosphorylation sites detected so far are localized in disordered regions267, 268. It comes 
thus with no surprise that phosphorylation has been implicated in the regulation of various 
biomolecular condensates, both positively and negatively240, 247, 265, 269-271 (for overview  
see236, 260 and references therein). Nevertheless, other PTMs such as methylation251, 261, 262, 272, 




Figure 1.7 | Molecular basis for liquid-phase separation of IDRs. 
a, Concept of the ‘stickers and spacers’ model244, 245. Stickers engage in intermolecular interactions with other 
stickers, while spacers are inert and form no such interactions. Formation of noncovalent intermolecular sticker-
sticker interactions gives rise to crosslinked network and promotes LLPS. In the context of IDRs, stickers 
correspond to single amino acids or short motifs, but note that the concept can be further extended to entire folded 
or disordered domains224, 244, 245. b, Molecular nature of sticker-sticker interactions between IDRs. Charge-charge, 
cation-π, or π-π interactions appear to be the prevalent driving force for LLPS. Note that LLPS of IDRs might not 
strictly depend on a single type of interaction but combinations thereof. Figure is adapted based on  









1.5 Aims and scope of this work 
1.5.1 RNA polymerase II clustering through CTD phase separation 
Eukaryotic gene transcription is highly regulated at the step of initiation, which involves the 
recruitment of the transcriptional machinery to the gene promoter107. Prior to transcription 
initiation, Pol II enzymes cluster in short-lived nuclear ‘hubs’ near active gene promoters208, 211. 
However, the molecular mechanisms that may underlie the dynamic formation and disassembly 
of Pol II clusters have remained enigmatic. Liquid-liquid phase separation, which is based on 
weak multivalent interactions between disordered protein domains, constitutes a fundamental 
mechanism to concentrate proteins inside cells225, 231, 235, 275. Pol II possesses a disordered  
C-terminal repeat domain that is essential for factor recruitment during the transcription  
cycle21, 22, 276. In the unphosphorylated form, the Pol II CTD assumes a compact, globular 
conformation13, 36-38, indicating intramolecular interactions between different CTD repeats. 
Given the existence of weak repeat-repeat interactions and the intrinsic flexibility of the CTD 
structure, the question arises whether CTD molecules might be able to engage in multivalent 
intermolecular interactions that could lead to liquid-liquid phase separation and whether such 
interactions might underlie Pol II clustering in vivo. Because the CTD becomes strongly 
phosphorylated throughout the transcription cycle, it is important to investigate how 
phosphorylation might affect these interactions. This work aimed to provide answers to these 
questions. First, homotypic CTD phase separation was successfully reconstituted in a simplified 
system in vitro. Results from these experiments demonstrated that the human CTD can undergo 
phase separation through weak multivalent intermolecular interactions. They allowed then to 
further probe the dependence of CTD length on LLPS by comparing the human with the half 
as long yeast CTD. The strong dependence of LLPS on CTD repeat number that became 
apparent from in vitro phase separation assays then served as the basis to investigate the effect 
of CTD length on Pol II clustering as well as its dynamics in live human cells. The subsequent 
microscopic analyses of different cell lines with varying CTD repeat number revealed that, 
similar to our in vitro results, CTD length also determines Pol II clustering and dynamics in 
human cells. Together the combined findings indicated that interactions of unphosphorylated 
CTDs underlie Pol II clustering near active gene promoters in living cells through a phase 
separation mechanism. Finally, the direct effect of initiation-coupled phosphorylation on phase 









The obtained results imply a model for gene activation that involves CTD-mediated clustering 
of initiation-competent Pol II and release through CTD phosphorylation upon transcription 
initiation.  
 
1.5.2 NELF condensation accompanies stress-induced transcriptional 
downregulation 
 
Promoter-proximal pausing of Pol II during early elongation constitutes a metazoan-specific 
regulatory checkpoint73, which plays a key role during genome-wide heat stress-induced 
transcriptional downregulation162, 163, 189. In human cells, the enhanced recruitment of the 
pausing factor NELF to downregulated gene promoters175 leads to the genome-wide 
stabilization of paused Pol II162, 175, 176. However, the underlying molecular basis of the 
increased residence time of NELF at chromatin upon stress is unclear. In Drosophila, heat 
stress-induced transcriptional activation of pro-survival genes results in the formation of  
a transcriptional compartment that facilitates local factor recycling and retardation185, 188. This 
work aimed to investigate whether an analogous phase separation mechanism could underlie 
the increased residence time of NELF at downregulated gene promoters, and to understand its 
heat stress-specific regulation. To attain this aim, it was first necessary to construct human cell 
lines with fluorescently labelled NELF and examine the nuclear redistribution upon heat shock. 
The results revealed that NELF clustered in numerous puncta upon heat shock that possessed 
properties consistent with phase-separated condensates. To enable further investigation of the 
underlying molecular mechanism, the four-subunit NELF complex was recombinantly 
produced to reconstitute phase separation using a simplified in vitro system. This allowed to 
identify the disordered tentacles as drivers of NELF self-association. The combination of in 
vivo and in vitro approaches then enabled the investigation of mechanisms that underlie the 
heat stress-specific regulation of NELF condensation. The experiments unveiled that heat 
stress-induced inactivation of the pause release factor P-TEFb counteracts phase separation 
through phosphorylation of disordered NELF regions. In addition, they revealed that stress-
induced sumoylation contributes to NELF condensation. Taken together, these results describe 
the molecular basis for stress-induced NELF condensation and suggest a mechanistic 
framework that controls stress-induced genome-wide transcriptional downregulation. 
 







2 Material and methods 
2.1 Materials 
2.1.1 E. coli strains 
Table 1 | E. coli strains used in the study. 
Strain Genotype Supplier 
   
XL1-blue 
recA1 endA1 gyrA96 thi-1 hsdR17 supE44 relA1 lac [F’ proAB lacIq 
Z∆M15 Tn10 (Tetr)] 
Agilent 
5-alpha 
fhuA2a(argF-lacZ)U169 phoA glnV44 a80a (lacZ) M15 gyrA96 recA1 




F– ompT hsdS (rB–mB–) dcm+ Tetr gal λ(DE3) endA Hte [argU ileY 
leuW Camr] 
Agilent 
BL21 Rosetta 2 
(DE3) pLysS 
F- ompT hsdSB(rB- mB-) gal dcm (DE3) pLysSRARE2 (CamR) Novagen 
DH10EMBacY 
F- mcrA Δ(mrr-hsdRMS-mcrBC) ϕ80dlacZΔM15 ΔlacX74 endA1 
recA1 deoR Δ(ara, leu)7697 araD139 galU galK λ- rpsL nupG / 
bMON14272‡ yfp+/ pMON7124 
Geneva Biotech 
 
2.1.2 S. cerevisiae strains 
Table 2 | S. cerevisiae strains used in the study. 
Strain Genotype Source 
   
BJ5464 
RPB3-His6-Bio 
BJ5464 MATa ura3-52 trp1 leu2-Δ1 his3-Δ200 pep4::HIS3 




2.1.3 Insect cell lines 
Table 3 | Insect cell lines used in the study. 
Cell line Species Source Supplier 
    
Sf9 Spodoptera frugiperda 
Immortalized ovarian cells (clonal 
derivative of Sf21 cell line) 
Thermo Fisher 
Scientific 

















2.1.4 Culture media 
Table 4 | Growth media for E. coli and yeast cell cultures. 
Medium Organism Composition Supplier 
    
LB E. coli 
1% (w/v) tryptone, 0.5% (w/v) yeast extract, 0.5% (w/v) NaCl 
(1.5% (w/v) agar for plates) 
homemade 
2xYT E. coli 1.6% (w/v) tryptone, 1% (w/v) yeast extract, 0.5% (w/v) NaCl homemade 
SOC E. coli 
2% (w/v) peptone, 0.5% (w/v) yeast Extract, 10 mM NaCl, 
2.5 mM KCl, 10 mM MgCl2, 10 mM MgSO4, 20 mM glucose 
NEB 
YPD S. cerevisiae 
2% (w/v) peptone, 2% (w/v) glucose, 1.5% (w/v) yeast extract 
(1.8% (w/v) agar for plates) 
homemade 
 
Table 5 | Media for insect cell culture. 
Medium Cell line Supplier 
   
Gibco® Sf-900 III SFM Spodoptera frugiperda Sf9/Sf21 Thermo Fisher Scientific 
ESF921 Trichoplusia ni Hi5 Expression Systems 
 
  
2.1.5 Antibiotics and additives 
Table 6 | Antibiotics and other additives. 
Substance Working concentration Stock concentration Solvent 
    
Ampicillin 100 µg/mL 100 mg/mL 100% EtOH 
Chloramphenicol 34 µg/mL 34 mg/mL 70% EtOH 
Gentamycin 10 µg/mL 10 mg/mL Ultrapure water 
IPTG 0.5 mM 1 M Ultrapure water 
Kanamycin 50 µg/mL 50 mg/mL Ultrapure water 
Tetracycline 10 µg/mL 10 mg/mL Ultrapure water 
X-gal 150 µg/mL 150 mg/mL DMSO 
 
 







2.1.6 Expression plasmids 
Table 7 | Bacterial expression plasmids used in the study. Detailed description of the constructs with the protein 
regions they contain for expression, the respective vector backbone and the cloning method used to generate them. 
The pET24d(+) plasmid was initially obtained from EMD Biosciences, the 1C vector was obtained from Addgene 
(#29654). 1-C* denotes a 1-C-derivative plasmid, in which the Asn10-linker was replaced by a SGGS-linker. All 
plasmids possess a kanamycin-resistance cassette. NA, not applicable. 










H. sapiens RPB1 
residues 1593-1970 






















H. sapiens RPB1 
residues 1593-1970, 
tyrosine replaced by 









H. sapiens RPB1 
residues 1593-1970, 
tyrosine replaced by 






































































Table 8 | Insect cell expression plasmids used in this study. Detailed description of the constructs with the 
protein regions and tags they contain for expression as well as the respective vector backbone. 




     
TFIIH kinase 
module  
H. sapiens CDK7 full-length 
H. sapiens CCNH full-length 




438-B Goran Kokic [278] 
NELF complex  
H. sapiens NELFA full-length 
H. sapiens NELFB full-length 
H. sapiens NELFD full-length 





438-B Seychelle Vos [76] 
NELF complex 
ΔA tentacle 
H. sapiens NELFA 1-188 
H. sapiens NELFB full-length 
H. sapiens NELFD full-length 





438-B Seychelle Vos [76] 
NELF complex 
ΔE tentacle 
H. sapiens NELFA full-length 
H. sapiens NELFB full-length 
H. sapiens NELFD full-length 





438-B Seychelle Vos [76] 
P-TEFb WT 
H. sapiens CDK9 1-372  
H. sapiens CCNT1 1-272 
His8-TEV- 
GST-TEV- 
pACEBac1 Matthias Geyer [76] 
P-TEFb  
kinase-dead 
H. sapiens CDK9 1-372 D149N 
H. sapiens CCNT1 1-272 
His8-TEV- 
GST-TEV- 
pACEBac1 Matthias Geyer [76] 
 
 
2.1.7 Common buffers and solutions 
Table 9 | Common buffers and solutions used in this study. 
Buffer Composition 
    
1x PBST 
10 mM Na2HPO4 pH 7.4, 1.76 mM KH2PO4 pH 7.4, 137 mM NaCl, 
2.7 mM KCl, 0.1% Tween-20 
1x TAE running buffer 250 mM Tris-acetate, 5 mM EDTA pH 8.0 at 20°C 
1x MES SDS running buffer 50 mM MES pH 7.3, 50 mM Tris base, 0.1% SDS, 1 mM EDTA 
1x MOPS SDS running buffer 50 mM MOPS pH 7.7, 50 mM Tris base, 0.1% SDS, 1 mM EDTA 
100x Protease inhibitor cocktail 
0.028 mg/mL leupeptin, 0.137 mg/mL pepstatin A, 17 mg/mL PMSF, 
33 mg/mL benzamidine in 100% EtOH 
 
 







2.1.8 Kits and consumables 
Table 10 | Kits and consumables used in this study. 
Kit Supplier 
  
Qiaprep Spin Miniprep kit, Plasmid Plus Midi kit, Plasmid Plus Maxi kit Qiagen 
MinElute DNA extraction kit Qiagen 
MinElute PCR purification kit Qiagen 
 
2.1.9 Antibodies 
Table 11 | Antibodies used in this study. 
Antibody Reactivity and description Host  Clonality Dilution Supplier 
      
Anti-Ser5P  
Ser5-phosphorylated  
Pol II CTD, clone 3E8  
Rat Monoclonal 1:60 Dirk Eick [39] 
Anti-MBP 
Maltose-binding protein,  
HRP-coupled 








H. sapiens NELFA  
C-terminus (499-549) 





H. sapiens NELFB 
C-terminus (550-580)  





H. sapiens NELFCD  
N-terminus (1-300) 
Mouse Monoclonal  1:500 
Santa Cruz  
(sc-393972) 
Anti-NELFE 
H. sapiens NELFE  
N-terminus (75-125) 





H. sapiens ZNF451 
N-terminus 





Rabbit IgG, HRP-coupled 
secondary antibody  
Donkey Polyclonal 1:5000 




Mouse IgG, HRP-coupled 
secondary antibody 





Rat IgG, HRP-coupled 
secondary antibody 
Goat Polyclonal 1:5000 












2.2.1 General techniques in molecular biology 
2.2.1.1 Quantitation of nucleic acids and proteins 
DNA and protein concentrations were determined spectrophotometrically using a NanoDrop 
device (Peqlab). Double-stranded DNA concentrations were calculated based on the 
assumption that an absorbance at 260 nm of 1 corresponds to a concentration of 50 µg/µL. 
Protein concentrations were determined according to the Lambert-Beer law based on the 
absorbance at 280 nm and the theoretical molar extinction coefficient calculated with the 
software tool Protean (DNAStar Lasergene Suite, version 12.0).  
 
2.2.1.2 Transformation of chemically competent E. coli cells 
Chemically competent E. coli cells were thawed on ice for 10 min. For each transformation, 
50 µL E. coli cell suspension were mixed with 1 µL plasmid DNA (50-100 ng) or up to 5 µL 
ligation/assembly mix (as indicated below) and incubated for 10-30 min on ice. The cells were 
then heated to 42 °C for 45 s, followed by a 2 min incubation on ice. Immediately afterwards 
450 µL pre-warmed SOC recovery medium were added and the cells were incubated for  
45-90 min at 37 °C. The recovered cells were then spread on LB agar plates containing 
appropriate antibiotics (see Table 6) and incubated overnight at 37 °C. 
 
2.2.1.3 Polymerase chain reaction (PCR) 
PCR reactions were performed using Phusion High-Fidelity (HF) 2x PCR master mix (NEB) 
using a T3000 thermocycler (Biometra) or a Lab Cycler Basic (SensoQuest). A typical PCR 
reaction contained 50-100 ng template DNA, both primers at a final concentration of 0.5 µM, 
3% DMSO, and 1x Phusion HF master mix in a total volume of 50 µL. Double-stranded 
template DNA was initially denatured at 98 °C for 30 s and then amplified in 25-30 consecutive 
cycles with three steps each: (1) Denaturation (98 °C, for 10-30 s) of the DNA double strand, 
(2) primer annealing to the single-stranded DNA (depending on the specific melting 
temperature of the primer-template hybrid or in a gradient setting with annealing temperatures 
varying between 50-65 °C, for 30 s), and (3) primer extension (72 °C, for 30 s per kb, 
 







depending on the product length). Afterwards, a final extension step was carried out (72 °C, 
10 min). For each PCR reaction, a negative control reaction without template DNA was 
conducted in parallel to exclude contamination of PCR components with active amplicons. 
Reactions were analyzed using agarose gel electrophoresis and PCR products with the correct 
size were recovered from the gel as described in Section 2.2.1.4. 
 
2.2.1.4 Agarose gel electrophoresis and preparative DNA isolation 
DNA fragments were analyzed using agarose gel electrophoresis. Agarose was dissolved at  
a concentration of 1% (w/v) by heating in 1xTAE buffer. The molten agarose solution was 
mixed with SYBR safe DNA stain (Invitrogen; 6 µL per 100 mL agarose solution) in an 
appropriately-sized casting tray and polymerized at room temperature. DNA samples, pre-
mixed with DNA loading dye (NEB), were separated along with a DNA ladder (GeneRuler 
1 kb Plus, Thermo Fisher Scientific) on the agarose gel at a suitable voltage (~10 V/cm gel) in 
1x TAE buffer. After a sufficient separation was achieved (usually after 30-45 min), DNA 
fragments were visualized using a Gel IX20 Imager System (Intas). In cases where isolation of 
PCR products was required for downstream applications, DNA fragments with the correct size 
were visualized under blue light with a Bio Transilluminator (BioStep) and excised from the 
gel using a scalpel. DNA was subsequently isolated from the gel using the MinElute gel 
extraction kit (Qiagen) according to the manufacturer’s instructions, and eluted in 10-12 µL 
ultrapure water.  
 
2.2.1.5 Restriction digestion 
Plasmid DNA was digested for restriction endonuclease-based cloning (see Section 2.2.1.6) or 
to produce a linearized template for polymerase chain reaction. For this, 1-5 µg plasmid DNA 
were digested with 50 units of the appropriate restriction endonuclease(s) (NEB) in an enzyme-
specific 1x digestion buffer in smallest possible volume for 2 h at 37 °C. If the plasmid DNA 
was used for restriction enzyme-based cloning, 5’-ends of respective vector fragments were 
dephosphorylated for 30 min at 37 °C by subsequent addition of 2 µL FastAP alkaline 
phosphatase (Thermo Fisher Scientific) directly to the digestion reaction. Plasmid digestion 
reactions, in which only a single restriction enzyme was used, were cleaned up using the 
 







MinElute PCR purification kit according to the manufacturer’s instructions. Double digest 
reactions were analyzed on an agarose gel and correctly-sized fragments were excised and 
purified as described in Section 2.2.1.4. 
 
2.2.1.6 DNA ligation 
Purified digested DNA fragments with complementary sticky ends were ligated using T4 DNA 
ligase. For a standard ligation reaction, 30 fmol vector and 60 fmol insert fragments were mixed 
in the smallest possible volume. Then, an equivalent volume of 2x ligase mix consisting of 
1/5 vol T4 DNA ligase stock solution (NEB), 1/5 vol 10x T4 DNA ligase buffer and  
3/5 ultrapure water was added to the DNA fragments. A background control without insert 
fragment was carried out in parallel to control for self-ligation of vector fragments. The ligation 
reaction was incubated for 30 min at 37 °C, before heat inactivation of T4 DNA ligase for 
10 min at 70 °C. Half of the ligation reaction was then used to transform chemically competent 
E. coli cells (see Section 2.2.1.2).  
 
2.2.1.7 Gibson assembly reaction 
Gibson assembly279 was used for seamless, restriction endonuclease-independent cloning of 
insert fragments into a vector backbone. Primers with an appropriate 5’-overhang were used to 
generate insert and vector fragments containing overlapping ends of 15-20 bp. The primers 
were designed using the NEBuilder Assembly Tool (NEB). For a typical Gibson assembly 
reaction, 0.1-0.5 pmol of each fragment (insert(s) and vector) were mixed with 2x Gibson 
assembly master mix (NEB) in a total volume of 10 µL and incubated for 15 min at 50 °C.  
As a background control, a reaction lacking Gibson assembly mix was conducted in parallel. 
Generally, 5 µL of the reaction mix were used for transformation of chemically competent 
E. coli 5-alpha cells. 
 
2.2.1.8 Site-directed mutagenesis 
PCR-based site-directed mutagenesis was used to introduce small insertions into a given vector 
sequence (insertion mutagenesis) or delete defined DNA sequences from a parental vector 
 







(deletion mutagenesis). If an appropriate restriction endonuclease site was available, the 
parental vector was first linearized and then amplified by PCR. In case of deletion mutagenesis, 
the primers were designed to hybridize on both sites of the sequence to be deleted, facing it 
with their 5’-ends. In case of insertion mutagenesis, the primers are designed to bind at the 
precise location where the insertion shall be introduced. Either one or both of the primers 
possesed an overhang at the 5’-end encoding the corresponding insertion. PCR amplification 
(see Section 2.2.1.3) then generated a linear product fragment carrying the corresponding 
modification. In order to allow for the re-circularization of the blunt-ended PCR product by  
T4 ligase, the 5’-ends of the fragments were phosphorylated using T4 polynucleotide kinase. 
Due to similar buffer requirements of both enzymes, phosphorylation and ligation was carried 
within the same reaction. For this, 200-500 ng of the purified PCR product were incubated with 
0.4 µL T4 polynucleotide kinase (NEB), 1 µL T4 ligase (NEB) in a total volume of 10 µL  
1x T4 ligase buffer (NEB) for 30 min at 37 °C. T4 ligase was subsequently inactivated through 
a 10 min incubation at 70 °C. As background control, a parallel reaction without T4 ligase was 
conducted. Due to the relatively small size difference between the unmodified template and the 
PCR product that carries the insertion or deletion, low amounts of template DNA are often  
co-excised upon isolation of the PCR product from the agarose gel and might cause a substantial 
background. For this reason, the ligation reaction was treated with the restriction endonuclease 
Dpn1, which cleaves specifically the E. coli methylated template DNA. For this, 8 µL of the 
ligation reaction were mixed with 1 µL 10x CutSMART buffer (NEB) and 1 µL Dpn1 (NEB) 
and incubated for 2 h at 37 °C.  After completion, 5 µL of the reaction mixture were directly 
transformed in chemically competent E. coli strains XL1-blue or 5-alpha. 
 
2.2.1.9 Plasmid DNA preparation and sequencing 
To identify positive clones from cloning reactions, 6-8 different non-overlapping colonies were 
selected and grown overnight in test tubes containing 8 mL LB medium and appropriate 
antibiotics. Preparation of plasmid DNA was generally performed using the Qiaprep Spin 
Miniprep kit (see Table 10) according to the manufacturer’s instructions. Plasmid sequences 
were verified by Sanger sequencing (Microsynth Seqlab, Göttingen). From plasmids that were 
frequently used in cloning reactions, larger quantities were prepared using the Qiagen Plasmid 
Plus Midi or Maxi kit respectively (see Table 10), according to the manufacturer’s instructions.  
 







2.2.1.10 Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) 
Protein samples were separated according to their molecular weight using SDS-PAGE280. For 
this, protein samples were mixed with 4x NuPAGE LDS sample buffer (Thermo Fisher 
Scientific) and boiled at 95 °C for 1-10 min. Samples were spun down and loaded on a precast 
NuPAGE 4-12% Bis-Tris protein gel (Invitrogen) together with 2 µL PageRuler Prestained 
protein ladder (Thermo Fisher Scientific). The protein samples were separated at a constant 
voltage of 160-200 V for 45-60 min using either 1x MOPS or 1x MES running buffer (Thermo 
Fisher Scientific). Protein bands were then stained using InstantBlue staining solution 
(Expedeon) or silver staining. For silver staining, the gel was incubated for 20 min in 50% 
EtOH, 20 min in 5% EtOH and soaked with 35 µM DTT for 5 min. The gel was then incubated 
for 10 min with silver nitrate solution (containing 1 mg/mL silver nitrate and 0.1 µL/mL 37% 
formaldehyde in H2O), stained with developing solution (30 mg/mL sodium carbonate and 
0.5 µL/mL 37% formaldehyde in H2O) to a desired intensity and quenched using solid citric 
acid monohydrate.  
 
2.2.2 Insect cell culture techniques 
2.2.2.1 Cloning of vectors for insect cell expression 
Single subunits of multisubunit protein complexes were cloned first individually into the 
pFastBac-derived-MacroBac 438 vector series281 using ligation-independent cloning. Open 
reading frames encoding single subunits were either cloned into the vector 438A (no tag), or 
in-frame into the vectors 438B (6xHis-TEV-tag) or 438C (6xHis-MBP-TEV-tag). For this, in 
either case, SspI-linearized vector and insert fragments (50-500 ng each) were treated with  
2 units T4 DNA polymerase in the presence of 2.5 mM dGTP or dCTP, respectively, and  
1x T4 DNA polymerase buffer containing 5 mM DTT for 40 min at 25 °C. Reactions were 
combined and incubated at room temperature for 30 min to allow for fragment annealing, 
followed by transformation in E. coli XL1-blue cells (see Table 1). Plasmid DNA was prepared 
using the Qiaprep Spin Miniprep kit and verified as described in 2.2.1.9. In order to combine 
single subunits from two different vectors, restriction digestion with Pme1 was used to excise 
the prospective subunit-encoding insert fragment. The second vector encoding a different 
complex subunit served as recipient and was concomitantly digested with Swa1. Vector and 
 







insert fragments were treated again for 40 min at 25 °C with 2 units T4 DNA polymerase in the 
presence of 2.5 mM dGTP or dCTP, respectively. Fragments were annealed for 30 min at room 
temperature and transformed in E. coli XL1-blue cells. The obtained two-subunit encoding 
plasmid might then serve as the recipient vector for the addition of another subunit-encoding 
insert following the same strategy. Successive rounds of this ligation-independent cloning 
strategy allowed the combination of all subunits of multi-subunit complexes in a single plasmid. 
Expression of each subunit is controlled by a separate PolH promoter and followed by a  
SV40 termination site. In addition, the outermost subunit-encoding open reading frames (ORFs) 
are flanked together with a gentamycin resistance cassette by Tn7 transposase target sites.  
 
2.2.2.2 Recombination in E. coli DH10αBacY and bacmid isolation 
About 0.5 µg plasmid DNA was transformed in E. coli DH10αBacY cells using a MicroPulser 
electroporator (BioRad), which was set to 25 µF and 1.8 kV. This E. coli strain carries a bacmid 
that encodes lacZ with an internal Tn7 transposase insertion site (attTn7) and YFP under control 
of a PolH promoter as well as a helper plasmid encoding the Tn7 transposase. This allows the 
transfer of the target gene cassettes and gentamycin resistance marker, which are both flanked 
by Tn7 target sites from the MacroBac 438 series into the bacmid vector, thereby disrupting the 
lacZ ORF. Immediately after transformation, LB medium was added and cells were recovered 
for 5-16 h at 37 °C and plated on LB agar plates containing X-gal, IPTG, and gentamycin. Cells 
from white colonies, which are indicative of successful transposition, were used to inoculate  
a 5 mL LB overnight culture containing gentamycin. Cells were then harvested by 
centrifugation, resuspended in 250 µL buffer P1 (50 mM Tris pH 8.0, 10 mM EDTA, 50 mM 
glucose, 0.1 mg/ml RNase A), and lysed by addition of 250 µL lysis buffer P2 (0.2 M NaOH, 
1% SDS). After the solution turned clear, 350 µL neutralization buffer P3 (4 M KOAc pH 5.5) 
were added and the lysate was cleared from cell debris twice by centrifugation (20,000g, 
10 min, room temperature). The supernatant was then removed and mixed with 700 µL 
isopropanol to precipitate DNA by incubation at -20 °C for several hours. After centrifugation 
(20,000 g, 30 min, 4 °C), the DNA pellet was washed with 500 µL 70% ethanol, covered with 
70% ethanol and stored at -20 °C until further use. 
 
 







2.2.2.3 Expression of recombinant proteins in insect cells 
Sf9 and Hi5 insect cell stocks were constantly maintained in culture, protected from light and 
at constant temperature (27 °C) and agitation (60 rpm). Cell density, diameter and viability 
were analyzed regularly using a CASY TT150 cell counter (Omni Life Science).  
Cell morphology was regularly monitored using light microscopy. Table 8 gives an overview 
of the combined vectors that were used in this study for insect cell expression. 
Sf9 insect cells grown in SF900-III SFM medium to a density of ~106 cells/mL were transfected 
with reconstituted bacmid DNA using X-tremeGENE9 transfection reagent. After 48 h 
incubation in the dark without agitation, cells were inspected under a fluorescence microscope 
for YFP expression, which is indicative of successful transfection and resulting virus 
production. If YFP expression was detected for at least 5 cells, the virus-containing supernatant 
V0 was collected 72 h after transfection. Subsequently, 0.15-3 mL V0 virus were used to infect 
25 mL insect cell culture grown to a density of ~106 cells/mL. Insect cells were grown until 
proliferation arrest and then incubated for additional 48-72 h. The V1 virus-containing 
supernatant was then separated from cells by mild centrifugation (320 g, 10 min, 4 °C) and 
either stored in the dark at 4 °C or used directly for infection of an expression culture.  
For protein expression, 0.2-2 mL V1 virus solution were used to infect 600 mL Hi5 cell culture 
that was grown in ESF921 medium to a density of 106 cells/mL. If low expression yield was 
expected, multiple expression cultures were prepared in parallel as required. Cells were 
incubated under standard conditions (27 °C, 60 rpm), and culture density, cell diameter, cell 
viability and YFP expression were monitored regularly in 24 h intervals. After the viability 
decreased to 80-90% (usually after 48-72 h), the cells were harvested by centrifugation (238 g, 
30 min, 4 °C), resuspended in an appropriate lysis buffer, flash-frozen in liquid nitrogen and 
stored at -80 °C until further use. 
 
2.2.2.4 Lysis and preparation of cleared insect cell extract 
Insect cell suspension from the expression culture was thawed and lysed by sonication. For this, 
the cell suspension was transferred to a metal beaker and sonicated on ice with a Branson 250 
Digital Sonifier (Marshall Scientific) at 30% power for 2 min, with ON and OFF times of 0.6 s 
and 0.4 s respectively. The obtained lysate was then first cleared from cell debris  
 







by centrifugation at 26,195 g for 30 min at 4 °C, followed by ultracentrifugation at 158,420 g 
for 1 h at 4 °C. The clarified lysate was passed through a syringe filter with 0.8 µm pore size, 
before target proteins were further purified using an ÄKTA Pure chromatography system (GE 
healthcare). 
 
2.2.3 E. coli cell culture techniques 
2.2.3.1 Expression of recombinant proteins in E. coli  
All bacterial expression constructs were expressed in E. coli BL21 CodonPlus (DE3)-RIL cells. 
The cells carry additional copies of the argU, ileY and LeuW tRNA genes on  
a chloramphenicol-resistant plasmid to facilitate a more efficient translation of heterologous 
proteins, and are thus always cultured in the presence of chloramphenicol. Table 7 gives an 
overview of the vectors that were used in this study for recombinant protein expression  
in E. coli. 
Chemically competent E. coli cells were transformed with the respective expression plasmid 
(see Section 2.2.1.2, Table 7). The recovered culture was unevenly spread on LB agar 
containing appropriate antibiotics and incubated overnight at 37 °C. A single E. coli colony was 
then used to inoculate a 400 mL LB-preculture containing antibiotics, which was incubated 
overnight at 37 °C and shaking at 110 rpm. On the next day, 2 L LB medium containing 
appropriate antibiotics were inoculated with 60 mL preculture and shaken in a baffled 5 L flask 
at 37 °C and 110 rpm until an OD600 of ~0.8 was reached. The volume of the expression culture 
was scaled up as required, based on the expected expression level (see Table 12). Expression 
temperature and duration varied also for different constructs and are summarized in Table 12. 
Protein expression was induced at the respective expression temperature with 0.5 mM IPTG 
and further incubated with agitation (110 rpm). Cells were then harvested by centrifugation 
(15 min, 7000 rpm, 4 °C) and cell pellets were resuspended in the respective lysis containing 
protease inhibitors buffer (see Section 2.3, Table 9). The E. coli cell suspension was flash-
frozen in liquid nitrogen and stored at -80 °C. 
 
 







Table 12 | Conditions for overexpression of recombinant proteins in E. coli.  Overexpression temperature and 
duration as well as culture volume for all purified proteins. For more information on the expression construct refer 
to Table 7. 
Construct Temperature Duration Volume E. coli strain  
     
MBP-hCTD WT/YF/YL 37°C  3-4 h 6x 2 L BL21-CodonPlus (DE3) RIL 
MBP-yCTD 37°C 4 h 6x 2 L BL21-CodonPlus (DE3) RIL 
MBP 37°C 4 h 2 L BL21-CodonPlus (DE3) RIL 
GST-yCTD 18°C 16 h 6x 2 L Rosetta 2 (DE3) pLysS 
GST 18°C 3 h 2 L Rosetta 2 (DE3) pLysS 
GFP-NELFA tentacle 22°C 3.5 h 6x2 L BL21-CodonPlus (DE3) RIL 
GFP-NELFE tentacle 22°C 3.5 h 6x2 L BL21-CodonPlus (DE3) RIL 
NELFE tentacle-GFP-
NELFA tentacle 
22°C 4 h 6x2 L BL21-CodonPlus (DE3) RIL 
SUMO2 18 °C 6 h 3x2 L BL21-CodonPlus (DE3) RIL 
      
 
2.2.3.2 Lysis and preparation of cleared E. coli extract  
Frozen E. coli cell suspension was thawed and lysed by sonication using a Branson 250 Digital 
Sonifier. Sonication was conducted in metal beakers placed in an ice-water bath. Cells were 
lysed with alternating pulses of 10 s at an amplitude of 60% followed by an OFF period of 50 s, 
for a total ON time for 2.30 min. The cell lysate was then centrifuged for 1 h at 27.000 g and 
4 °C. The cleared cell lysate was recovered and filtered through 0.8 µm syringe filters prior to 














2.3 Project-specific techniques 




This section describes project-related methods and techniques that were specifically developed 
and applied in this study. Several protocols presented in this section have been published: 
  
RNA polymerase II clustering through carboxy-terminal domain phase separation 
M. Boehning*, C. Dugast-Darzacq*, M. Rankovic*, A. S. Hansen, T. Yu, H. Marie-Nelly,  
D. T. McSwiggen, G. Kokic, G. M. Dailey, P. Cramer, X. Darzacq, M. Zweckstetter 
Nature Structural and Molecular Biology 25, 833–840 (2018) 
 
 
A detailed list of published items can be found in the Appendix (‘List of items from 
publications’, Page 149). Published methods presented within this section are marked with an 
asterisk (*). Contributions from co-authors of the publication are stated below the caption and 
can be found on Page VI. In some cases the caption deviates from the publication and different 




2.3.1.1 Purification of MBP-tagged human and yeast CTD and MBP 
6xHis-MBP-hCTD, 6xHis-MBP-yCTD or 6xHis-MBP were overexpressed in E. coli BL21-
CodonPlus (DE3) RIL cells, harvested and resuspended in lysis buffer (LB) 300 (20 mM Na-
HEPES, pH 7.4, 300 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL 
leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) as described 
in Section 2.2.3. The cleared and filtered E. coli lysate was applied to a 5 mL HisTrap HP 
column (GE healthcare) that was equilibrated in LB300. The HisTrap column was washed 
extensively with 20 CV of high-salt buffer HSB1000 (20 mM Na-HEPES, pH 7.4, 1 M NaCl, 
 







30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). Afterwards the column was equilibrated again 
in LB300 and then attached inline to a XK-16 column (GE healthcare) that was filled with 
~20 mL amylose beads (NEB) and pre-equilibrated in LB300. The HisTrap column was then 
developed with nickel elution buffer 300 (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 500 mM 
imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) to elute bound proteins directly onto the 
amylose column. The HisTrap column was subsequently removed and the amylose column was 
washed again with 4-5 CV of HSB1000 buffer. The column was then equilibrated in LB300 
and MBP-tagged proteins were eluted with amylose elution buffer (20 mM Na-HEPES, pH 7.4, 
300 mM NaCl, 10% glycerol, 1 mM DTT, 117 mM maltose, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). All elution factions 
were pooled and concentrated using a 30 kDa MWCO Amicon Ultra centrifugal filter (Merck). 
The protein solution was then applied to a Superdex 200 10/300 Increase column (GE 
healthcare) that was equilibrated in SE300 buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 
10% glycerol, 1 mM TCEP). The purity of the elution fractions was assessed using SDS-PAGE 
and Coomassie staining (as described in 2.2.1.10). Fractions containing pure protein were 
pooled and concentrated using a 30 kDa MWCO Amicon Ultra concentrator. Protein 
concentrations were determined based on the predicted molar extinction coefficient (section 
2.2.1.1). Concentrated protein solutions (>100 µM) were divided in small aliquots (5-10 µL), 
frozen in liquid N2 and stored at -80°C until further use.  
 
2.3.1.2 Purification of GST-tagged yeast CTD and GST  
Purification of 6xHis-GST-yCTD was conducted using a similar strategy as described 
previously282 with minor modifications. The protein was overexpressed in E. coli BL21 Rosetta 
2(DE3)pLysS cells as described in Section 2.2.3.2 and Table 12. Afterwards the cells were 
collected by centrifugation, resuspended in lysis buffer (LB) 150 (20 mM Na-HEPES, pH 7.4, 
150 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) and lysed by 
sonication (Section 2.2.3.2). The cleared and filtered E. coli extract was loaded onto a 5 mL 
HisTrap HP column that was pre-equilibrated with LB150. The HisTrap column was then 
 







washed extensively with high salt buffer (HSB) 800 (20 mM Na-HEPES, pH 7.4, 800 mM 
NaCl, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL 
PMSF, 0.33 mg/mL benzamidine). The column was equilibrated again with LB150 and 
connected inline to a pre-equilibrated 5 mL HiTrap Q HP column (GE healthcare). The HisTrap 
column was then developed over a 18 CV-linear gradient ranging from 0-100% nickel elution 
buffer (20 mM HEPES, pH 7.4, 150 mM NaCl, 500 mM imidazole, 10% glycerol, 1 mM DTT, 
0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL 
benzamidine) and flow-through fractions were collected. Flow-through fractions were analyzed 
using SDS-PAGE and Coomassie staining and pooled accordingly. The sodium chloride 
concentration of the pooled protein solution was adjusted to 50 mM through dilution in no-salt 
buffer (20 mM Na-HEPES, pH 7.4, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) and concentrated using 
a 30 kDa Amicon Ultra spin filter. The concentrated protein solution was then applied to a 1 mL 
HiTrap S column (GE healthcare) pre-equilibrated in LB50 (20 mM Na-HEPES, pH 7.4, 
50 mM NaCl, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). The flow-through fractions were analyzed by 
SDS-PAGE and Coomassie staining, pooled accordingly and concentrated using a  
30-kDa MWCO Amicon Ultra spin concentrator. The protein was then subjected to size-
exclusion chromatography using a Superdex 200 Increase 10/300 column (GE healthcare) 
equilibrated in SE300 buffer. Peak fractions were analyzed using SDS-PAGE and Coomassie 
staining and appropriate fractions were pooled and concentrated using a 30 kDa MWCO 
Amicon centrifugal filter. Clarified and 0.8 µm-filtered E. coli extract from overexpression of 
6xHis-GST-TEV was loaded on a 5 mL HisTrap HP column. The column was washed with 
HSB800, and then developed with a linear gradient of 0-100% nickel elution buffer 150. The 
eluate was concentrated using a 10 kDa MWCO Amicon concentrator and then applied to a 
Superdex 200 Increase 10/300 column as described above. Purified proteins were concentrated, 











2.3.1.3 Purification of TFIIH kinase modules (*) 
Purified yeast TFIIH kinase module was a kind gift of Dr. Sandra Schilbach (Department of 
Molecular Biology, MPI for Biophysical Chemistry). Purification of the human TFIIH kinase 
module was conducted by Dr. Goran Kokic (Department of Molecular Biology, MPI for 
Biophysical Chemistry).         
The recombinant S. cerevisiae TFIIH kinase module consisting, of the subunits Kin28, Ccl1, 
and Tfb3, was prepared as described37. For purification of the three-subunit human TFIIH 
kinase module (CDK7, cyclin H, and Mat1), insect cells were lysed by sonication in lysis buffer 
(20 mM K-HEPES, pH 7.0, 400 mM KCl, 10% glycerol, 1 mM MgCl2, 10 μM ZnCl2, 5 mM  
β-mercaptoethanol, 30 mM imidazole, pH 8, 0.284 μg/mL leupeptin, 1.37 μg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). Clarified cell lysate was applied onto a HisTrap 
HP 5-mL column (GE Healthcare), washed with 20 CV of lysis buffer, and eluted with a linear 
gradient of 0–100% of elution buffer (20 mM K-HEPES, pH 7, 400 mM KCl, 10% glycerol, 
1 mM MgCl2, 10 μM ZnCl2, 5 mM β-mercaptoethanol, 500 mM imidazole, pH 8, 0.284 μg/mL 
leupeptin, 1.37 μg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) in 10 CV. 
Peak fractions were combined, supplemented with 2 mg of 6xHis-tagged TEV protease, and 
dialyzed overnight against 2 L dialysis buffer (20 mM K-HEPES, pH 7, 400 mM KCl, 10% 
glycerol, 1 mM MgCl2, 10 μM ZnCl2, 5 mM β-mercaptoethanol). The dialyzed solution was 
applied to a HisTrap HP 5-mL column pre-equilibrated in dialysis buffer. The trimeric complex 
was eluted with 10% elution buffer and concentrated using an Amicon Ultra 15-mL, 30-kDa 
MWCO centrifugal concentrator. The sample was applied to a Superdex 200 10/300 GL size 
exclusion column (GE Healthcare) pre-equilibrated in storage buffer (20 mM K-HEPES, pH 7, 
350 mM KCl, 10% glycerol, 1 mM MgCl2, 10 μM ZnCl2, 5 mM β-mercaptoethanol). Peak 
fractions containing stoichiometric kinase trimer were pooled, concentrated using an Amicon 
Ultra 15-mL, 30-kDa MWCO centrifugal concentrator to 130 μM, aliquoted, flash-frozen in 











2.3.1.4 Pol II preparation and fluorescent labeling (*) 
Pol II was prepared from the S. cerevisiae strain BJ5464 as described283 and treated with lambda 
phosphatase during purification. The Pol II subunit RPB3 contains an N-terminal biotin 
acceptor peptide, which can be biotinylated in vitro by the bacterial biotin-protein ligase BirA 
and used for site-specific labeling with fluorescent streptavidin conjugates. For this, 200 µg 
Pol II were incubated with 6 µg BirA, 100 µM D(+)-biotin and 2 mM ATP for 2 h at 20 °C in 
Pol II buffer (10 mM HEPES, pH 7.2, 200 mM KCl, 5% glycerol, 2 mM DTT). Excess biotin 
was removed using a Micro Bio-Spin 6 column (Biorad) according to the manufacturer’s 
suggestions. A small fraction of biotinylated Pol II was bound to streptavidin-coupled 
Dynabeads M-280 (Thermo Fisher Scientific) to confirm quantitative biotinylation. The 
remaining biotinylated Pol II was reacted with Alexa Fluor 594-coupled streptavidin (Thermo 
Fisher Scientific, ~2× molar excess) for 20 min at 20 °C. Pol II was then separated from 
unbound streptavidin by size-exclusion chromatography using a Superose 6 10/300 column (GE 
Healthcare) equilibrated in Pol II buffer. Pol II-containing fractions were pooled and 
concentrated (100-kDa MWCO Amicon Ultra spin filter unit), and flash-frozen aliquots were 
stored in the dark at –80 °C. 
 
2.3.1.5 CTD phosphorylation (*) 
GST-yCTD was phosphorylated using the recombinant S. cerevisiae TFIIH kinase module. For 
this, 50 µM GST-yCTD were incubated with 0.4 µM kinase module and 3 mM ATP for 1 h at 
30 °C in kinase reaction buffer (20 mM HEPES, pH 7.4, 200 mM NaCl, 5 mM MgCl2, 10% 
glycerol, 1 mM TCEP). Upon completion, the phosphorylation reaction was quenched by 
addition of EDTA to a final concentration of 10 mM. Phosphorylation of MBP-hCTD was 
performed using the recombinant human TFIIH kinase module. For this, MBP-hCTD (100 µM) 
was incubated with 2 µM kinase module in reaction buffer (20 mM HEPES, pH 7.4, 260 mM 
NaCl, 20 mM MgCl2, 20 µM ZnCl2, 10% glycerol, 2 mM TCEP). The reaction was started by 
addition of 8 mM ATP, incubated for 1 h at 30 °C, and quenched by addition of 40 mM EDTA. 
Control reactions lacking either the kinase or ATP were conducted in both cases under identical 
conditions. After completion of GST-yCTD and MBP-hCTD phosphorylation experiments, all 
reactions were mixed with 20% dextran (in buffer containing 20 mM HEPES, pH 7.4, 200 mM 
NaCl) at a ratio of 1:4 (v/v) and then analyzed microscopically (as described below). To study 
 







phosphorylation-induced dissolution of preformed CTD droplets, MBP-hCTD was mixed at a 
final concentration of 20 µM into 16% dextran containing 20 mM HEPES, pH 7.4, 220 mM 
NaCl, 1.6 mM ATP, 4 mM MgCl2, 20 µM ZnCl2, and 1 mM TCEP to induce phase separation. 
Immediately before imaging, the reaction was started by addition of human TFIIH kinase 
module to a final concentration of 0.4 µM and immediately analyzed by microscopy. 
 
2.3.1.6 Kinase activity assay (*) 
Kinase activity was analyzed by mobility shift assays. One microgram of CTD fusion protein 
from kinase and control reactions was separated on 4–15% Tris-glycine Protean TGX 
polyacrylamide gels (Biorad) and stained with Coomassie solution (InstantBlue, Expedeon). 
Phosphorylation of the CTD substrates by human and yeast TFIIH kinase modules results in a 
pronounced decrease of electrophoretic mobility. Phosphorylation of the CTD residue Ser5 was 
confirmed by immunoblotting. For this, samples (100 ng/lane) were separated on 4–15% Tris-
glycine Protean TGX gels and blotted onto a PVDF membrane with a Trans-Blot Turbo 
Transfer System (Bio-Rad). The membrane was blocked for 1–2 h at room temperature  
(20–24 °C) with 5% (w/v) milk powder in phosphate-buffered saline containing 0.1% Tween-
20 (PBST). The blocked membrane was then incubated with either anti-MBP HRP conjugate 
(ab49923; Abcam) or anti-GST HRP conjugate (RPN1236; GE Healthcare) for 2 h at room 
temperature. SuperSignal West Pico Chemiluminescent Substrate (Thermo Fisher) was used to 
develop the membrane before scanning with a ChemoCam Advanced Fluorescence imaging 
system (Intas Science Imaging). For immunoblot analysis of CTD phosphorylation, the 
membrane was subsequently stripped by incubation in stripping buffer (200 mM glycine-HCl, 
pH 2.2, 0.1% SDS, 1% Tween-20), blocked with 5% (w/v) milk powder in PBST, and probed 
overnight at 4 °C with primary CTD antibody against phosphorylated Ser5 (3E8; diluted 1:60 
in 2.5% (w/v) milk powder in PBST). The anti-Ser5 CTD antibody was a kind gift of D. Eick 
(Molecular Epigenetics Research Unit, Helmholtz Center, Munich). The membrane was then 
incubated with an anti-rat HRP-conjugate (A9037, Sigma-Aldrich) in 2.5% milk-PBST for 1 h 
at room temperature and developed as describe above. 
 
 







2.3.1.7 Disorder prediction (*) 
Recent cryo-EM analysis of mammalian RNA polymerase II could derive an atomic model only 
to RPB1 position P1487284, indicating a high conformational flexibility of the following RPB1-
linker and the C-terminal repeat domain. We thus used the VLXT predictor implemented in 
PONDR285 to calculate the disorder propensity for the human RPB1 residues 1,488–1,970. 
 
2.3.1.8  Differential interference contrast (DIC) and fluorescence microscopy (*) 
These experiments were conducted by Dr. Marija Rankovic (Dept. of Translational Structural 
Biology in Dementia, DZNE).           
Droplet formation of protein samples was monitored by DIC and fluorescence microscopy. 
Samples were fluorescently labeled using Alexa Fluor 488 Microscale Protein Labeling Kit 
(Thermo Fisher Scientific, #A30006) according to the manufacturer’s instructions. Small 
amounts (< 0.5 µM) of labeled protein, which are not sufficient to induce droplet formation by 
itself, were mixed with unlabeled protein to the final concentration indicated in the text.  
In experiments with Ficoll PM 400 (Sigma, #F4375) at a final concentration of 150 mg/mL 
(buffer containing 20 mM HEPES, pH 7.4, 200 mM NaCl) was used. In experiments using 
dextran T500 (Pharmacosmos) as a crowding agent, dextran was added to reach the indicated 
final concentrations in 20 mM HEPES, pH 7.4, 220 mM NaCl. In all experiments, reducing 
conditions were maintained during droplet formation through the presence of TCEP, generally 
at a final concentration of 0.2 mM. Five to 10 µL of samples were loaded onto glass slides, 
covered with ø18 mm coverslips, and sealed. DIC and fluorescent images were acquired on a 
Leica DM6000B microscope with a 63× objective (water immersion) and processed using Fiji 
software (NIH). In experiments requiring MBP-tag removal, fusion proteins were incubated 
with TEV protease in molar ratio TEV:protein = 1:25 for 3 h at 25 °C. Complete tag removal 
was confirmed by SDS-PAGE analysis and Coomassie staining of the digested samples. 
In experiments with aliphatic alcohols, the MBP-tag was cleaved off from MBP-yCTD and 
MBP-hCTD as indicated above, followed by addition of the protein to a premix containing 
dextran (final concentration 16%) and either 1,6-hexanediol (Sigma, #240117) or  
2,5-hexanediol (Sigma, #H11904). The final protein concentration in the sample was 50 µM  
 







for yCTD and 20 µM for hCTD, and hexanediol concentrations varied from 2.5 to 10%. 
Samples were imaged by DIC microscopy as indicated above. 
All experiments with droplet formation were performed at room temperature except when the 
influence of temperature was tested. In the latter case, MBP-hCTD or MBP-yCTD was mixed 
with small amounts (<0.2 µM) of the corresponding Alexa Fluor 488-labeled protein, from 
which the MBP-tag was cleaved off using TEV protease as described above. Final protein 
concentrations in the samples were 20 µM for MBP-hCTD and 40 µM for MBP-yCTD in 
20 mM HEPES, pH 7.4, 220 mM NaCl, 0.2 mM TCEP with 16% dextran. Samples were then 
incubated for 1 h on ice (4 °C), at room temperature (22 °C), or in an incubator at 37 °C or 45 °C 
before microscopy analysis. Labeled (without MBP tag) and unlabeled (MBP-tagged) proteins 
were also mixed in experiments testing the influence of ionic strength. Final protein 
concentrations were 10 µM for MBP-hCTD and 40 µM for MBP-yCTD, and samples contained 
indicated NaCl concentrations in 20 mM HEPES, pH 7.4, 0.2 mM TCEP and 16% dextran. 
 
2.3.1.9 Pol II co-recruitment experiments (*) 
These experiments were conducted by Dr. Marija Rankovic (Dept. of Translational Structural 
Biology in Dementia, DZNE).                 
For Pol II co-recruitment experiments, Alexa Fluor 594-labeled Pol II (final concentration 
0.02 µM) was mixed with preformed GST-yCTD droplets (final concentration 25 µM) that were 
visualized by addition of Fluor Alexa 488-labeled GST-yCTD (final concentration 2.3 µM) in 
20 mM HEPES, pH 7.4, 220 mM NaCl, 0.2 mM TCEP containing 16% dextran. Co-recruitment 
was documented by DIC and fluorescent microscopy using red and green channels (GFP and 
N3 filter cubes) on a Leica DM6000B microscope as described. 
 
2.3.1.10 In vitro FRAP experiments (*) 
These experiments were performed by Dr. Marija Rankovic (Dept. of translational structural 
biology in dementia, DZNE).                 
The dynamics of human and yeast CTD molecules in the phase-separated state were 
investigated by fluorescence recovery after photobleaching (FRAP). MBP-tagged human and 
 







yeast CTD proteins were labeled on a single Cys residue that is present C-terminal to the TEV 
protease cleavage site (see above) using Alexa Fluor 488 C5 maleimide dye (Thermo Fisher 
Scientific, #A10254) according to the manufacturer’s recommendations. Briefly, proteins were 
incubated in a light-protected Eppendorf tube with the dye freshly dissolved in DMSO in  
a molar ratio of 1:15 = protein:dye in 20 mM HEPES, pH 7.4, 300 mM NaCl, 1 mM TCEP, 
10% glycerol for 3 h at room temperature. Excess label and salt were removed by desalting 
samples twice with 0.5-mL 7000 MWKO Zeba spin desalting columns (Thermo Fisher 
Scientific, #89882). The MBP-tag was then cleaved from labeled and unlabeled human and 
yeast CTD using TEV protease as indicated above. Droplets for FRAP measurements were 
made in 16% dextran T500 in 20 mM HEPES, pH 7.4, 220 mM NaCl, 0.2 mM TCEP by adding 
mixtures of labeled and unlabeled yCTD (or hCTD) in a molar ratio of 1:100 to the final CTD 
concentration of 20 µM. To minimize droplet movement, FRAP recordings were done after 
approximately 30 min, which is the time required for freshly formed droplets to settle down on 
the glass slide and become less mobile. 
FRAP experiments were recorded on a Leica TCS SP8 confocal microscope using  
a 63× objective (water immersion) at a zoom corresponding to a pixel size of 96 nm × 96 nm 
and using the 488-nm argon laser line. A circular region of ~1.4 µm in diameter was chosen in 
a region of homogenous fluorescence away from the droplet boundary and bleached with  
10 iterations of full laser power. Recovery was imaged at low laser intensity (0.057%). Fifty 
frames were recorded, with 1 frame per 330 ms. Pictures were analyzed in Fiji (NIH), and FRAP 
recovery curves were calculated using standard methods. For calculating half time recoveries, 
normalized values from each recording were separately fit to a single exponential model, and 
half time recoveries were presented as mean ± standard error. 
 
2.3.1.11 Analysis of human CTD Y1 mutants 
To investigate the influence of tyrosine substitution on CTD phase separation, MBP-hCTD WT, 
the Y1→F1- and Y1→L1-variants were labelled on a single cysteine residue with Alexa Fluor 
647 C2 maleimide (Thermo Fisher Scientific). For this, MBP-hCTD was incubated in a light 
protected tube on ice at a final concentration of 25 µM for 4-5 h with 10x excess dye in buffer 
containing 20 mM Na-HEPES, 300 mM NaCl, 10% glycerol and 5 mM TCEP. Excess dye was 
 







removed in a first step using either PD10 desalting columns (GE healthcare) or Micro Bio-Spin 
P6 gel columns (Biorad) that were equilibrated in SE300 buffer (20 mM Na-HEPES, pH 7.4, 
300 mM NaCl, 10% glycerol, 1 mM DTT) and then through at least five diafiltration steps using 
an 0.5 mL 30 kDa MWCO Amicon concentrator. 
Differential interference contrast and fluorescence microscopy was used to examine droplet 
formation. For this, Alexa Fluor 647-labelled and unlabelled proteins were combined at a molar 
ratio of 1:10 and then mixed with dextran T500 to reach a final concentration of 20 µM in 
20 mM Na-HEPES, pH 7.4, 220 mM NaCl, 2% glycerol, 1 mM TCEP, 16% dextran. 5 µL 
microliters of the resulting solution were trapped between a passivated glass slide and  
a coverslip, which was subsequently sealed. Samples were imaged using a Leica DM6000B 
microscope equipped with a 63x water-immersion objective and a 60R filter cube 
(wavelength/bandwidth: 600/37 nm (excitation), 675/67 nm (emission)). FRAP experiments 
were performed using a Leica SP8 confocal microscope. Imaging was performed in passivated 
50-well CultureWell chambered coverslides (Grace Bio-Labs) (see Section 2.3.2.3). Phase 
separation was induced as described above and 3 µL of the solution were transferred to the 
coverslide. The plate was then sealed using transparent tape (Scotch) and incubated at RT for 
2 h prior to imaging to allow the droplets to settle on the coverslip surface. FRAP movies were 
recorded at a resolution of 256x256 pixels with a pixel size of 96 nm x 96 nm and a scan speed 
of 1400 Hz. Bidirectional scanning was used with a phase X offset of -30.01. The 633 nm 
helium neon laser line was used at full intensity to photobleach a circular spot of 1 µm in the 
center of 6.5-8 µm-sized droplets. Recovery of fluorescence was recorded every 300 ms for  
200 frames at low laser intensity (0.3 %). Fluorescence recovery of the bleached spot was 
analyzed using FIJI (version 1.52h), background subtracted, corrected for acquisition bleaching 
using an unbleached reference droplet and normalized to the mean pre-bleach intensity.  












2.3.1.12  Cell line establishment and characterization (*) 
These experiments were conducted by Dr. Claire Dugast-Darzacq together with Dr. David T. 
McSwiggen (UC Berkeley, Dept. of Molecular and Cell Biology).       
Human U2OS osteosarcoma cells (Research Resource Identifier (RRID): CVCL_0042) were 
used in this study. The parental U2OS cell line was authenticated by the UC Berkeley cell 
culture facility on 05/05/2017 by STR analysis. The result was a 100% match with the U2OS 
cell line reference. The parental U2OS cell line was tested for mycoplasma contamination 
before establishing the RPB1 cell lines and thereafter regularly (approximately every 6 months) 
checked to confirm mycoplasma-negativity. Cells were grown in a Sanyo copper-alloy IncuSafe 
humidified incubator (MCO-18AIC(UV)) at 37 °C/5.5% CO2 in low-glucose DMEM with 10% 
FBS (full recipe: 500 mL DMEM (ThermoFisher #10567014), 50 mL FBS (HyClone FBS 
SH30910.03 lot #AXJ47554), and 5 mL penicillin–streptomycin (ThermoFisher #15140122)) 
and were passaged every 2–4 d before reaching confluency. Plasmids expressing N-terminally 
tagged (either Dendra2 or Halo) α-amanitin-resistant mutated (N792D) human RPB1 were 
stably transfected into U2OS cells using Fugene 6 following the manufacturer’s instruction 
(Promega #E2692). The RPB1-52R vectors encode the 52 CTD repeats originally present in 
the endogenous RPB1 cDNA. The RPB1-25R expressing vectors contain only 25 repeats of the 
original 52, corresponding to repeats 1 to 21 and repeats 49 to 52. The RPB1-70R cell lines 
express either a Dendra2-RPB1 protein containing 66 repeats in its CTD (repeats 1 to 51, then 
repeats 38 to 52) or a Halo-RPB1 protein containing 70 repeats in its CTD (repeats 1 to 47, then 
repeats 42 to 47, then repeats 38 to 52), as assessed by sequencing of the RPB1 mRNA 
expressed in these cells. Details of cloning strategies are available upon request. α-Amanitin 
(SIGMA #A2263) was used during the stable selection process at a concentration of 2 μg/mL 
and was used thereafter in permanence in the culture of the cells at a concentration of 1 μg/mL 
to avoid endogenous RPB1 re-expression as described in ref.208. Even though these lines cannot 
genotypically be considered as endogenously tagged (the endogenous wild-type RPB1 gene is 
still present; a cDNA expressing the tagged version of RPB1 is incorporated in the genome), 
phenotypically they can, as the expression of endogenous RPB1 protein is replaced by the 
tagged version of the protein at all time. RT-PCR analysis (Superscript III with oligo (dT)20, 
Invitrogen (#18080093), and NEB Phusion High-Fidelity DNA Polymerase (#M0530S) 
followed by sequencing was performed to confirm the sequence of the RPB1-CTD expressed 
in the various cell lines. 
 







Western blot (*). Cells were collected after ice-cold PBS wash by scraping into 0.5 mL/10 cm 
plate of high-salt lysis buffer (0.5 M NaCl, 50 mM HEPES, 5 mM EDTA, 0.5% NP-40, and 
protease inhibitors), with 125 U/mL of benzonase (Novagen, EMD Millipore), passed through 
a 25-gauge needle, rocked at 4 °C for 30 min, and centrifuged at maximum speed at 4 °C for 
20 min. Supernatants were quantified by the Bradford method. The same amount of proteins 
was loaded onto 7% Bis-Tris SDS-PAGE gel, transferred onto nitrocellulose membrane 
(Amershan Protran 0.45-µm NC, GE Healthcare) for 2 h at 80 V, blocked in TBS-Tween with 
5% milk for at least 1 h at room temperature, and blotted overnight at 4 °C with primary 
antibodies (anti-Pol II (N20) from SantaCruz, #sc-899; anti-Lamin A from Abcam, #ab26300) 
in TBS-T with 5% milk. HRP-conjugated secondary antibodies were diluted 1:5,000 in TBS-T 
with 5% milk and incubated at room temperature for 1 h. 
FACS analysis (*). Expression of the exogenous RPB1 protein was assessed by flow cytometry 
analysis on live cells on a BD LSR Fortessa, performed according to the manufacturer’s 
protocols. For the Halo-tagged line, Halo-TMR labeling (500 nM) was performed for 30 min at 
37 °C before harvesting the cells. 
xCELLigence analysis (*). The Cell Index (a representation of cell growth and viability) was 
measured in real time using the RTCA-SP (Acea Biosciences) according to manufacturer’s 
instructions. Cells were seeded at a density of 2,000 cells/well (Dendra2-tagged cell lines) or 
4,000 cells/well (Halo-tagged cell lines), respectively. The Cell Index was normalized at 3 h 
after seeding to account for slight variations in the number of counted cells between various 
lines. 
Doubling time analysis (*). Doubling time analysis was performed (using FarRed CFSE from 
a CellTrace CFSE Cell Proliferation Kit, Thermo Fisher Scientific #C34554) to compare the 
growth capacities of the different lines. More precisely, for doubling time analysis, data was 
collected on a BD Bioscience LSR Fortessa; the geometric fluorescent mean intensity of each 
sample for each timepoint (day 1 to day 5) was extracted from FlowJo, and the average change 
over the 5-d period was calculated. The average change was then converted to log scale to 
calculate the doubling time. 
 
 







2.3.1.13 Cell imaging conditions (*) 
These experiments were conducted by Dr. Claire Dugast-Darzacq, Dr. Anders Hansen, and Dr. 
Hervé Marie-Nelly (UC Berkeley, Dept. of Molecular and Cell Biology).             
For live-cell imaging, the medium was identical, except DMEM without phenol red was used 
(ThermoFisher #31053028). U2OS cells expressing α-amanitin-resistant Halo-RPB1-25R, 
Halo-RPB1-52R, or Halo-RPB1-70R were grown overnight with α-amanitin on plasma-cleaned 
25-mm circular no. 1.5 H cover glasses (Marienfeld High-Precision 0117650). For the 
flavopiridol experiments, cells were treated for 30–45 min with flavopiridol (2 μM final 
concentration), and then imaged for a maximum of 30–45 min. Prior to all experiments, the 
cover glasses were plasma-cleaned and then stored in isopropanol until use. For live-cell FRAP 
experiments, cell preparation was identical except cells were grown on glass-bottomed 
(thickness #1.5) 35-mm dishes (MatTek P35G-1.5-14-C). 
 
2.3.1.14 PALM imaging (*) 
These experiments were conducted by Dr. Hervé Marie-Nelly (UC Berkeley, Dept. of Molecular 
and Cell Biology).                  
Six videos of ~50,000 frames were acquired for each condition at 30 ms/frame. The axial drift 
was corrected in real time with a perfect-focus system. A cylindrical lens was added to the 
system to induce astigmatism in the point-spread function (PSF) of the optical setup. 300,000 
detections were collected on average per video. Single-molecule detection and localization was 
performed with a modified version of the multiple-target tracking algorithm. The 3D position 
of single detections was inferred from the lateral elongation of the PSF. The lateral drift of the 
sample was corrected by using fluorescent beads (TetraSpeck microspheres). To correct for 
blinking of the Dendra2 fluorophore, detections in a disk of 30 nm diameter and adjacent in 











Nuclei and nucleoli were automatically detected and segmented for further processing. N(r) is 





∑ ∑ 𝑓(𝑖, 𝑗, 𝑟)
𝑖≠𝑗𝑖∈𝑃
 
where P is the set of all detections, and Np is the total number of detections. The f function
286,287 
corrects for biases generated by points located at short distances to the borders (nucleus or 
nucleoli) 
𝑓(𝑖, 𝑗, 𝑟) = {





where d(i,j) is the distance between i and j, and Cin is the length of that part of a circle of radius 
d(i,j) centered on i which is inside the area of study, the nucleus. 
The null hypothesis, complete spatial randomness (CSR), is a homogeneous Poisson process 




We estimated four spatial statistics based on N(r): n(r), K(r), L(r) and G(r)287, 288. The local 
neighbor density function, is defined as n(r) = N(r)/πr2. The K-Ripley function is defined as 
K(r)=N(r)/λ. The linearized K-Ripley function is given by 𝐿(𝑟) =  √𝐾(𝑟)/ 𝜋 − 𝑟. The pair 
density function G(r) is simply the derivative of K(r). 
Under CSR, the expected value taken by n(r) (resp. K(r), L(r), and G(r)) is λ (resp. πr2, 0, and 
1). Triangulation of the areas was performed with a custom python script and we used the ADS 
R package289 to estimate the four spatial statistics. To estimate the s.d. and standard error 
associated with these measurements, we performed a bootstrapping analysis of the dataset. We 
randomly selected 10,000 detections from each original dataset 100 times and fed these 
subsampled data to the R script computing the spatial statistics. 
 
 







2.3.1.15 Single-molecule imaging (spaSPT) (*) 
These experiments were performed by Dr. Claire Dugast-Darzacq together with Dr. Anders S. 
Hansen (UC Berkeley, Dept. of Molecular and Cell Biology).     
After overnight growth, cells were labeled with 50 nM PA-JF549
290 for ~15–30 min and washed 
twice (first wash: medium removed; second wash: PBS). At the end of the final wash, the 
medium was replenished and changed to phenol red-free medium, keeping all other aspects of 
the medium the same (and adding back α-amanitin). Single-molecule imaging was performed 
on a custom-built Nikon TI microscope equipped with a 100×/NA 1.49 oil-immersion TIRF 
objective (Nikon Apochromat CFI Apo TIRF 100× Oil), EM-CCD camera (Andor iXon Ultra 
897; frame-transfer mode; vertical shift speed: 0.9 μs; –70 °C), a perfect focusing system to 
correct for axial drift and motorized laser illumination (Ti-TIRF, Nikon) and which allows 
incident angle adjustment to achieve highly inclined and laminated optical sheet illumination291. 
An incubation chamber maintained a humidified 37 °C atmosphere with 5% CO2, and the 
objective was also heated to 37 °C. Excitation was achieved using a 561-nm (1 W, Genesis 
Coherent) laser for PA-JF549. The excitation laser was modulated by an acousto-optic tunable 
filter (AA Opto-Electronic, AOTFnC-VIS-TN) and triggered by the camera TTL exposure 
output signal. The laser light was coupled into the microscope by an optical fiber, reflected 
using a multiband dichroic (405 nm/488 nm/561 nm/ 633 nm quad-band, Semrock), and 
focused in the back focal plane of the objective. Fluorescence emission light was filtered using 
a single-bandpass filter placed in front of the camera using a Semrock 593/40-nm bandpass 
filter. The microscope, cameras, and hardware were controlled through NIS-Elements software 
(Nikon). 
We recorded single-molecule tracking movies using our previously developed technique, 
stroboscopic photoactivation single-particle tracking (spaSPT)292, 293. Briefly, 1-ms, 561-nm 
excitation (100% AOTF) of PA-JF549 was delivered at the beginning of the frame to minimize 
motion blurring; 405-nm photoactivation pulses were delivered during the camera integration 
time (~447 μs) to minimize background, and their intensity optimized to achieve a mean density 
of ~1 molecule per frame per nucleus. We recorded 30,000 frames per cell per experiment. The 
camera exposure time was 7 ms, resulting in a frame rate of approximately 134 Hz 
(7 ms + ~447 μs per frame). 
 







spaSPT data was analyzed (localization and tracking) and converted into trajectories using  
a custom-written Matlab implementation of the MTT algorithm294 and the following settings: 
localization error: 10–6.25; deflation loops: 0; blinking (frames): 1; max competitors: 3; max  
D (μm2/s): 20. 
We recorded ~5–10 cells per replicate and performed three independent replicates on three 
different days. Specifically, across three replicates we imaged 29 cells for 25 R Halo-RPB1 and 
obtained 448,362 trajectories with 690,682 unique displacements at a mean density of  
1.2 localizations per frame. Similarly, we imaged 30 cells for 52 R Halo-RPB1 and obtained 
324,928 trajectories with 619,247 unique displacements at a mean density of 1.1 localizations 
per frame. Finally, we imaged 26 cells for 70 R Halo-RPB1 and obtained 333,720 trajectories 
with 571,345 unique displacements at a mean density of 1.0 localization per frame. In the 
flavopiridol treated experiment, we imaged 13 cells for 25 R Halo-RPB1 and obtained 598,941 
trajectories with 926,057 unique displacements at a mean density of 2.4 localizations per frame. 
We imaged 15 cells for 52 R Halo-RPB1 and obtained 395,206 trajectories with 671,492 unique 
displacements at a mean density of 1.5 localizations per frame. Finally, we imaged 28 cells for 
70 R Halo-RPB1 and obtained 616,088 trajectories with 1,030,523 unique displacements at a 
mean density of 1.9 localizations per frame. 
 
2.3.1.16 FRAP in cells (*) 
These experiments were conducted by Dr. Claire Dugast-Darzacq together with Dr. Anders S. 
Hansen (UC Berkeley, Dept. of Molecular and Cell Biology).        
FRAP experiments were performed and analyzed as previously described292. Briefly, FRAP 
was performed on an inverted Zeiss LSM 710 AxioObserver confocal microscope equipped 
with a motorized stage, a full incubation chamber maintaining 37 °C/5% CO2, a heated stage, 
an X-Cite 120 illumination source as well as several laser lines. Halo-TMR was excited using 
a 561-nm laser. Images were acquired on a 40× Plan NeoFluar NA1.3 oil-immersion objective 
at a zoom corresponding to a 100 × 100-nm pixel size, and the microscope was controlled using 
the Zeiss Zen software. In FRAP experiments, 300 frames were acquired at 1 frame per s, 
allowing 20 frames to be acquired before the bleach pulse to accurately estimate baseline 
fluorescence. A circular bleach spot (r = 10 pixels) was chosen in a region of homogenous 
 







fluorescence at a position at least 1 μm from nuclear and nucleolar boundaries. The spot was 
bleached using maximal 561-nm laser intensity and pixel dwell time corresponding to a total 
bleach time of ~1 s. We generally collected data from 3–5 cells per cell line per condition per 
day and all presented data is from at least three independent replicates on different days. 
To quantify and drift-correct the FRAP movies, we used a previously described custom-written 
pipeline in Matlab292. Briefly, we manually identify the bleach spot. The nucleus was 
automatically identified by thresholding images after Gaussian smoothing and hole-filling (to 
avoid the bleach spot being misidentified as not belonging to the nucleus). We use an 
exponentially decaying threshold (from 100% to ~85% (measured) of initial over one video) to 
account for whole-nucleus photobleaching during the time-lapse acquisition. Next, we 
quantified the bleach spot signal as the mean intensity of a slightly smaller circle (r = 0.6 μm), 
which is more robust to lateral drift. The FRAP signal was corrected for photobleaching using 
the measured reduction in total nuclear fluorescence (~15% over 300 frames at the low laser 
intensity used after bleaching) and internally normalized to its mean value during the 20 frames 
before bleaching. We corrected for drift by manually updating a drift vector quantifying cell 
movement during the experiment. Finally, drift- and photobleaching corrected FRAP curves 
from each single cell were averaged to generate a mean FRAP recovery. We used the mean 











2.3.2 NELF condensation accompanies stress-induced transcriptional 
downregulation 
 
2.3.2.1 Purification of full-length NELF and tentacle deletion variants 
Purification of NELF was conducted together with Dr. Seychelle Vos (Department of Molecular 
Biology, MPI for Biophysical Chemistry).  
NELF complex was overexpressed in 3x600 mL Hi5 insect cells as described in see Section 
2.2.2. The cells were harvested by centrifugation (238 g, 30 min, 4 °C) and resuspended in lysis 
buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM 
DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL 
benzamidine). The cell suspension was lysed by sonication and a cleared extract was prepared 
as described in Section 2.2.2.4. NELF complex was purified essentially as described87, 156.  
In brief, the cleared insect cell lysate was loaded on a 5 mL HisTrap HP column (GE healthcare) 
pre-equilibrated in lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 30 mM imidazole, 
10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL 
PMSF, 0.33 mg/mL benzamidine) and washed with high salt buffer (20 mM Na-HEPES,  
pH 7.4, 800 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). The column was then 
attached inline to a 5 mL HiTrap Q column (GE healthcare), equilibrated in low salt wash buffer 
(20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 
0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL 
benzamidine) and eluted using elution buffer (20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 
500 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin 
A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). Flow-through fractions were analyzed using 
SDS-PAGE and Coomassie staining, appropriate fractions were pooled and mixed with 2 mg 
6xHis-tagged TEV protease and 0.8 µM Lambda protein phosphatase. The protein solution was 
then transferred to a Slide-A-Lyzer cassette (Thermo Fisher Scientific) and dialyzed overnight 
against lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 30 mM imidazole,  
10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL 
PMSF, 0.33 mg/mL benzamidine) containing 1 mM MnCl2. The dialysate was applied to  
a 5 mL HisTrap column pre-equilibrated in lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM 
NaCl, 30 mM imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL 
 







pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) to remove TEV protease and the 
6xHis tag. The flow-through fractions were then concentrated using a 100 kDa MWCO  
Amicon spin filter (Merck) and subjected to gel filtration using a HiLoad 16/600 Superdex 200 
pg column in NELF size-exclusion buffer (20 mM Na-HEPES, pH 7.4, 150 mM NaCl,  
10% glycerol, 1 mM DTT). Fractions were analyzed by SDS-PAGE and Coomassie staining.  
Pure fractions were pooled and concentrated with a 100 kDa MWCO Amicon filter (Merck). 
To produce P-TEFb-treated NELF, an aliquot was removed and incubated with 0.4 µM 
gluthathion S-transferase-tagged P-TEFb, 6 mM MgCl2, and 3 mM ATP for 2 h at 30 °C.  
GST-tagged P-TEFb was bound to pre-equilibrated GSTrap 4B resin (GE healthcare) and the 
NELF-containing supernatant was subjected again to size-exclusion chromatography on  
a HiLoad 16/600 Superdex 200 pg column.  
 
2.3.2.2 Purification of GFP-NELF tentacle fusion proteins 
GFP-NELF tentacle fusion proteins were overexpressed in E. coli BL21-CodonPlus (DE3) RIL 
cells as described in Section 2.2.3. The cleared and filtered E. coli lysate was loaded on a 5 mL 
HisTrap HP column pre-equilibrated in lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 
10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL 
PMSF, 0.33 mg/mL benzamidine). The column was washed extensively with high salt buffer 
(20 mM HEPES, pH 7.4, 1000 mM NaCl, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) and eluted in a linear 
gradient over 20 CV with elution buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 500 mM 
imidazole, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). Purity of the elution fractions was assessed by 
SDS-PAGE and Coomassie staining and appropriate fractions were pooled. Single tentacle GFP 
fusion proteins were concentrated using a 30 kDa MWCO Amicon Ultra centrifugal filter and 
directly applied to a Superdex 200 10/300 Increase column equilibrated in NELF size-exclusion 
buffer (20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 1 mM DTT). The eluate 
containing the double tentacle GFP fusion protein was mixed with 6xHis-tagged TEV protease 
to cleave the N-terminal hexahistidine tag and dialyzed overnight in a 10 kDa Slide-A-Lyzer 
cassette against lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 10% glycerol, 1 mM 
DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL 
 







benzamidine). The protein was then applied to a 5 ml HisTrap column pre-equilibrated in lysis 
buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 10% glycerol, 1 mM DTT, 0.284 µg/mL 
leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine).  
Flow-through fractions were collected and concentrated using a 30 kDa MWCO Amicon Ultra 
spin filter (Merck) and then applied onto a Superdex 200 10/300 Increase column (GE 
healthcare) that was pre-equilibrated in NELF size exclusion buffer (20 mM HEPES, pH 7.4, 
150 mM NaCl, 10% glycerol, 1 mM DTT). Peak fractions were assessed by SDS-PAGE and 
Coomassie staining. Pooled fractions were concentrated and protein concentration was 
calculated based on the absorbance at 280 nm and the predicted molar extinction coefficient. 
Small aliquots were flash-frozen in liquid nitrogen and stored at -80°C.  
 
2.3.2.3 Purification of P-TEFb 
Purification of P-TEFb was conducted by Dr. Seychelle Vos (Department of Molecular Biology, 
MPI for Biophysical Chemistry).                 
Wild-type P-TEFb and catalytically inactive P-TEFb (D149N) were expressed in Hi5 insect 
cells as described in Section 2.2.2. P-TEFb was purified from 4 L expression culture, essentially 
as described87. In brief, the clarified and filtered cell lysate was loaded on a 5 mL HisTrap HP 
that was pre-equilibrated in lysis buffer (20 mM Na-HEPES, pH 7.4, 300 mM NaCl, 10% 
glycerol, 30 mM imidazole, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 
0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). The column was washed with HSB1000 
(20 mM Na-HEPES, pH 7.4, 1 M NaCl, 10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 
1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine), equilibrated in lysis 
buffer and washed with low-salt buffer LB150 (20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 
10% glycerol, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL 
PMSF, 0.33 mg/mL benzamidine). The column was then connected inline to a HiTrap S column 
(GE healthcare) that was pre-equilibrated in LSB150. The HisTrap column was eluted using  
a linear gradient from 0-100% nickel elution buffer 150 (20 mM Na-HEPES, pH 7.4, 150 mM 
NaCl, 10% glycerol, 500 mM imidazole, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL 
pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). Collected flow-through fractions 
were analyzed by SDS-PAGE and Coomassie staining and P-TEFb peak fractions were pooled, 
mixed with 6xHis-tagged TEV protease and dialyzed overnight in a 10 kDa MWCO Slide-A-
 







Lyzer cassette (Thermo Fisher Scientific). The protein solution was then applied to a 5 mL 
HisTrap column that was equilibrated in lysis buffer. Flow-through fractions were pooled, 
concentrated using a 10 kDa MWCO Amicon Ultra spin filter and applied to a HiLoad S200 
16/600 pg column pre-equilibrated in SE300 buffer (20 mM Na-HEPES, pH 7.4, 300 mM 
NaCl, 10% glycerol, 1 mM TCEP). Pure peak fractions, as assessed by SDS-PAGE and 
Coomassie staining, were pooled, concentrated in a 10 kDa MWCO Amicon Ultra concentrator 
and aliquots were flash-frozen and stored at -80 °C until further use. 
 
2.3.2.4 Purification of SUMO2/3 and E1/E2/E3 enzymes 
6xHis-TEV-SUMO2 was overexpressed in E. coli BL21-CodonPlus (DE3) RIL cells as 
described in Section 2.2. Cells were harvested and resuspended in low-salt buffer 150 (20 mM 
Na-HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT, 0.284 µg/mL 
leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine). The cleared 
and 0.8 µm-filtered lysate was applied to a 5 mL HisTrap HP column equilibrated in low-salt 
buffer. The column was then washed with high-salt buffer 1000 (20 mM Na-HEPES, pH 7.4, 
1 M NaCl, 10% glycerol, 30 mM imidazole, 1 mM DTT, 0.284 µg/mL leupeptin, 1.37 µg/mL 
pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL benzamidine) and equilibrated in LSB150.  
The column was then developed over a linear 20 CV-gradient with nickel 150 elution buffer 
(20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 500 mM imidazole, 1 mM DTT, 
0.284 µg/mL leupeptin, 1.37 µg/mL pepstatin A, 0.17 mg/mL PMSF, 0.33 mg/mL 
benzamidine). The protein solution was incubated overnight with 6xHis-TEV protease at a mass 
ratio of 40:1 and then applied to a 5 mL HisTrap column equilibrated in low-salt buffer.  
Flow-through fractions were analyzed by SDS-PAGE and Coomassie staining and concentrated 
using a 3 kDa MWCO Amicon Ultra centrifugal filter. The concentrated protein solution was 
then applied to a Superdex 75 10/300 GL column that was equilibrated in size-exclusion buffer 
(20 mM Na-HEPES, pH 7.4, 150 KOAc, 5% glycerol, 1 mM TCEP). Fractions were analyzed 
by SDS-PAGE and Coomassie staining and pure peak fractions were pooled and concentrated 
using a 3 kDa MWCO Amicon Ultra spin filter. A part of the purified protein solution was 
fluorescently labelled using Alexa Fluor 647 maleimide as described in Section 2.3.2.5.  
The remaining protein solution was aliquoted, snap-frozen and stored at -80°C. HA-tagged 
4xSUMO3, His-Aos1-His-Uba2 (E1), Ubc9 (E2), and ZNF451-1-N 1-246 (E3) were a kind gift 
 







of Dr. Andrea Pichler (MPI for Immunobiology and Epigenetics, Freiburg) and purified as 
previously described295.   
 
2.3.2.5 Fluorescent labeling of proteins  
NELF complex was chemically labeled using fluorescent TFP-Alexa Fluor 488 dye (Molecular 
Probes). For this, NELF complex was incubated with a 10-fold molar excess of the dye for 1 h 
on ice in the dark. The reaction was quenched by addition of a 10-fold molar excess of L-lysine 
(in 50 mM Tris-HCl pH 7.0) to the dye. To remove unreacted dye, the reaction was desalted 
using a Micro Bio-Spin P6 gel column (Biorad) pre-equilibrated in NELF size-exclusion buffer 
according to the manufacturer’s instructions followed by multiple diafiltration steps using  
a 30 kDa MWCO Amicon Ultra spin filter unit. The protein was then concentrated and small 
aliquots were flash-frozen and stored at -80 °C. The protocol results in a labeling density of  
~1.0-1.2 fluorophores per NELF molecule. 
The native cysteine residues of SUMO2 (C48) and SUMO3 (C47) were used for labeling with 
Alexa Fluor 647 C2 maleimide (Molecular Probes). For Alexa Fluor 647 C2 maleimide labeling 
of MBP the engineered single cysteine residue C-terminal of the TEV cleavage site was used 
for labeling87. Proteins were incubated with a 10-fold molar excess of the dye for 4 h on ice in 
the dark. Unbound dye was removed using PD-10 desalting columns (GE healthcare) according 
to the manufacturer’s instructions and extensive diafiltration using an Amicon Ultra centrifugal 
concentrator (Merck) with an appropriate molecular weight cut off.  
 
2.3.2.6 Phase separation assays and microscopy 
Phase separation assays were conducted in 50-well CultureWell chambered coverslides (Grace 
Bio-Labs) to which an additional silicon gasket was attached. To minimize nonspecific 
adsorption of molecules to the glass surface, the coverslide was passivated through a covalently 
attached layer of polyethylene glycol, following a similar procedure as described272. For this, 
the coverslides were washed with 2% Hellmanex III solution (Hellma Analytics) for 2 h, then 
extensively rinsed with ultrapure water, and dried. The coverglass surface was etched with 1 M 
NaOH for 1 h, extensively washed with ultrapure water, dried and incubated overnight with 
 







mPEG5K-silane (25 mg/mL in 95% EtOH; Nanosoft Polymers). The glass slide was 
subsequently rinsed extensively with ultrapure water, dried and sealed with crystal clear tape.  
For phase separation assays with NELF complex, unlabeled and Alexa Fluor 488-labeled 
protein were mixed at a molar ratio of 1:9 and diluted to the appropriate protein concentration 
using NELF size-exclusion buffer (20 mM Na-HEPES, pH 7.4, 150 mM NaCl, 10% glycerol, 
1 mM DTT). Generally, 1.7 µL protein solution were then diluted with 3.4 µL LLPS buffer 
(20 mM Na-HEPES, pH 7.4, 10 % glycerol, 1 mM DTT) to induce phase separation. The plate 
was sealed with crystal clear tape to minimize sample evaporation. The plate was generally 
incubated for 1-2 h in the dark prior to imaging to assure that formed droplets have settled down 
quantitatively onto the coverslide surface. All images were acquired directly above the 
coverslide surface using an inverted Leica TCS SP8 laser scanning confocal microscope 
equipped with a HC PL APO 63x/1.40 CS2 objective (oil immersion) at room temperature 
(22±1 °C). For excitation of Alexa Fluor 488 and GFP, the 488 nm argon laser line was used at 
low intensity (usually 1 %). For NELF complex samples, emitted fluorescence between  
492-550 nm was detected using a PMT detector gain of 750-850 V.  Emitted light from GFP-
tagged fusion proteins was detected between 500-600 nm with a typical PMT detector gain of 
420-510 V. At least 5 images per condition were taken in non-overlapping regions, and are 
considered representative for the droplet distribution on the entire slide. Images were further 
analyzed and processed using FIJI (version 1.52h).  
 
2.3.2.7 Hexanediol sensitivity assays 
To test the sensitivity of phase separation towards the aliphatic alcohol 1,6-hexanediol,  
1.3 µL of a 77 µM solution of the NELFE-GFP-NELFA double tentacle fusion protein were 
mixed with 3.7 µL LLPS assay buffer (20 mM Na-HEPES, pH 7.4, 15 mM NaCl,  
10% glycerol, 1 mM DTT) either containing 13.6% or no 1,6-hexanediol. The coverslide was 
subsequently sealed with tape, incubated in the dark for 90 min to allow the droplets to settle 
on the coverslide surface and imaged as described above.  
 
 







2.3.2.8 In vitro FRAP experiments 
Fluorescence recovery after photobleaching (FRAP) was used to determine the influence of  
P-TEFb phosphorylation on the mobility of molecules in the condensed phase. Two types of 
FRAP experiments can be distinguished: Fluorescence recovery after bleaching only small parts 
of the condensed phase is largely dependent on the mobility of the molecules in the condensed 
phase, while the recovery after full droplet bleaching is a measure of the exchange between 
droplet material and the bulk solution over the phase boundary. Lambda phosphatase (λPPase)-
treated NELF as well as NELF that was first treated with λPPase and afterwards with P-TEFb 
during purification were diluted in LLPS buffer to induce LLPS. A final NELF concentration 
of 2 µM and 2.5 µM was used for partial and full droplet FRAP experiments, respectively. After 
induction of phase separation, the plate was incubated for 1 h in the dark prior to imaging. 
FRAP movies were recorded with 1400 Hz scan speed at a resolution of 256 x 256 pixels with 
a pixel size of 96 x 96 nm. Bidirectional scanning was enabled using a phase X offset of -30.01. 
The 488 nm line was used at full laser intensity (80% output) to photobleach a defined region 
of interest to ~10-20% of its initial fluorescence. For partial droplet bleaching, a 1 µm circular 
region was bleached in the center of droplets with a diameter of 6.0-7.5 µm. Fluorescence 
recovery was imaged every 500 ms over a period of 250 s. For full droplet FRAP, the entire 
area of droplets with a diameter of 5.2-5.8 µm was photobleached and 600 frames were 
recorded with a frame rate of 0.5 s-1. Fluorescence recovery of the bleached region was analyzed 
using FIJI (version 1.52h). For this, the fluorescence intensity of the bleached spots was 
background subtracted, normalized to the fluorescence intensity of the first post-bleach image, 
then corrected for acquisition bleaching using an unbleached reference droplet of similar size 
within the frame, and normalized to the mean prebleach intensity. The resulting recovery curves 
were fit to a double-exponential recovery model using GraphPad Prism (version 5.03). 
 
2.3.2.9 Real-time P-TEFb droplet phosphorylation 
For real-time P-TEFb droplet phosphorylation experiments, Alexa Fluor 488-labeled and 
unlabeled NELF complex were mixed at a molar ratio of 1:9 at a final concentration of 3 µM. 
Phase separation was then induced by mixing 1.7 µL of the NELF solution with 3.4 µL of LLPS 
buffer (20 mM HEPES, pH 7.4, 10 % glycerol, 1 mM DTT) containing 1.5 mM ATP and 
4.5 mM MgCl2. The required P-TEFb co-substrate ATP and cofactor MgCl2 both affect NELF 
 







phase separation and were thus included already during induction of LLPS. The coverslide was 
then sealed and incubated in the dark on the microscope stage for 2 h to assure that the NELF 
droplets have settled quantitatively on the coverslide surface. Subsequently, either active  
P-TEFb or a catalytically inactive P-TEFb variant (containing the D149N substitution in 
CDK9)87 were added gently in a small volume (0.4 µL) to a final concentration of 0.2 µM. 
Immediately after P-TEFb addition, a series of images (usually 10-12) with variable z-position 
was acquired in a representative area spanning 92 x 92 µm as described above. After an 
incubation of 30 min, 60 min and 120 min, the same region was imaged again similarly over  
a comparable range of different focal planes. For the different time points, the images in which 
the focal plane intersects approximately the center of the largest droplet within a specified 
region were selected manually, cropped and contrast-adjusted using identical settings. After the 
experiment was completed, 3 µL 4x LDS sample buffer were added and the sample was 
retrieved from the well to confirm protein integrity using SDS-PAGE with subsequent silver 
staining.  
 
2.3.2.10 P-TEFb phosphorylation of NELF double tentacle-GFP fusion protein 
NELF double tentacle-GFP fusion protein was mixed at a final concentration of 50 µM with 
either 1 µM wild-type or catalytically inactive P-TEFb in kinase buffer (20 mM Na-HEPES, 
pH 7.4, 140 mM NaCl, 6 mM MgCl2, 4% glycerol, 1 mM DTT). The reaction was started by 
addition of ATP to a final concentration of 3 mM and incubated at 30 °C for 4 h. To induce 
LLPS, 1.7 µL of the reaction were mixed with 3.4 µL LLPS buffer (20 mM Na-HEPES,  
pH 7.4, 10% glycerol, 1 mM DTT) containing 4.5 mM EDTA. The plate was sealed, incubated 
for 2 h in the dark and then imaged as described above. 
 
2.3.2.11 Mass spectrometric analysis of P-TEFb phosphorylation  
In-gel digestion, phosphopeptide enrichment and mass spectrometric analysis were kindly 
performed by Monika Raabe and Annika Reinelt (Laboratory of Prof. Dr. Henning Urlaub, 
MPI for Biophysical Chemistry).   
Dephosphorylated or P-TEFb-treated NELF samples (see Section 2.3.2.1) were separated on a 
SDS-PAGE gel and stained with Coomassie solution (see Section 2.2.1.10). Appropriate bands 
 







were selected for in-gel digestion and phosphopeptides were enriched using TiO2 
chromatography (GL Sciences) as described296. Desalted peptides were analyzed using a 
Dionex UltiMate 3000 nano liquid-chromatography system (Thermo Fisher Scientific) coupled 
to a Q-Exactive HF mass spectrometer (Thermo Fisher Scientific) as described296. Raw files 
were searched against the human proteome database using the Andromeda search engine of 
MaxQuant (version 1.5.2.8)297. Default settings were used, except serine, threonine, and 
tyrosine phosphorylation, methionine oxidation, and carbamidomethlyation of cysteine were 
set as variable modifications. Identified phosphorylation sites were filtered for high confidence 
(posttranslational modification (PTM) score > 0.75) and only sites that were exlusively detected 
in the P-TEFb-treated sample were considered relevant. 
 
2.3.2.12 Droplet interaction assays  
Alexa Fluor 647-labeled HA-(SUMO3)4, SUMO2 or MBP were diluted in NELF size exclusion 
buffer and mixed at a final concentration of 3 µM with 9 µM of Alexa 488-labeled NELF 
complex. The solution was incubated for 5 min at room temperature before phase separation 
was induced through a 1:2 (v/v) dilution in LLPS buffer. The plate was sealed with transparent 
tape and incubated for 1 h prior to imaging as described in Section 2.3.2.6. In addition to the 
488 nm line, the 633 nm helium neon laser line was used to excite Alexa Fluor 647 in sequential 
scanning mode. Emitted fluorescence was detected between 652-750 nm using a hybrid 
detector. 
 
2.3.2.13 In vitro sumoylation assay 
For in vitro sumoylation reactions, NELF was mixed at a final concentration of 1 µM with 
0.1 µM E1, 0.1 µM E2, 0.5 µM E3 and 10 µM SUMO2 in assay buffer (20 mM K-HEPES,  
pH 7.4, 110 mM KOAc, 2 mM MgOAc, 0.2 mg/mL ovalbumin, 0.05 % Tween-20, 1 mM 
DTT). The reaction was started by addition of ATP to a final concentration of 5 mM and 
incubated at 30 °C for 60 min. Control reactions without ATP or E3-ligase were conducted in 
parallel. The reactions were carried out in 30 µL volumes in low protein binding tubes.  
The reaction was quenched by addition of 10 µL 4x LDS sample buffer. Sumoylation causes 
an apparent mass shift of ~20 kDa in SDS-PAGE, which was evaluated using western blotting. 
 







For this, 4 µL of each reaction were separated on 4-15% Tris-glycine Protean TGX gels 
(Biorad) run in 1x TGS buffer (Biorad). Proteins were transferred onto a PVDF membrane 
using a Trans-Blot Turbo Transfer System (Biorad). The membrane was then blocked at RT 
for 1 h with 5% (w/v) milk powder in 1x PBS containing 0.1% Tween-20 (PBST, Table 9).  
The membrane was then incubated at RT for 3 h with NELF subunit-specific antibodies 
(Table 11) that were diluted in 2.5% milk powder/PBST. The membrane was washed 3x for 
5 min with 1x PBST and then incubated at RT for 1 h with the appropriate HRP-conjugates 
secondary antibody (Table 11) in 2.5% milk powder/PBST. The membrane was washed again 
3x for 5 min with 1x PBST and was then developed using SuperSignal West Pico 
Chemiluminescence Substrate (Thermo Fisher Scientific). Chemiluminescence was detected 
using a ChemoCam Advanced Fluorescence imaging system (Intas Science Imaging).  
 
2.3.2.14 Cell line establishment and cell culture 
These experiments were conducted by Prashant Rawat (Laboratory of Dr. Ritwick Sawarkar, 
MPI for Immunobiology and Epigenetics).           
Human HeLa Flp-In T-Rex cells (kind gift from Prof. Dr. Marc Timmers, University of 
Freiburg) and HEK293 Flp-In T-Rex cells were cultured in DMEM high glucose medium 
supplemented with 10% fetal bovine serum (FBS) (Sigma Aldrich, F0804), 2 mM L-glutamine 
(Sigma Aldrich, P4333) and 1% penicillin-streptomycin (Sigma Aldrich, G7513) in  
a humidified incubator at 37 °C and 5% CO2. Cells were routinely checked for mycoplasma 
contamination by PCR.  
Human open reading frames cloned into pDONOR vectors were obtained from BIOSS 
(University of Freiburg). Coding sequences were then transferred into pDestination vectors 
encoding either C-terminal GFP tag (obtained from Prof. Dr. Marc Timmers, University of 
Freiburg) or mCherry tag (obtained from Dr. Robin Shaw, addgene #31907) using the Gateway 
LR clonase II enzyme kit (Life Technologies, 11791020) according to the manufacturer’s 
instructions. HeLa cells were transfected with Lipofectamine 3000 (Life Technologies, L3000) 
as suggested by the manufacturer. For transient expression, HeLa cells were transfected with 
NELFA-mCherry WT and a NELFA-mCherry dIDR variant (lacking amino acids 321-460). To 
generate the stable cell lines, HeLa Flp-In T-Rex cells that were cultured in the presence of 
 







100 µg/mL Zeocin (Invitrogen, R25001) for seven days were transfected with NELFA-GFP 
plasmid DNA according to the manufacturer’s instructions. Selection of stable positive clones 
was carried out over a period of three weeks with 15 µg/mL blasticidin S (Carl Roth CP14.1) 
and 100 µg/mL hygromycin B. Additionally, Flp-In HEK293 T-Rex cell lines that stably 
express NELFA-GFP and CDK9-GFP were constructed in the same way. 
 
2.3.2.15 Heat shock treatment and cell imaging  
These experiments were conducted by Prashant Rawat (Laboratory of Dr. Ritwick Sawarkar, 
MPI for Immunobiology and Epigenetics).             
Adherent HeLa cells were used for imaging. Prior to each experiment, cells were grown on 
Nunc Lab-Tek 8-well chambers (Thermo Fisher Scientific, 155411) for 24 h at 37 °C. Cells 
were then either transfected transiently or expression of the stable cell line was induced for 24 h 
with 1 µg/mL tetracycline (Sigma Aldrich, T7660). For heat shock experiments, cells were 
either shifted to a 43 °C incubator for 30 min or left at 37 °C. Prior to imaging, cells were treated 
with fixative solution (Invitrogen, FB002) for 10 min at 37°C and washed three times with  
1x PBS (Sigma-Aldrich, D8537). DAPI (Serva, 18860) was added for 30 min at RT 
immediately before imaging using a Zeiss LSM780 confocal microscope. Images of stable cell 
lines were acquired at constant laser power. For transiently transfected cell lines, laser power 
was adjusted within a narrow window to avoid oversaturation of the images. Images were 
contrast adjusted using the Min/Max intensity function of the Zeiss Zen software (version 
2012).  
Treatments. Prior to the hexanediol treatment, expression was induced for 24 h with 1 µg/mL 
tetracycline. The cells were either incubated at 43°C without or with 10% 1,6-hexanediol for 
15 min and imaged as described above. The number of puncta per cell were determined 
automatically with Imaris software (version 9.3) using a custom-written script. Two replicates 
were done on different days and one of the representative replicates is shown. Treatment with 
the SUMO E1 inhibitor ML-792 (kind gift from UbiQ) was performed at a final concentration 
of 1 µM for 1 h immediately before induction of heat shock. To induce oxidative stress, the 
cells were treated with 100 µM arsenic trioxide for 1 h prior to fixation. 
 







FRAP in live cells. FRAP was done in live cells using a Zeiss LSM780 confocal microscope 
with 405 nm and 488 nm laser. A strip of the nucleus was bleached at 100% laser power for 
2x30 µs and recovery was imaged at low laser intensity every 600 ms over 260 frames. The 
fluorescence intensity of the bleached region, an unbleached reference region and the 
background were determined using Zeiss Zen software. Normalized recovery curves were fit to 
a double exponential model using easyFRAP298. 
  
2.3.2.16 Analysis of CDK9 interactome and NELFA phosphorylation 
These experiments were conducted by Prashant Rawat (Laboratory of Dr. Ritwick Sawarkar, 
MPI for Immunobiology and Epigenetics).           
Quantitative mass spectrometry was carried out using the SILAC approach299. For the analysis 
of the CDK9 interactome, Flp-In T-Rex HEK293 cells that stably express C-terminally GFP-
tagged CDK9 or GFP (kind gift of Dr. Asifa Akhtar300) were cultured in normal medium 
(‘light’), medium containing 2H4-lysine and




13C6-arginine (‘heavy’) supplemented with dialyzed FBS (Thermo Fisher Scientific, 
88440) and non-essential amino acids (Gibco, 11140050) for at least five cell divisions (starting 
density <1%). Light-, medium- and heavy-labelled cells were then either exposed to heat shock 
conditions (43 °C, 1.5 h) or left at 37 °C. Three replicate experiments were conducted following 
the label-swap strategy301 (Park et al., 2012). After the treatment, cells were chemically 
crosslinked using 1% formaldehyde for 10 min and quenched for 5 min using excess L-glycine. 
Cells were then lysed in 1xRIPA buffer (50 mM Na-HEPES, pH 7.4, 150 mM NaCl,  
0.5% sodium deoxycholate, 0.1% SDS, 0.1% Triton X-100, 5 mM MgCl2, 10% glycerol) and 
combined in equal amounts. The cell lysate was sonicated using a BioRuptor system and cleared 
by centrifugation.  The cleared cell lysate was then applied to GFP-trap magnetic agarose beads 
(ChromoTek, gtma 20) for 1 h at 4°C. Beads were then washed with high salt buffer (50 mM 
Tris-HCl pH 7.4, 1 M NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, 1 mM EDTA) 
and non-denaturing buffer (50 mM Tris-HCl pH 7.4, 100 mM NaCl, 0.1% Tween-20). Proteins 
were digested sequentially on the beads with LysC and then with trypsin in solution. Peptides 
were desalted and analyzed using a Q-Exactive mass spectrometer (Thermo Fisher Scientific) 
coupled to an nLC 1000 Nano UHPLC (Thermo Fisher Scientific). Raw files were processed 
using MaxQuant297 (version 1.5.7.4) and analyzed using Perseus (version 1.5.2.4). First, decoy 
 







and contaminant entries were removed. Next, specific CDK9 interactors were discriminated 
from background interactors under steady-state and heat shock conditions. For this, Student’s 
t-tests were performed based on the iBAQ intensities of proteins quantified in GFP and GFP-
CDK9 pulldowns. Proteins exhibiting ≥2-fold enrichment and a t-test p-value ≥ 0.1 were 
defined as GFP-CDK9 specific interactors in both conditions. Subsequently, SILAC ratios of 
common CDK9 interactors under steady state and heat shock conditions were extracted and 
normalized so that the SILAC ratio of CDK9 equals one to account for slight variations in  
IP efficiency. Simultaneous Western blots of the input material were performed to confirm that 
the intracellular CDK9 level did not change upon heat shock. 
For analysis of NELFA phosphorylation, Flp-In T-Rex HEK293 T-Rex cells that stably express 
C-terminally GFP-tagged NELFA were used. All procedures were conducted in triplicates as 
described above. Three different phosphorylation sites on NELFA were detected in each of the 
replicates with high confidence (PTM score > 0.99).  
 







3 RNA polymerase II clustering through carboxy-
terminal domain phase separation 
 
3.1 Results 
We concluded from published findings that CTD repeats must have a weak attractive interaction 
to each other13, 21, 35-38. This prompted us to ask whether CTD molecules could engage also in 
multivalent intermolecular interactions that result in liquid-liquid phase separation. In order to 
investigate whether such CTD-mediated LLPS could be the molecular mechanism underlying 
Pol II clustering, we expressed human CTD (hCTD) and yeast CTD (yCTD) in Escherichia coli 
fused to the solubility enhancing maltose-binding protein (MBP) tag or to the MBP and 
glutathione S-transferase (GST) tags, respectively. We chose a prokaryotic expression system 
to prevent the covalent attachment of any eukaryotic post-translational modifications during 
protein expression. CTD fusion proteins were purified to homogeneity (Fig. 3.1a) and then 
fluorescently labeled with Alexa Fluor 488. 
 
Except for Section 3.1.3, the results presented in this Chapter have been published.  
 
RNA polymerase II clustering through carboxy-terminal domain phase separation 
M. Boehning*, C. Dugast-Darzacq*, M. Rankovic*, A. S. Hansen, T. Yu, H. Marie-Nelly,  
D. T. McSwiggen, G. Kokic, G. M. Dailey, P. Cramer, X. Darzacq, M. Zweckstetter 
Nature Structural and Molecular Biology 25, 833–840 (2018) 
 
The published text was adapted to match the style of this thesis. Numbering and references to 
figures as well as references to the literature thus deviate from the published version. A detailed 
list of published items can be found in the Appendix (‘List of items from publications’, 
Page 149). Co-author contributions are stated on Page VI. 
 
 







3.1.1 CTD of Pol II phase separates into liquid-like droplets 
Next we investigated the ability of CTD to undergo LLPS using a combination of differential 
interference contrast microscopy and fluorescence microscopy. Differential interference 
contrast microscopy revealed the formation of micrometer-sized droplets at a concentration of 
20 M hCTD in the presence of 5-10% of the molecular-crowding agent dextran (Fig. 3.2a). 
Fluorescence microscopy demonstrated that hCTD molecules were strongly concentrated 
within the droplet interior compared to the surrounding milieu (Fig. 3.2a, lower panels).  
At higher dextran concentration (16%), droplets could be detected already at a concentration  
of 5 M hCTD (Fig. 3.1b-c). The number of droplets increased with increasing protein 
concentration (Fig. 3.1c), consistent with the general concentration dependence of liquid phase 
separation235. In addition, hCTD formed droplets in the presence of another molecular-
crowding agent, the polysaccharide Ficoll (Fig. 3.2b). hCTD also underwent LLPS after 
cleavage of the maltose-binding protein (MBP) tag, while MBP alone did not form droplets  
in presence of molecular-crowding agents (Fig. 3.2c). hCTD droplet formation was robust 
against changes in ionic strength (Fig. 3.2d), and against incubation of the sample for 1 h  
at different temperatures (Fig. 3.2e). Like hCTD, yCTD formed droplets in a concentration-
dependent manner (Fig. 3.1d; Fig. 3.4d). Contacts of both hCTD and yCTD droplets led to 
fusion and formation of a single spherical droplet (Fig. 3.1e-f). At concentrations subcritical  
for LLPS, yCTD was incorporated into preformed hCTD droplets and hCTD was included into 
preformed yCTD droplets (Fig. 3.3c), in agreement with the ability of CTD to be trapped into 
droplets and hydrogels of LCD proteins 134, 135. Formation of yCTD droplets was also resistant 
against changes in ionic strength (Fig. 3.2d) and temperature (Fig. 3.2e), similarly to hCTD.  
The combined data show that the CTD of Pol II formed LCD-LCD interactions and readily 















Figure 3.1 | Phase separation of Pol II CTD into liquid-like droplets. 
a, Representative SDS-PAGE analysis of purified proteins used in this study reveals high purity and homogeneity. 
Due to low expression yields, several batches of the CTD fusion proteins were purified. b, Addition of 16% dextran 
to a 20 μM solution of MBP-hCTD turns the solution turbid, a characteristic property of liquid phase separation.  
c, Differential interference contrast (DIC) and fluorescence microscopy demonstrate the concentration-dependent 
formation of liquid droplets of MBP-hCTD in the presence of 16% dextran. Images are representative of three 
independent experiments. d, Concentration-dependent liquid phase separation of glutathione S-transferase (GST)-
tagged yCTD (GST-yCTD) in the presence of 16% dextran. Images are representative of three independent 
experiments. e,f,  GST-yCTD (e) and MBP-hCTD (f) droplets rapidly fuse upon contact into one spherical droplet. 
g, Liquid phase separation of yCTD is sensitive to 1,6-hexanediol (1,6-hex; 10%). Images from at least five 
representative images taken for both conditions are shown. h, FRAP kinetics of photobleaching a spot within 
hCTD (blue) and yCTD (red) droplets, which were formed in the presence of 16% dextran. Data points represent 
mean values across three independent replicates and error bars show the standard error. i, Pol II (red, Alexa  
Fluor 594) is concentrated in preformed yCTD droplets (green, Alexa Fluor 488). Representative images from one 












Figure 3.2 | Physicochemical properties of hCTD phase separation. 
a, Phase separation of MBP-hCTD (20 μM) in the presence of different concentrations of dextran.  
b, Concentration-dependent LLPS of MBP-hCTD in the presence of Ficoll (150 mg/mL). c, Concentration-
dependent LLPS of hCTD after cleavage of the MBP tag with tobacco etch virus (TEV) protease (left) in 16% 
dextran. MBP alone (25 μM) did not undergo phase separation (right) under these conditions. For panels a–c, 
images shown are representative of at least five images recorded for each condition. d,e, LLPS of MBP-hCTD in 
16% dextran shows little sensitivity to ionic strength changes (d) and is stable during incubation of the sample at 




Liquid droplets and cellular puncta are held together by weak, distributed interactions between 
LCDs that are sensitive to aliphatic alcohols252, 302, 303. As expected for such interactions, liquid 
phase separation of yCTD and hCTD was counteracted by addition of 5-10% 1,6-hexanediol 
(Fig. 3.1g; Fig. 3.4a-b, upper panels). Addition of 5-10% of the hexanediol isomer  
2,5-hexanediol also inhibited CTD droplet formation (Fig. 3.4a-b, lower panels). Because it 
was shown that 2,5-hexanediol is less efficient in dissolving droplets and hydrogels139, the data  
 
 







indicate that CTD droplets are more sensitive to aliphatic alcohols than other LCD-LCD 
interactions. On the contrary, CTD phase separation is robust to changes in ionic strength  
(Fig. 3.2d; Fig. 3.3c). 
 
 
Figure 3.3 | Physicochemical properties of yCTD phase separation. 
a, GST alone (10 µM) did not undergo phase separation in 16% dextran. b, Concentration-dependent phase 
separation of GST-yCTD in the presence of 150 mg/ml Ficoll. c, upper panels. Recruitment of Alexa 488-labeled 
MBP-hCTD (green; right) to preformed droplets of GST-yCTD that were visualized by DIC microscopy (left) and 
by recruitment of a TMR-labeled YSPTSPS peptide (red; middle). c, lower panels. Recruitment of Alexa 488-
labeled GST-yCTD (green; right) to preformed droplets of MBP-hCTD. Preformed hCTD droplets were visualized 
by DIC microscopy (left) and by recruitment of the TMR-labeled YSPTSPS peptide (red; middle). d, LLPS of 
MBP-yCTD in 16% dextran is not sensitive to ionic strength changes. e, LLPS of MBP-yCTD in 16% dextran is 
robust against incubation of the sample for one hour at the indicated temperatures. All experiments were performed 
two times with similar outcome and representative images are shown. Scale bars correspond to 10 µm in all panels. 
 
 
3.1.2 CTD length influences CTD phase separation in vitro 
A characteristic property of liquid-like droplets is fast diffusion of molecules in their interior231. 
We used fluorescence recovery after photobleaching (FRAP) to compare diffusion kinetics of 
hCTD and yCTD molecules within droplets. MBP-tagged hCTD and yCTD proteins were 
fluorescently labeled on a single cysteine residue that is present C-terminally to the tobacco 
 







etch virus protease cleavage site. After cleavage of the MBP tag and droplet formation, circular 
regions in the interior of CTD droplets were bleached. Within hCTD droplets, the bleached 
fluorescence recovered with a half time of 4.08 s ± 0.88 s (Fig. 3.1h). For yCTD, recovery was 




Figure 3.4 | Influence of aliphatic alcohols and solubility tags on CTD phase separation. 
a-b, Influence of aliphatic alcohols on CTD LLPS. 1,6-hexanediol (1,6-hex) and 2,5-hexanediol (2,5-hex) 
counteract LLPS of hCTD (a) or yCTD (b) in a concentration-dependent manner. Images from ≥ 5 representative 
images taken for each condition are shown. (c) The solubilizing effect of an N-terminal MBP-tag inhibits droplet 
formation of yCTD at low protein concentrations. Concentration-dependent LLPS of MBP-hCTD, MBP-yCTD 
and GST-yCTD in 16% dextran. MBP-hCTD undergoes liquid phase separation already at a concentration of 5 µM 
(top), while a ≥ 4-fold higher concentration of MBP-yCTD is required for droplet formation (middle). Replacement 
of MBP by a GST-tag decreases the critical concentration for yCTD phase separation to approximately 5 µM 




These results demonstrate that CTD molecules within droplets are generally highly dynamic, 
confirming the liquid-like nature of CTD droplets. The difference in fluorescence recovery 
between hCTD and yCTD further suggests that the higher number of repeats in hCTD 
strengthened CTD-CTD interactions. This observation is consistent with the concentration-
dependent ability of hCTD and yCTD to undergo LLPS when fused to the MBP tag.  
 







MBP-hCTD phase separated at a concentration of 5 M (Fig. 3.1c; Fig. 3.4c). In contrast, LLPS 
of MBP-yCTD started only at a four- to sixfold higher protein concentration (Fig. 3.4c). When 
the smaller, dimerizing glutathione S-transferase tag was used to replace the more soluble MBP 
tag304, the critical concentration for yCTD phase separation decreased to approximately 5 M 
(Fig. 3.4c; Fig. 1d). These results suggest that the solubilizing effect of MBP counteracts droplet 
formation. This effect is more easily overcome by hCTD because the higher repeat number and 
valency results in stronger CTD-CTD interactions compared to yCTD. We conclude that the 
length of CTD influences the stability and dynamics of LLPS droplets, with a longer CTD 





Figure 3.5 | Aromatic interactions drive CTD phase separation. 
a, Hydrophobicity prediction of the wild-type (WT) CTD sequence in comparison to the Y→F and Y→L variants 
with the ProtParam tool (Expasy suite) based on Kyte & Doolittle305. The higher the GRAVY score, the higher the 
hydrophobicity. The variants are predicted to have approximately similar hydrophobicity and are more 
hydrophobic than the wild-type CTD sequence. b, WT hCTD and the Y→F variant form droplets at a final 
concentration of 20 µM, while the Y→L variant does not undergo phase separation. The depicted result is 
representative for two independent experiments. Scale bar, 10 µm. c, FRAP analysis of hCTD WT and Y→F 
droplets. Curves show the average normalized recovery (mean ± standard error) of five different droplets each. 
 
 








Figure 3.6 | Human Dendra2-RPB1 cell lines for imaging CTD-dependent Pol II clustering. 
a, Pairwise alignment of CTD sequences from S. cerevisiae and human Dendra2-RPB1-25R cell line. The RPB1-
25R cell line encodes a truncated version of human RPB1 comprising only 25 CTD repeats. This hCTD truncation 
closely resembles the yeast CTD in length (189 amino acids (aa) in RPB1-25R vs. 192 aa in yCTD) and amino 
acid composition (similarity, 87.2%; identity, 83.2%). The alignment was generated using the EMBOSS needle 
tool306 with default settings, and aligned residues are colored red or pink according to their degree of similarity.  
b, Overview of the strategy used to establish the RPB1-25R, RPB1-52R, and RPB1-70R cell lines. Cells are 
transfected with a plasmid encoding an α-amanitin-resistant RPB1 variant (N792D). Upon growth in α-amanitin-
containing medium, endogenous RPB1 is degraded and functionally replaced by the exogenous RPB1 variant. αA, 
α-amanitin. c, Western blot analysis of the expression level of Dendra2-RPB1-25R, -52R and -70R.  
RPB1-70R is expressed at lower levels than the other two proteins. Image representative of an experiment 
performed five times. d, Confocal images of RPB1-25R (left), RPB1-52R (middle), and RPB1-70R (right) cell 
lines showing the nuclear localization of Dendra2-RPB1 in all three cell lines. Images are representative of five 
images taken for each cell line. D2, Dendra2. Scale bar, 5 µm. (Figure caption continued on next page.) 
 








Figure 3.6 | Human Dendra2-RPB1 cell lines for imaging CTD-dependent Pol II clustering. (Figure caption 
continued from previous page.) 
e, Fluorescence-activated cell sorting (FACS) analysis to evaluate expression levels of the different Dendra2-RPB1 
cell lines. One of three representative experiments is shown. FITC, fluorescence intensity in green fluorescein 
isothiocyanate channel; SSC-A, side scatter area. f, Growth-curve analysis of the three different Dendra2-tagged 
RNA Pol II cell lines in comparison to the osteosarcoma U2OS wild-type cell line (WT U2OS). The growth rates 
of all cell lines are similar. Growth curves are representative of an experiment performed independently three times 
and show the mean across six replicates. Error bars represent the s.d. and are shown only for the WT U2OS cell 
line to aid readability. 
 
3.1.3 Aromatic interactions are critical for CTD phase separation 
Tolerance of CTD phase separation against changes in ionic strength and sensitivity towards 
1,6-hexanediol, which is known to disrupt hydrophobic contacts246, 252, 303, 307, indicate that CTD 
self-association is mediated through weak hydrophobic interactions. Hydrophobic interactions 
between aromatic systems have been shown to be important for LLPS of various  
IDRs251, 256, 308-312 and aromatic residues are strongly conserved within the CTD sequence as 
well as between species (Figure 1.2b). We thus speculated whether aromatic interactions 
between Y1 CTD residues could drive CTD phase separation. If, on the other hand, mere 
hydrophobicity drives CTD self-association, Y1 replacement with more hydrophobic amino 
acids should further enhance LLPS. To test this, we generated hCTD variants, in which all 
52 tyrosine residues are replaced either by leucine (Y→L) or phenylalanine (Y→F) residues 
that are both classified to be more hydrophobic than tyrosine (Fig. 3.5a). Replacement of 
tyrosine by leucine fully abolished phase separation, while the phenylalanine variant underwent 
LLPS in the droplet assay similar to the wild-type (Fig. 3.5b). To further probe for smaller 
quantitative differences, the molecular mobility was assessed using FRAP. The fluorescence 
recovery kinetics of both variants were identical for both variants, indicating that replacement 
of tyrosine by phenylalanine does not detectably affect the interaction strength between the 
hCTD molecules (Fig. 3.5c). Together, these results suggest a critical role of aromatic 
interactions and imply that the lack of these interresidue contacts cannot be simply compensated 












3.1.4 CTD droplets recruit intact Pol II 
The above results indicate that CTD-CTD interactions within liquid droplets may underlie  
Pol II clustering. However, we could not test directly whether intact Pol II forms LLPS droplets 
in vitro because it was impossible to prepare Pol II at a sufficient concentration in the presence 
of dextran or Ficoll. We could, however, test whether Pol II could be trapped within CTD 
droplets. We purified Pol II from yeast cells, labeled it with the fluorescent dye Alexa Fluor 
594, and added it to preformed CTD droplets at a concentration of 0.02 µM. Fluorescence 
microscopy showed that Pol II located to CTD droplets (Fig. 3.1i). 
 
3.1.5 CTD length controls Pol II clustering in human cells 
To explore whether CTD-based LLPS may underlie Pol II clustering in cells, we engineered 
two human cell lines that express a fluorescent Dendra2-tagged version of RPB1. To create 
these cell lines, we transfected cells with a plasmid containing an -amanitin-resistant RPB1 
variant (N792D) and selected cells in the presence of -amanitin, which leads to the degradation 
of endogenous RPB1208. Such cell lines are known to recapitulate the behavior of endogenous 
wild-type Pol II208, 313, 314, 315. One cell line contained the full-length CTD with 52 repeats 
(RPB1-52R), whereas the other cell line contained a truncated CTD with 25 repeats (RPB1-
25R) that closely resembles the yCTD sequence (Fig. 3.6a-b). The two cell lines remained 
viable upon degradation of endogenous RPB1 after treatment with -amanitin and expressed 
similar levels of the Dendra2-tagged exogenous Pol II, as assessed by western blotting  
(Fig. 3.6c), confocal imaging and fluorescence-activated cell sorting (FACS; Fig. 3.6d-e).  
The two cell lines also grew at similar rates (Fig. 3.6f). 
We then studied clustering of Pol II in these human cell lines with the help of three-dimensional 
photoactivated localization microscopy (3D-PALM) using induced astigmatism by a cylindrical 
lens (Fig. 3.7)208, 316. Compared to cells with full-length CTD (52R), cells with the truncated, 
yeast-like CTD (25R) showed less Pol II clustering (Fig. 3.7a-b). These results suggested that 
CTD interactions underlie Pol II clustering in cells and that the CTD length influences 
clustering. To test this directly, we further created a cell line containing an artificially extended 
CTD (RPB1-70R, Methods). This cell line was also viable and grew at a similar rate as the 
other two lines upon degradation of endogenous RPB1 (Fig. 3.6f), though it expressed RPB1 at  
 








Figure 3.7 | CTD-dependent Pol II clustering in human cells. 
a, 3D-PALM reconstruction of RPB1-25R (left), RPB1-52R (middle), and RPB1-70R (right). Each detection is 
color-coded by the number of detections within a surrounding radius of 120 nm (number of detections per 120-nm 
disk). Images are representative of six images taken for each cell line. Scale bars, 500 nm. b, Local density 
distribution (radius = 120 nm). Histograms of the average number of detections in a 120-nm-radius disk of 
Dendra2-RPB1-25R (top), Dendra2-RPB1-52R (middle), and Dendra2-RPB1-70R (bottom). Histograms are 
representative of six images taken for each cell line. c, G-pair correlation function. The null hypothesis of complete 
spatial randomness is rejected because the curves strongly deviate from 1. A strong clustering signal is displayed 
for r ≥ 100 nm. All things being equal (blinking, localization accuracy), Dendra2-RPB1-70R exhibits stronger 
clustering power than Dendra2-RPB1-52R, which is stronger than Dendra2-RPB1-25R (P = 1.08 10−21, 
Kolmogorov–Smirnov test). Analysis based on n = 6 independent measurements for each cell line. d, L-modified 
Ripley function. Linearized representation of the classic Ripley function. The null model of complete spatial 
randomness is rejected because the curves positively deviate from zero. All three curves exhibit strong clustering 
at all scales. Analysis based on n = 6 independent measurements for each cell line. 
 
 







a lower level (Fig. 3.6c). Despite this difference in expression level, the 70R cell line showed 
even more Pol II clustering than cells with wild-type, full-length CTD (Fig. 3.7a-b), strongly 
supporting our findings.  
For all three cell lines, differences in CTD-dependent cluster density were supported by 
quantitative analysis on the basis of a modified Ripley function, L(r), which compares the 
spatial distribution of localizations to complete spatial randomness (L(r)=0 for all r) 317. In all 
cells, L(r) curves showed strong clustering signatures (Fig. 3.7c-d). Whereas the sharp increase 
observed at scales less than 100 nm can be influenced by photophysical effects, such as blinking 
of Dendra2318, the continuous increase at larger spatial distances is representative of Pol II 
clustering at multiple length scales. Taken together, these results demonstrate that Pol II 
clustering in cells depends on the CTD and increases with increasing CTD length.  
 
3.1.6 CTD length influences Pol II dynamics in cells 
We next investigated the impact of CTD length on Pol II dynamics in vivo using two orthogonal 
approaches, live-cell single-particle tracking (SPT)293 and FRAP experiments. Because these 
methods require a high signal-to-noise ratio and a photostable fluorescent label, we established 
cell lines with a Halo tag on RPB1-25R, RPB1-52R and RPB1-70R (Supplementary Fig. 7.1). 
We then tracked single molecules of Pol II in live cells as demonstrated by single-step 
photoactivation and photobleaching (Fig. 3.8a-b). Subsequent two-state kinetic modeling 
analysis assuming a free and bound state (Fig. 3.8c, Supplementary Fig. 7.2) revealed that 
29.1% of wild-type Pol II (RPB1-52R) in live cells was immobile and therefore presumably 
chromatin-associated. The bound Pol II fraction was decreased to 21% in RPB1-25R cells and 
was increased to 38.4% in RPB1-70R cells (Fig. 3.8d, Supplementary Fig. 7.2). In addition, the 
diffusion coefficients for free Pol II were higher and lower, respectively, for RPB1-25R and 
RPB1-70R cells. Free diffusion coefficients of 3.74, 2.97, and 2.34 m2/s were measured in 
RPB1-25R, RPB1-52R and RPB1-70R cells, respectively (Fig. 3.8e). These large differences 
in diffusion coefficients cannot be explained solely by differences in mass or size 
(Supplementary Note). Therefore, our results indicate that CTD length strongly influences  
Pol II mobility in vivo, with shorter and longer CTDs leading to higher and lower mobility, 
respectively. 
 









Figure 3.8 | CTD-dependent Pol II dynamics in human cells. 
a, Overview of stroboscopic photoactivation SPT (spaSPT) at ~133 Hz. Halo-RPB1 labeled with photoactivatable 
Janelia Fluor 549 (PA-JF549) is photoactivated with a 405-nm laser and excited with 1-ms stroboscopic pulses  
of a 561-nm laser. This simultaneously minimizes motion-blurring by strobing the excitation laser and minimizes 
tracking errors by maintaining a low average density of ~1 localization per frame. b, Representative spaSPT images 
with overlaid trajectories. Scale bar, 1 µm. c, Cumulative distribution functions (CDF) for displacements. CDF of 
displacements for the representative time-lag Δτ = 30 ms is shown for Halo-RPB1-25R, Halo-RPB1-52R, and 
Halo-RPB1-70R. Data shown are merged from three independent replicates (n = 29, 30, and 26 cells in total for 
Halo-RPB1-25R, -52R, and -70R, respectively). d, Bound fractions of Halo-RPB1-25R, -52R, and -70R.  
The bound fraction was inferred from two-state model fitting to the spaSPT displacement data using Spot-On293. 
Each of three independent replicates was fitted separately, and bar graphs show the mean and standard error.  
e, Diffusion coefficients (D) of the free populations of Halo-RPB1-25R, -52R, and -70R. Free diffusion 
coefficients were inferred from a two-state model fitting to the spaSPT displacement data using Spot-On293. Each 
of three independent replicates was fitted separately, and bar graphs show the mean and standard error. f, FRAP 
dynamics. Mean drift and photobleaching-corrected FRAP recoveries are shown for Halo-RPB1-25R, Halo-RPB1-
52R, and Halo-RPB1-70R. FRAP data were collected at 1 frame per s for 300 s, and bleaching was performed 
before frame 21. FRAP curves show means across three independent replicates (n = 15, 15, and 8 cells in total for 











These findings in cells match our observed length-dependence of CTD-CTD interactions in 
vitro (Fig. 3.1h; Fig. 3.5c). Indeed, FRAP recovery curves in human cells depended on CTD 
length (Fig. 3.8f), consistent with differences in FRAP recovery kinetics observed between 
hCTD and yCTD droplets in vitro (Fig. 3.1h). Analysis of these FRAP recovery curves by  
a reaction-dominant two-state model214, 292 further showed that the fraction that did not recover 
within a few seconds increased from 27.7% in RPB1-25R cells to 35.5% in RPB1-52R cells  
to 38% in RPB1-70R cells (Supplementary Fig. 7.2). This trend is consistent with the SPT 
results (Fig. 3.8d), which also showed a higher chromatin-associated fraction for Pol II with  
a longer CTD. Notably, both SPT and FRAP analysis showed that this putative chromatin-
associated fraction of Pol II decreased to similar levels in all three cell lines after flavopiridol 
treatment, which blocks the transition into productive elongation by targeting positive 
elongation factor B (P-TEFb; Supplementary Fig. 7.3). This favors an interpretation in which 
the CTD-length-dependent bound fraction is linked to polymerase activity. Together our data 
show that longer CTDs result in more clustered Pol II and chromatin association in vivo, 
reflecting the influence of CTD length on LLPS in vitro. 
 
3.1.7 CTD phosphorylation dissolves droplets  
Finally, we investigated whether CTD phosphorylation impacts phase separation. It has long 
been known that assembly of the pre-initiation complex at Pol II promoters requires an 
unphosphorylated CTD, and that subsequent CTD phosphorylation at S5 CTD residues by the 
cyclin-dependent kinase 7 (CDK7) in transcription factor IIH (TFIIH) stimulates the transition 
of Pol II into active elongation67, 319. We treated hCTD with recombinant human TFIIH 
subcomplex containing CDK7 kinase320 and ATP, leading to S5 phosphorylation of hCTD (Fig. 
3.9a). The resulting CDK7-phosphorylated hCTD was no longer able to form droplets, whereas 
prior incubation with ATP alone did not inhibit LLPS (Fig. 3.9b). Phosphorylation of yCTD by 
the yeast TFIIH kinase subcomplex also inhibited phase separation (Fig. 3.10). In addition, 
phosphorylation of preformed hCTD droplets by human CDK7 caused gradual shrinking and 
ultimately disappearance of hCTD droplets (Fig. 3.9c). Therefore, phosphorylation at S5 
positions is incompatible with CTD phase separation and transfers the CTD from the highly 
concentrated state within droplets to the dispersed pool. 
 








Figure 3.9 | CDK7 phosphorylation counteracts phase separation of human CTD. 
a, Sodium dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) and western blot analysis  
of phosphorylated MBP-hCTD fusion protein. MBP-hCTD was treated with recombinant human CDK7 complex. 
The hCTD substrate became highly phosphorylated, resulting in a pronounced mobility change during 
polyacrylamide gel electrophoresis in comparison to the nonphosphorylated substrate (control reactions without 
ATP and without kinase). Western blotting confirms phosphorylation of heptad position Ser5. Corresponding 
loading controls are shown to correct for potential differences in blotting efficiency. Western blot analysis of Ser5 
phosphorylation was performed in duplicate. b, hCTD phase separation is inhibited upon CTD phosphorylation 
by the human TFIIH subcomplex containing the CDK7 kinase. This effect is caused neither by hydrotropic 
properties of ATP321 nor by the simple presence of the kinase, since MBP-hCTD readily forms droplets in control 
reactions containing ATP or kinase alone. Images from at least ten representative images taken for each condition 
are shown. c, CDK7 phosphorylation dissolves preformed hCTD droplets over time. Images are representative of 















Figure 3.10 | TFIIK phosphorylation counteracts phase separation of yeast CTD. 
a, Sodium dodecyl sulfate polyacrylamide gel electrophoresis and western blot analysis of phosphorylated GST-
yCTD fusion protein. GST-yCTD was treated with recombinant yeast TFIIK. The CTD substrate became highly 
phosphorylated, resulting in a pronounced mobility change during polyacrylamide gel electrophoresis in 
comparison to the non-phosphorylated substrate (–ATP and –kinase control reactions). Western blotting confirms 
phosphorylation of heptad position Ser5. Corresponding loading controls are shown to correct for potential 
differences in blotting efficiency. Western blot analysis of Ser5-phosphorylation was performed in duplicate.  
b, Phosphorylation of GST-yCTD by recombinant TFIIK inhibits phase separation. GST-yCTD was pre-incubated 
with TFIIK and ATP leading to its phosphorylation. A 10 µM solution of TFIIK-phosphorylated GST-yCTD does 
not undergo phase separation in 16 % dextran. This effect is neither caused by hydrotropic properties of ATP nor 
the pure presence of the kinase, since GST-yCTD readily forms droplets in control reactions containing ATP or 



















Here we show that the Pol II CTD can undergo concentration-dependent liquid-liquid phase 
separation in vitro and that this behavior is strongly influenced by CTD length/repeat number. 
We further find that CTD length also controls Pol II clustering as well as its dynamics in living 
human cells. Our results indicate that the intermolecular interactions between CTD molecules 
are driven by weak hydrophobic contacts between the aromatic tyrosine residues in heptad 
position 1. These repeat-repeat interactions are sensitive to CTD phosphorylation by the cyclin-
dependent kinase CDK7, which dissolves CTD droplets in vitro. Several implications emerge 
from these findings. I will first discuss direct consequences for our understanding of CTD 
structure and function, and then discuss broader implications for our emerging view of the 
spatiotemporal organization of eukaryotic gene transcription. 
 
3.2.1 Implications for CTD structure and function   
3.2.1.1 Multivalent interactions contribute to Pol II CTD function 
Many previous studies suggested that CTD function is mainly based on binary interactions 
between short CTD regions with CTD-binding factors. These factors were found to bind  
1-3 CTD heptad repeats in a transcription stage-dependent manner (reviewed in21,22). Together 
these studies led to the notion that short heptad motifs may constitute the functional unit of the 
Pol II CTD322, 323. While such binary interactions are undoubtedly an important aspect of CTD 
function, they do not suffice to explain the extreme overall conservation of CTD length. For 
example, why is a consecutive stretch of 26 consensus heptad repeats strongly conserved 
between yeast and human if binding sites of all known CTD binders only span three repeats or 
less? Instead our results indicate that CTD function is additionally based on multivalent 
intermolecular interactions that manifest in liquid-liquid phase separation. Phase separation is 
known to be strongly controlled by the interaction valency and very sensitive to small valency 
changes231, 245, 251, 324. Consistent with this, our in vitro data shows that the ability to engage in 
such intermolecular interactions and their strength is strongly dependent on the CTD repeat 
number. In live human cells, CTD truncation reduced Pol II clustering and mobility, while an 
artificial CTD extension beyond the wild-type length had the reverse effect. These results 
 







suggest that weak multivalent interactions govern Pol II localization and dynamics in vivo and 
together emphasize their importance for CTD function.  
 
3.2.1.2 Aromatic interactions underlie CTD phase separation  
We find that replacement of all 52 tyrosine residues within the human CTD by phenylalanine 
still supports phase separation, while replacement by leucine abolishes it. This indicates that 
aromatic but not mere hydrophobic interactions drive CTD self-association. It seems likely that  
π-π interactions between the strongly conserved Y1 residues play a dominant role in this context. 
The similar behavior of hCTD WT and Y→F variants in phase separation assays can be 
rationalized by results from fluorescence spectroscopy measurements, which suggest very 
similar binding energies for aromatic π-π interactions formed between two tyrosine and between 
two phenylalanine aromatic ring systems325. This might offer a plausible explanation for the 
similar behavior of hCTD WT and Y→F variants in phase separation assays. Beyond the 
aromatic interaction, Vernon et al.256 pointed out that the conceptual basis of π-π interactions 
can furthermore be extended to all sp2 hybridized atoms that occur in the peptide bond or amino 
acid side chain and interact through exposed π orbitals. While not as strong π-π interactions 
between aromatic systems, the widespread occurrence of π-π interactions between aromatic and 
non-aromatic π-orbitals was shown to have profound impact on phase separation propensity256. 
Thus, the small side chain size of the CTD consensus residues serine, threonine and proline 
might allow for additional extensive contacts of the aromatic tyrosine residues with the  
π orbitals of the exposed sp2 hybridized peptide bond. Indeed, such interactions are frequently 
observed in crystal structures of folded proteins256. Taken together, our in vitro results suggest 
that π interactions involving the aromatic systems constitute the underlying basis for CTD phase 
separation.      
The requirement of an aromatic residue in the first heptad position for phase separation is 
consistent with results from genetic in vivo studies, which found that replacement of all CTD 
tyrosine residues by leucine is lethal in yeast276, 326. Tyrosine substitution with phenylalanine 
was found to be tolerated in up to half of the human CTD repeats, but results in severe 
termination defects327; complete replacement of tyrosine with phenylalanine was found to be 
lethal in S. cerevisae and human cells28, 328, 329. As the phenolic hydroxyl group is not required 
 







to form homotypic heptad-heptad interactions, this points toward an additional role of Y1 in 
vivo: Indeed, Y1 is well known to undergo reversible phosphorylation during the transcription 
cycle, which prevents termination factor recruitment to elongating Pol II42, to contribute to CTD 
stability and has been implicated in upstream-antisense and enhancer RNA transcription328, 329. 
In addition, the Y1 hydroxyl group frequently engages in favorable interactions with additional 
factors binding to the CTD, for example, the Y1 hydroxyl group forms stabilizing hydrogen 
bonds with the capping enzyme subunit Cgt170  as well as with the CTD-interacting domain of 
Pcf11330.   
 
3.2.2 Implications for the organization of Pol II transcription 
3.2.2.1 Unphosphorylated CTD recruits RNA Pol II to activated gene promoters 
How transcription is organized inside the crowded nuclear environment has been an intense 
area of research200-202. Transcription initiation requires a complex sequence of protein-protein 
and protein-DNA interactions to facilitate pre-initiation complex formation59. However, during 
stimulus-activated gene transcription (for example upon heat shock), Pol II initiates at a rate 
that is solely limited by the elongation velocity of already engaged Pol II clearing the promoter 
(~40 Pol II/min)162, 331, 332. Recent super-resolution microscopy experiments revealed that  
Pol II forms transient clusters208. These Pol II clusters were found to precede mRNA synthesis 
and localize into close proximity to gene promoters208, 211. However, the underlying molecular 
mechanism of Pol II clustering could not be deciphered in these studies, hampering further 
functional interpretation.  
Here, we have shown that the unphosphorylated RNA Pol II CTD possesses the ability to self-
interact and undergo liquid-liquid phase separation in vitro. We further demonstrate that Pol II 
clustering strongly correlates with CTD length in live human cells. From these findings, a model 
emerges for Pol II recruitment to activated gene promoters (Fig. 3.10): Multivalent interactions 
between unphosphorylated CTDs mediate the formation of Pol II condensates inside living cells 
(Fig. 3.10). Super-resolution imaging techniques and computational modeling estimated these 
condensates to contain on average ~80 Pol II molecules211. Such Pol II condensates might 
provide a concentrated pool of initiation-competent Pol II that might help to overcome rate-
limiting steps and facilitate high initiation rates upon activated gene transcription.   
 







It is likely that transcriptional activators that bind near gene promoters or distant enhancer 
elements can direct the formation of Pol II condensates through their long, disordered activation 
domains. In fact, studies have demonstrated that activation domains of several transcription 
factors can self-interact through aromatic contacts to form phase-separated droplets or 
hydrogels in vitro135, 245 that recruit Pol II CTD135. Inside the nucleus, these activation domains 
were also shown to form punctate condensates that co-localize with Pol II condensates333. 
Similarly, the well-known yeast activator GCN4 was recently shown to undergo LLPS through 
aromatic interactions334, and CTD truncation leads to gene activation defects in yeast30, 335 and 
mammalian cells32. Together with the strong dependence of CTD phase separation on aromatic 
amino acids, these results suggest a predominant role of aromatic contacts in the interaction 
between transcription factors and the Pol II CTD. Strikingly, results from systematic mutational 
screens of various different transcription factors suggest that exposed aromatic residues within 
the activation domain are crucial to mediate transcriptional activation135, 229, 333, 336, 337. It is thus 
an attractive possibility that aromatic interactions between the Pol II CTD and activation 
domains drive the co-condensation of both factors at activated gene promoters. An important 
consequence that follows from such interaction with DNA-bound transcription factors is that 
Pol II condensation could occur even below the saturation concentration if attractive 
interactions between the Pol II CTD and spatially constrained transcription factor activation 
domains increase the Pol II concentration locally above the saturation threshold. Additionally, 
such mechanism would constitute a simple yet effective way to ensure that Pol II condensation 
occurs at gene promoters only upon transcription factor binding. Consequently, the 
unphosphorylated CTD delivers and condenses Pol II at sites of active transcription. This idea 
is consistent with work from Lu et al.338, who show that the Pol II CTD is both required and 












Figure 3.11 | Model for the role of CTD-driven phase separation in activated transcription. 
Pol II clusters in nuclear condensates or ‘hubs’ through multivalent intermolecular interactions between 
unphosphorylated CTDs. Transcriptional activators that bind to regulatory sites such as enhancers might promote 
the formation of Pol II clusters through their disordered transactivation domains. High Pol II concentrations at 
gene promoters might facilitate efficient transcription initiation. Initiation-coupled CTD phosphorylation releases 
single Pol II enzymes into active early elongation. During elongation the phosphorylated CTD can form novel 
multivalent interactions with selected factors. Figure was adapted from Boehning et al. (2018)25. 
 
While our study was completed and under peer review several other factors that bind to super-
enhancers at high density were described to form phase-separated condensates275, 339.  
Sabari et al.340 provided experimental evidence that the surrogate subunit MED1 of the 
Mediator complex and the bromodomain-containing co-activator BRD4 form condensates at 
super-enhancers and that their IDRs can undergo liquid-liquid phase separation in vitro.  
Cho et al.212 showed that Pol II and Mediator form large stable condensates in mouse embryonic 
stem cells that co-localize in a transcription-dependent manner, in addition to the small transient 
Pol II condensates in differentiated cells described here and elsewhere208, 211. Boija et al.334 
showed that various activation domains of transcription factors form phase-separated 
condensates that interact with Mediator. Together with previous findings131, 132, 339, these results 
are consistent with the model that enhancers serve as scaffolds, on which transcription factors 
and transcriptional co-activators such as BRD4 and Mediator accumulate.  
 
 







Ultimately, transcriptional activation requires enhancer-promoter communication116. 
Interesting results from recent live-cell microscopy studies suggest that this does not involve 
direct physical enhancer-promoter interaction, but that mere proximity (~100-300 nm) of 
enhancer and promoter suffices to trigger gene transcription116, 121, 341. This action at a distance-
behavior can be rationalized in light of a promoter condensate or hub model in which Pol II 
(this study, and212) and Mediator co-activator340, promoted by transcription factors334, condense 
through weak multivalent IDR-IDR interactions between enhancer and promoter elements. The 
formation of a liquid-like phase-separated condensate at the gene promoter results in the local 
accumulation of these factors that might simultaneously act as functional and structural 
bridge342. The all-or-nothing nature of phase separation might explain rapid (dis-)assembly 
kinetics of the promoter condensate and can provide an underlying mechanistic basis for the 
enigmatic phenomenon of transcriptional bursting343. In such a model the condensate lifetime 
might then dictate the lifetime of the enhancer-promoter interaction and correlate with the 
bursting frequency. Whether the condensate only forms after sustained enhancer-promoter 
proximity121, 341 or whether it results from coalescence of distinct condensates that might be 
pre-formed at enhancers (containing e.g. Mediator) and promoters (containing i.e. Pol II)212, is 
still part of active research. Interestingly, the surface tension resulting from (thermodynamically 
favorable) coalescence of such phase-separated chromatin domains can in principle provide 
sufficient force to pull two genomic loci into close spatial proximity344. 
 
3.2.2.2 CTD phosphorylation releases Pol II from promoter condensates 
Incorporation of Pol II into the pre-initiation complex results in CTD phosphorylation of S5 
residues through the TFIIH kinase CDK7 (Fig. 3.11). CDK7 phosphorylation disrupts the weak 
hydrophobic interactions that underlie CTD self-association and concentration of Pol II within 
the promoter condensate. This liberates the Pol II enzyme after transcription initiation from the 
promoter and allows the transition into active transcription elongation (Fig. 3.11).  
During elongation, the phosphorylated CTD allows Pol II subsequently form novel multivalent 
interactions with selected factors. The disordered histidine-rich C-terminal region of cyclin T1, 
a subunit of P-TEFb, can form phase separated droplets that incorporate the CDK7-
phosphorylated CTD345. In vivo, P-TEFb foci have long been known to co-localize with  
 







S5-phosphorylated Pol II, but not S2-phosphorylated Pol II
204. Such a mechanism ensures 
efficient CTD hyperphosphorylation and might enable the rapid activation of the paused Pol II 
elongation complex through P-TEFb87, 345. Additionally, hyperphosphorylated CTD was shown 
to be recruited to phase-separated droplets formed by splicing factors in vitro346, 347. Splicing 
factors often possess low-complexity RS-rich domains and are condensed in splicing 
speckles231, 348, 349. Splicing occurs co-transcriptionally90, 350 and speckles locate to genomic loci 
with high transcriptional activity351. Indeed, speckles are well known to co-localize with 
phosphorylated Pol II350, 352. Thus, the co-condensation between the Phospho-CTD and SR 
proteins through weak multivalent interactions might underlie the coordinated coupling of 
transcription with mRNA splicing346.  
In summary, our results together with recently published findings from other groups suggest 
that the CTD can undergo phase separation through two different mechanisms. During the pre-
initiation phase, homotypic intermolecular interactions with other CTD molecules (Fig. 3.1) or 
heterotypic interactions with transcriptional activators or coactivators promote CTD phase 
separation. These interactions are largely based on weak-hydrophobic (i.e. aromatic) contacts 
(Fig. 3.5). After promoter release and concomitant CTD phosphorylation, the weak-
hydrophobic interaction network is disrupted and the CTD does not engage in homotypic 
intermolecular interactions anymore (Fig. 3.9-10). Upon elongation into the gene body, the 
phosphorylated (negatively charged) CTD rather engages in multivalent heterotypic 
interactions with elongation and RNA processing factors. These interactions are likely 
electrostatic in nature and thus physiochemically distinct from the interactions within the 
promoter condensate as implied by the positively charged histine-rich cyclin T1 domain or RS 
domains of splicing factors. Thus, CTD phosphorylation may serve as a molecular switch that 
regulates partitioning between ‘promoter condensates’ and ‘gene-body condensates’ (Fig. 3.9-
10)346, 347. Upon CTD dephosphorylation during transcription termination, the Pol II enzyme is 
released from interactions with elongation and RNA processing factors and relocates to the 











4 NELF condensation accompanies stress-induced 
transcriptional downregulation 
   
4.1 Results 
___________________________________________________________________________ 
The results presented in this section were obtained in collaboration with Prashant Rawat from 
the laboratory of Dr. Ritwick Sawarkar (Max Planck Institute for Immunology and Epigenetics, 
Freiburg) and are currently prepared for publication. Experiments that were not performed by 
the author of this dissertation, but are included in this section for a coherent presentation of the 
obtained findings, are marked in the figure legends. Detailed author contributions can be found 
on Page VI. 
___________________________________________________________________________ 
 
The cellular response to proteotoxic stress such as heat shock involves the downregulation of 
thousands of genes involved in metabolism, cell cycle and protein synthesis162, 173, 175. In human 
cells, stress-induced transcriptional downregulation is accompanied by enhanced recruitment 
of the negative transcription elongation factor NELF to downregulated genes and is thus 
thought to be regulated at the step of promoter-proximal pausing175, 176, 189, 353. However, the 
underlying molecular basis of the increased residence time of NELF at chromatin and stable 
Pol II pausing upon stress has remained unclear. 
 
4.1.1 NELF concentrates in punctate structures upon stress 
In order to visualize the nuclear redistribution of NELF upon heat shock, we transfected HeLa 
cells transiently with a plasmid encoding the mCherry-tagged NELFA subunit. Under normal 
conditions, NELFA was fairly homogenously distributed throughout the nucleus and only a few 
 







nuclear puncta were visible, consistent with a previous study that revealed co-localization with 
histone gene loci354. In contrast, heat shock stress caused the rapid concentration of NELF into 
droplet-like structures that formed throughout the entire nucleoplasm (Fig. 4.1a). To confirm 
these findings, we additionally constructed a stable human cell line that expresses a GFP-tagged 
version of the NELFA subunit at similar levels to the endogenous protein. As in transfected 
cells, NELF formed numerous clusters inside the nucleus upon heat stress (Fig. 4.1b). After the 
heat stress ceased, NELF puncta readily dispersed within a 1 h recovery period (Fig. 4.1c). 
Similar to heat shock, arsenic treatment induced puncta formation, suggesting that NELF 
condensation is a general consequence of proteotoxic stress rather than caused by the mere 
temperature difference (Fig. 4.1d). The ability of NELF to concentrate in punctate structures 
raises the possibility that sequestration within these puncta could cause its increased residence 
time at chromatin. To characterize the properties of stress-induced NELF condensates, we 
conducted fluorescence recovery after photobleaching (FRAP) experiments in live cells. While 
GFP-NELFA showed rapid and complete recovery within few seconds in the absence of heat 
stress, its mobility decreased considerably upon heat shock (Fig. 4.1e). Such stable 
immobilization within puncta resembles the concentration of proteins within membraneless 
organelles225, 231. These protein condensates form through interactions between intrinsically 
disordered protein domains that lead to liquid-liquid phase separation into a protein-rich phase 
with liquid-like properties. Consistent with the liquid-like behavior, we observed puncta with 
shapes that were reminiscent of fusion events (Fig. 4.1f). Many intracellular condensates are 
stabilized by weak interactions that are disrupted by the aliphatic alcohol 1,6-hexanediol307, 355. 
To further explore whether NELF puncta possess properties consistent with phase-separated 
condensates, we treated the cells with 1,6-hexanediol after exposure to heat stress. Similar to 
other membraneless organelles, 1,6-hexanediol treatment strongly reduced the number of 
puncta, further supporting the idea that the same mechanisms may underlie their formation.   
 
 








Figure 4.1 | NELF forms puncta upon stress that resemble phase-separated condensates. 
a, Confocal image of human HeLa cells that were transfected with NELFA-mCherry fusion protein. While 
NELFA-mCherry is homogenously distributed in the absence of stress (NHS), it condenses into numerous puncta 
upon heat shock (HS). b, Confocal image of HeLa cells that stably express NELFA-GFP as single copy gene under 
a tetracycline-inducible promoter. The number of NELFA puncta drastically increases upon heat shock. c, Heat 
stress-induced NELFA puncta reversed (+Rec) upon 60 min incubation at 37°C. d, Similar to heat shock, arsenic 
treatment (+As) induces the formation of NELF-GFP puncta. e, Photobleaching-corrected FRAP recovery curves. 
While NELFA-GFP readily recovers in the absence of heat stress, its mobility is drastically reduced upon heat 
shock. Curves are representative for 10 (NHS) and 12 (HS) FRAP experiments. Error bars show the standard 
deviation. f, Stress-induced nuclear puncta formed by transiently transfected NELFA-mCherry undergo fusion.  
g, NELF puncta are sensitive to 1,6-hexanediol. HeLa cells that stably express NELFA-GFP were heat shocked 
(43°C) in the presence or absence of 10% 1,6-hexanediol. Representative confocal images are shown. Analysis 
based on 57 cells (HS – 1,6 hex) and 61 cells (HS + 1,6 hex), respectively. Boxes indicate mean and standard 
deviation. Scale bars, 5 µm in all panels. All experiments shown in this figure were conducted by Prashant Rawat 
(MPI for Immunology and Epigenetics, Freiburg).  
 
4.1.2 NELF is capable of liquid-liquid phase separation in vitro 
Resident proteins of various membraneless organelles have been shown to undergo phase 
separation in vitro. Prompted by the results we obtained in vivo, we wanted to investigate 
whether liquid-liquid phase separation could underlie NELF immobilization at chromatin.  
To test whether NELF is capable of undergoing liquid-liquid phase separation in vitro, we 
recombinantly expressed the human full-length four-subunit NELF complex in insect cells. 
 







Previous biochemical studies provided strong evidence that binding of unphosphorylated NELF 
induces Pol II pausing, while NELF phosphorylation causes its displacement from Pol II 
leading to pause release76, 87. To mimic the paused state, we dephosphorylated the NELF 
complex during its purification to homogeneity with Lambda phosphatase and labeled the 
complex with an amine-reactive Alexa Fluor 488 dye at a low labeling density of ~1 fluorophore 
per molecule (Fig. 4.2a-b). We then used fluorescence microscopy to assess the ability of the 
purified NELF complex to undergo phase separation using an in vitro phase separation assay.  
At a sodium chloride concentration of 50 mM which is commonly used to examine LLPS  
in vitro 262, 356, a 5 µM NELF solution underwent phase separation to form numerous spherical 
micron-sized droplets (Fig. 4.2c). Droplets formed in the bulk solution and settled onto the 
coverslip surface due to gravity. With increasing salt concentration, the number and size of the 
droplets decreased (Fig. 4.2c). This strong dependence of phase separation on ionic strength 
suggests that electrostatic interactions are required for NELF self-association. While NELF 
underwent phase separation in the absence of any crowding agents at low ionic strength, the 
inclusion of low amounts of the polysaccharide dextran promoted NELF phase separation under 
near-physiological salt conditions (Fig. 4.2d). At a salt concentration of 50 mM, NELF formed 
droplets with a critical concentration of ~0.5 µM (Fig. 4.2e). Upon contact, droplets coalesced 
into larger droplets that readily relaxed to spherical shape (Fig. 4.2f). This underpins the liquid-
like nature of NELF droplets that form in vitro and is reminiscent of the properties of NELF 
condensates that are observed in living human cells (Fig. 4.1f). We then further examined the 
dynamics of molecules within the condensed phase using FRAP. Rapid recovery of 
fluorescence within the bleached region demonstrated that NELF molecules can freely diffuse 
within the condensed phase (Fig. 4.2g). It has been shown for a few phase-separating systems 
that the molecular mobility within the condensed phase can decrease over time, an irreversible 
process that is referred to as ‘maturation’ and implicated in several neurodegenerative 
diseases303, 310, 357, 358. However, identical recovery kinetics even after prolonged incubation  
for 20 h suggest that NELF droplets maintain their liquid-like nature over longer time scales in 
vitro (data not shown). Taken together, our results indicate that NELF molecules can self-
associate to form liquid-like droplets in vitro, providing a potential mechanistic basis for stress-
induced NELF condensation in vivo. 
 
 








Figure 4.2 | NELF undergoes liquid-liquid phase separation in vitro. 
a, Coomassie-stained SDS-PAGE of purified NELF complex (~1 µg). The four subunits of the complex NELFA 
(57.3 kDa), NELFB (65.7 kDa), NELFD (isoform of NELFC that lacks the first nine amino acids; 66.2 kDa), 
NELFE (43.2 kDa) are indicated. b, SDS-PAGE fluorescence scan of NELF complex after chemical labeling using 
an amine-reactive Alexa Fluor 488 (AF488) dye. NELFA and NELFE subunits become preferentially labelled.  
c, Confocal microscopy reveals the formation of spherical droplets in dependence on the sodium chloride 
concentration. Concentration of NELF complex was 5 µM. d, Epifluorescence microscopic images of NELF phase 
separation in the presence of low amounts of molecular crowding agents. Addition of dextran to a final 
concentration of 3% promotes phase separation of a 5 µM NELF solution at near-physiological ionic strength.  
e, Confocal microscopy images of NELF phase separation at 50 mM NaCl. NELF forms spherical droplets with  
a critical concentration of 0.5 µM. f, Droplet fusion. Upon contact two NELF droplets coalescence into one larger 
droplet consistent with liquid-like behavior. g, Photobleaching-corrected and normalized FRAP recovery curves. 
Bleached fluorescence within a 1 µm circular spot distant from the droplet boundary recovers within seconds. The 
points show mean and standard error of three independent replicates and were fit with a double-exponential 
recovery curve. Scale bars, 20 µm in c, d, e, and 2 µm in f.  
 
 
4.1.3 NELF tentacles drive phase separation in vitro 
NELF consists of the two heterodimeric subcomplexes NELFA/C and NELFB/E, which 
associate via contacts between NELFB and NELFC to form a three-lobed structure76, 156. While 
the NELFB and NELFC subunits are largely composed of structured domains, NELFA and 
 







NELFE possess large flexible C-terminal regions that were termed ‘tentacles’74, 87 (Fig. 4.3). 
Multivalent interactions between intrinsically-disordered protein domains are well-known to 
promote LLPS of various proteins. To elucidate whether the flexible tentacles drive phase 
separation of NELF, we expressed both regions as GFP fusion proteins in Escherichia coli and 
purified them to homogeneity (Fig.  4.4a). We then used the pre-established in vitro droplet 
assay to test whether the GFP-tentacle fusion proteins can individually undergo phase 
separation under the same conditions that promote LLPS of the NELF complex. Both fusion 
proteins alone did not undergo phase separation, not even at very high concentrations (Fig. 
4.4b). This result indicates that the tentacles are not able to self-interact. However, when 
NELFA and NELFE tentacle fusion proteins were mixed at equimolar concentrations, they 
readily formed droplets at much lower concentrations (Fig. 4.4b). Instead of mixing both 
tentacles in trans we then aimed to combine them in cis to mimic their arrangement within the 
complex. For this we generated another GFP fusion protein that contains the NELFE tentacle 
at its N-terminus and the NELFA tentacle at its C-terminus (Fig. 4.4a). Genetic fusion of both 
tentacles to the same polypeptide reduced the critical concentration for phase separation 8-fold 
to about 5 µM (Fig. 4.4c). These results indicate that both NELF tentacles can form multivalent 
interactions with each other that lead to phase separation with increasing protein concentration. 
Since both tentacles are sufficient to promote phase separation of a GFP fusion tag independent 
of the NELF core, it further implies that the synergistic interaction between the flexible 
tentacles drives NELF phase separation. Although both tentacles are in principle sufficient to 
drive phase separation, the saturation concentration difference to the wild-type NELF complex 
suggests that the remaining parts of the complex (‘NELF core’) might also support phase 
separation, consistent with other examples in the literature134, 241, 245. In addition, the transfer of 
the C-terminal NELFE tentacle to the GFP N-terminus might compromise its ability to engage 












Figure 4.3 | NELFA and NELFE subunits possess disordered tentacles at the C-terminus.  
a, Domain architecture and disorder prediction of all four NELF subunits using the PONDR tool24. Subunits 
NELFA and NELFE possess long C-terminal regions with high disorder propensity, while NELFB and NELFC 
subunits are composed of structured protein domains. The disordered NELFA region comprising residues 189-528 
and the disordered NELFE region with residues 139-380 are referred to as ‘tentacles’76. The definition of the 
protein domains is taken from Vos et al. (2018)76. RD, arginine-aspartate repeat domain, RRM, RNA recognition 
motif. b, Sequence analysis of both NELF tentacles. The relative abundance of each amino acid was plotted against 
the relative abundance within vertebrate proteins359. Amino acids are color-coded based on their physicochemical 
properties: Negatively charged, red; positively charged, blue; polar, yellow; aromatic, orange; aliphatic, green. 
Proline (P) is particularly enriched within the NELFA tentacle, while arginine (R) and aspartate (D) are enriched 












Figure 4.4 | Flexible tentacles drive NELF phase separation.  
a, Coomassie-stained SDS-PAGE of GFP-NELF tentacle fusion proteins and truncated NELF complex variants. 
For single tentacle variants, sequences encoding the NELFA tentacle (NELFA residues 189-528) or the NELFE 
tentacle (NELFE residues 139-380) were fused individually to the GFP C-terminus. For double tentacle fusion 
proteins, the sequence encoding the NELFE tentacle was fused to the GFP N-terminus and the NELFA tentacle to 
the C-terminus. NELF complex truncation variants lack either the NELFA or NELFE tentacle region. About 1 µg 
of each protein was loaded for SDS-PAGE analysis. b, Phase separation of GFP-NELF tentacle fusion proteins. 
At a concentration of 160 µM GFP-NELFA tentacle or GFP-NELFE tentacle individually did not undergo LLPS 
in buffer containing 50 mM sodium chloride. If both fusion proteins were mixed at equimolar concentrations, 
phase separation was observed with a critical concentration of 40 µM. c, Phase separation of a double tentacle-
GFP fusion protein. The fusion protein contains the NELFE tentacle at its N-terminus and the NELFE tentacle at 
its C-terminus. Fusion of both tentacles to the same polypeptide further decreased the critical concentration to  
~5 µM. d, Effect of tentacle deletion on NELF complex phase separation. Deletion of either tentacle strongly 
attenuates phase separation of a 5 µM NELF solution. e, 1,6-hexanediol sensitivity of tentacle-driven phase 
separation. The addition of 10% 1,6-hexanediol inhibits phase separation of the double tentacle GFP fusion protein. 
f, Effect of NELFA IDR deletion on stress-induced condensation in vivo. Stress-induced NELF condensation into 
nuclear puncta is inhibited upon deletion of a highly disordered segment (amino acids 321-460, Fig. 4.3a) within 
the NELFA tentacle in transiently transfected HeLa cells. This experiment was conducted by Prashant Rawat (MPI 











The interdependence of both tentacles implies that the removal of either tentacle should heavily 
impair phase separation of the NELF complex. In order to test this, we produced two complex 
variants that lack either the NELFA tentacle or the NELFE tentacle (Fig. 4.4a). Compared to 
the wild-type complex, phase separation of both variants was heavily attenuated (Fig. 4.4d), 
strongly supporting our previous findings.  
We could not test whether phase separation of the full-length NELF complex is sensitive 
towards 1,6-hexanediol because the complex precipitated upon addition of the aliphatic alcohol 
in vitro. Our previous findings suggest that tentacle-tentacle interactions primarily drive NELF 
phase separation. We thus used the double tentacle GFP fusion protein as surrogate to probe 
whether the multivalent interactions formed between the NELF tentacles are sensitive to  
1,6-hexanediol. Indeed, addition of 10% 1,6-hexanediol fully abolished phase separation of the 
GFP double tentacle fusion protein (Fig. 4.4e), consistent with our observations in vivo (Fig. 
4.1g). 
 
4.1.4 NELF tentacles drive condensation in vivo 
Based on our findings in vitro, we wanted to investigate next whether multivalent interactions 
between both tentacles may also underlie NELF condensation in vivo. Following an identical 
rationale as in the in vitro droplet assay, we aimed to inhibit the formation of intermolecular 
interactions through deletion of the entire NELFA tentacle. This was however not feasible 
because the NELFA tentacle harbors a nuclear localization signal (residues 268-277) that is 
essential for nuclear import (data not shown). We therefore deleted a smaller segment of 
140 amino acids that is predicted to be highly disordered (residues 321-460; Fig. 4.3a) and 
named this variant ‘ΔIDR’. Deletion of this region did not impair the nuclear localization of the 
ΔIDR NELFA-mCherry fusion protein under normal growth conditions; however, it strongly 
attenuated NELF condensation upon heat shock (Fig. 4.4f). This is consistent with the 
interdependent interaction of both tentacles that drives phase separation in vitro (Fig. 4.4d). 
Thus, our combined results indicate that the NELFA- and NELFE-tentacles can engage in 
multivalent interactions with each other, which underlie NELF phase separation in vitro as well 
as condensation in vivo.  
 
 







4.1.5 NELF dephosphorylation promotes phase separation 
We then searched for the mechanism that could cause NELF condensation under heat shock 
conditions. It is well established that binding of unphosphorylated NELF to Pol II induces 
pausing and subsequent NELF phosphorylation by P-TEFb leads to its displacement and pause 
release74, 76, 87. We therefore wanted to test the effect of P-TEFb phosphorylation on NELF 
phase separation. For this we produced recombinant NELF complex that was treated with active 
P-TEFb during purification. We then analyzed untreated and P-TEFb-treated NELF complex 
using phosphate-affinity SDS-PAGE, which reduces the electrophoretic mobility of 
phosphorylated proteins due to the interaction with gel-embedded Phos-tag molecules360. 
Mobility shifts were observed for NELFA and NELFE, but not for the NELFB and NELFC/D 
subunits, indicating that primarily NELFA and NELFE are phosphorylated by P-TEFb (Fig. 
4.5a). Using mass spectrometry-based phosphorylation site mapping, we found 21 different  
P-TEFb phosphorylation sites that were exclusively located on the NELFA and NELFE 
subunits (Fig. 4.5b). In addition, the detected sites were located predominantly in disordered 
regions (compare to Fig. 4.3a), consistent with previous analyses87. Post-translational 
modifications that alter the physicochemical properties of the underlying amino acids sequence 
are emerging as key mechanism to regulate IDR-IDR interactions. We thus reasoned that  
P-TEFb phosphorylation within the flexible NELFA and NELFE tentacle regions might 
influence their ability to interact in a multivalent manner with each other.  
In order to test the effect of P-TEFb phosphorylation on NELF phase separation in vitro, we 
formed NELF droplets at low ionic strength and in the presence of magnesium chloride and 
ATP. After the droplets had settled on the coverslip surface, we added either active wild-type 
P-TEFb or a catalytically inactive P-TEFb variant87 to the preformed NELF droplets and 
tracked changes over time using fluorescence microscopy. Time-resolved imaging revealed no 
change in droplet diameter over a period of 2 h when inactive (kinase-dead) P-TEFb was added. 
In contrast, addition of active wild-type P-TEFb resulted in significant shrinkage of NELF 
droplets within the same time frame (Fig. 4.5c). This result implies that P-TEFb 
phosphorylation inhibits NELF phase separation. This hypothesis is further supported by FRAP 
analyses of droplets formed either with dephosphorylated or P-TEFb-treated NELF. The faster 
fluorescence recovery of P-TEFb-treated NELF suggests that phosphorylation weakens the 
interaction strength between the tentacles and renders the molecules more mobile within the 
 







condensed phase (Fig. 4.5d-f). While the molecules are generally mobile within the condensed 
phase (Fig. 4.5d), their exchange with the bulk solution over the phase boundary is much 
slower. While about 80% of phosphorylated NELF molecules exchanged with the surrounding 
solution after 20 min, the recovered fraction was lower than 40% for an equally-sized droplet 
formed by dephosphorylated NELF (Fig. 4.5e-f). This slower exchange illustrates the stronger 
intermolecular interactions that deplete non-phosphorylated NELF from the bulk solution and 
concentrate it inside droplets. Consistent with this, pre-phosphorylation of the double tentacle 
fusion protein with active P-TEFb resulted in smaller and fewer droplets that often deviated 
from the shape of an ideal sphere (Fig. 4.5g). Together, the combined in vitro data thus 
demonstrates that P-TEFb phosphorylation counteracts NELF phase separation.  
Since NELF puncta emerge upon heat shock and NELF dephosphorylation promotes its self-
association, the phosphorylation level of P-TEFb target sites on NELF should decrease upon 
heat shock in vivo. We affinity-purified NELF from heat-stressed and non heat-stressed cells 
and analyzed NELF phosphorylation sites using mass spectrometry. Three different 
phosphorylation sites on NELFA were detected in these experiments. They were mostly  
P-TEFb target sites (Fig. 4.5b) and their phosphorylation level decreased upon heat shock (Fig. 
4.5h). The result suggests that unphosphorylated NELF accumulates upon heat shock in vivo 
and is consistent with a model in which this increasing NELF fraction is involved in pause 
stabilization that underlies the genome-wide transcriptional downregulation upon heat  
shock76, 175.  
 
4.1.6 Heat shock stress causes P-TEFb inactivation in the 7SK snRNP 
complex 
 
To investigate the regulatory mechanism that prevents NELF phosphorylation during heat 
shock, we focused on the pause release kinase P-TEFb. In cells, P-TEFb exists in a dynamic 
equilibrium of a free active form that becomes inactivated upon incorporation into the 7SK 
snRNP complex168, 169. This raises the possibility that enhanced sequestration of P-TEFb within 
the inactivating 7SK snRNP complex upon heat shock could lead to reduction of NELF 
phosphorylation and accompanying Pol II pause-release. To test whether the ratio between 
active and inactive P-TEFb might change upon heat shock, we conducted a CDK9 pulldown in 
 







the presence or absence of heat stress, respectively, and examined CDK9-interaction partners 
using a SILAC-based quantitative mass spectrometry approach (Fig. 4.5i). Association with 
(co-)chaperone complexes HSP90/Cdc37 and HSP70 that bind a significant proportion of 
CDK9 inside cells361 did not change. Contrary to this, the fraction of CDK9 that was associated 
with components of the 7SK snRNP complex was ~6 times higher upon heat shock (Fig. 4.5i). 
These findings indicate that heat shock stress causes increased P-TEFb sequestration in the 
inactivating 7SK snRNP complex.  
 
4.1.7 NELF sumoylation enhances condensation 
The previous results suggested that P-TEFb inactivation could be sufficient to induce NELF 
condensation in cells. To explore this possibility, we treated cells with the chemical CDK9 
inhibitor DRB. However, DRB treatment did not induce the formation of NELF puncta in the 
absence of heat stress (not shown), indicating that the accumulation of dephosphorylated NELF 
is a required prerequisite, but not sufficient for puncta formation. Heat shock stress is known to 
cause extensive post-translational modification of nuclear proteins362-364. Prominently, 
modification of nuclear proteins with SUMO2/3 (Small ubiquitin-like modifier 2/3) upon heat 
shock was shown to be required for cellular survival363. Reanalysis of published proteome-wide 
datasets of stress-triggered sumoylation revealed that all four NELF subunits become modified 
with SUMO2/3 upon heat shock363, 364 (Fig. 4.6a).  
We thus wanted to explore whether sumoylation could be required for stress-induced NELF 
condensation. SUMO is attached through an enzymatic cascade involving an E1 activating 
enzyme, an E2 conjugating enzyme and an E3 ligase that ultimately modifies the target protein. 
In order to block the first step of the enzyme cascade, we treated cells with the E1 inhibitor  
ML-792. Considerably less NELF puncta formed upon heat shock (Fig. 4.6b), indicating that 
sumoylation is required for puncta formation in vivo. Consistent with this finding, published 
data suggests that the sumoylation machinery becomes enriched at chromatin upon heat shock 













Figure 4.5 | Effect of P-TEFb phosphorylation on NELF phase separation.  
a, Phosphate-affinity SDS-PAGE analysis of NELF complex treated with P-TEFb in vitro. Gel-embedded Phos-
tag molecules cause retardation of phosphorylated proteins. P-TEFb phosphorylates the NELFA and NELFE 
subunits. b, Mass spectrometry-based phosphorylation site mapping. In total, 21 different phosphorylation sites 
were detected after titanium dioxide-based phosphopeptide enrichment exclusively on the NELFA and NELFE 
subunits. The majority of P-TEFb phosphorylation sites were localized in flexible NELF regions. c, Time-resolved 
effect of P-TEFb phosphorylation on NELF phase separation. NELF droplets were either incubated with active 
wild-type P-TEFb or a catalytically inactive P-TEFb variant and then imaged in regular intervals. After incubation 
with active P-TEFb for 120 min the size of NELF droplets decreased considerably. The arrow indicates a droplet 
fusion event. Scale bar, 5 µm. d, Photobleaching-corrected and normalized FRAP recovery curves for partial 
droplet bleaching experiments. A 1 µm circular region in the droplet interior was bleached. Lines represent mean 
and standard error of five bleached droplets and the recovery was fit with a double exponential function. (Figure 
caption continued on next page.) 
 
 







Figure 4.5 | Effect of P-TEFb phosphorylation on NELF phase separation. (Figure caption continued from 
previous page.)  
e, Photobleaching-corrected and normalized FRAP recovery curves for full droplet bleaching experiments. Full 
droplets with equivalent diameter were photobleached. Lines represent mean and standard error of three bleached 
droplets. The recovery was fit to a double exponential model. f, Exemplary confocal images of the recovery of 
unphosphorylated and P-TEFb-treated NELF droplets in a full FRAP experiment. Scale bar, 2 µm. g, Effect of P-
TEFb phosphorylation on phase separation of GFP-fusion protein containing NELFA and NELFE tentacle regions. 
Pre-phosphorylation of the GFP fusion protein with active P-TEFb decreased the number and size of formed 
droplets. Droplets that formed from phosphorylated protein often possessed non-spherical, ‘crumbled’ shapes. 
Scale bar, 10 µm. h, Mass spectrometric quantification of NELFA phosphorylation sites. Heat shock caused 
reduction of the phosphorylation level of three NELFA sites, two of them being P-TEFb target sites (compare Fig. 
4.5b). Bars show mean and standard deviation for three independent replicates. i, Mass spectrometric 
quantification of CDK9 interactors in the presence or absence of heat shock. Bars show mean and standard 
deviation for three independent replicates. Experiments shown in panels h and i were conducted by Prashant Rawat 
(MPI for Immunology and Epigenetics, Freiburg). 
 
Prominently, the known E3 ligase zinc-finger protein 451 (ZNF451) exhibits an almost 6-fold 
higher chromatin association compared to steady state conditions (Aprile-Garcia et al.175, 
Supplementary Dataset 4). We thus asked whether ZNF451 could sumoylate NELF in vitro.  
To reconstitute the sumoylation reaction in vitro, we incubated E1, E2 and ZNF451 together 
with NELF, ATP and SUMO2. Indeed, western blot analysis revealed the modification of the 
NELF subunits NELFA, NELFC and NELFE with SUMO2 (Fig. 4.6c). 
How might sumoylation promote NELF phase separation? The tendency of a protein to undergo 
phase separation strongly depends on the valency of the intermolecular interaction.  
The covalent modification with (poly-)SUMO can provide additional interaction interfaces that 
bind short SUMO-interacting motifs (SIMs) to increase the effective interaction valency.  
We analyzed the NELF sequence for the presence of potential SIMs. Interestingly, the NELFE 
tentacle harbors a predicted SIM with the sequence 286IIDL289 that was shown before in other 
proteins to mediate the interaction with SUMO2/3365, 366. To investigate the possibility that 
sumoylation enhances NELF phase separation in vitro, we formed NELF droplets in the 
presence of ATP and added the E1/E2/E3 SUMOylation machinery. Due to the low reaction 
efficiency at conditions that support phase separation in vitro we could not observe any effect 
on NELF phase separation (not shown). In an orthogonal approach, we thus tested whether 
NELF can interact with SUMO2/3. Using fluorescence anisotropy assays, no significant 
binding could be detected between 1xSUMO and NELF up to a concentration of 10 µM, 
indicating that potential NELF-SUMO interactions must be weak-affine. To specifically probe 
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for the presence of such weak interactions, we formed NELF droplets and added 
substoichiometric amounts of Alexa Fluor 647-labeled 4xSUMO, 1xSUMO or MBP. Indeed, 
at high protein concentrations that exist within a condensed phase, NELF incorporated 
4xSUMO and to a lesser extent 1xSUMO, while MBP was excluded (Fig. 4.6d). This shows 
that NELF, at high protein concentrations, is able to specifically interact in trans with SUMO2/3 
in a chain length-dependent manner. Analogous to results we obtained for the tentacles (Fig. 
4.4b-c), covalent attachment of (poly-)SUMO2/3 should thus further enhance the interaction 
strength and promote self-interaction of the NELF complex.  
  
 








Figure 4.6 | NELF sumoylation enhances condensation. 
a, Mass spectrometric analysis of the human SUMO proteome in HeLa cells revealed that the NELF complex 
undergoes sumoylation upon heat shock. Plot is based on data published by Hendriks et al. (2017) (Supplementary 
Table 3)364. b, Effect of inhibition of the SUMO E1 activating enzyme. Treatment of HeLa cells with the SUMO 
E1 inhibitor ML-792 reduced the number of NELF puncta that formed upon heat shock. This experiment was 
conducted by Prashant Rawat (MPI for Immunology and Epigenetics, Freiburg). c, In vitro reconstituted 
sumoylation reaction with NELF and the SUMO E3 ligase ZNF451. Western blotting using subunit-specific 
antibodies revealed that ZNF451 can sumoylate the NELFA, NELFC, and NELFE subunits. d, NELF droplet 
partitioning analysis. Substoichiometric amounts of Alexa Fluor 647-labelled H6-MBP-N10-TEV (44.8 kDa),  
HA-(SUMO3)4 (43.9 kDa), or SUMO2 (10.7 kDa) were added to NELF prior to induction of LLPS. SUMO2 and 
SUMO3 are almost identical isoforms (sequence identity: 94.6% (88/93 residues), sequence similarity: 96.8% 
(90/93 residues), calculation is based on the recombinant protein). While tetra-SUMO3 became enriched in NELF 
droplets, similar-sized MBP was excluded. Compared to tetrameric SUMO3, monomeric SUMO2 showed weaker 
enrichment, suggesting that valency is the key factor that determines partitioning. e, Autosumoylation of ZNF451. 
Western blotting revealed that ZNF451 polysumoylates itself in reconstituted in vitro assays, consistent with 
published results295.  
  
 








Previous studies indicated that stress-induced transcriptional downregulation is mediated by the 
enhanced recruitment of the negative elongation factor NELF to chromatin175. NELF 
accumulation near gene promoters is thought to stabilize promoter-proximal pausing of 
Pol II175. However, the molecular basis for the increased residence time of NELF at chromatin 
has remained unclear. Here we provide evidence that a phase separation mechanism can explain 
the increased dwell time of NELF at chromatin upon stress. We show that multivalent 
interactions between the disordered NELF tentacles lead to the concentration of NELF in phase-
separated, liquid-like droplets in vitro and are essential for stress-induced NELF condensation 
in vivo. P-TEFb phosphorylation counteracts NELF phase separation in vitro and is prevented 
through the inactivation of P-TEFb upon heat shock in vivo. Our results imply that sumoylation 
is further required for stress-induced NELF condensation. NELF itself can be sumoylated in 
vitro and interacts with SUMO2/3 in a chain length-dependent manner, representing a potential 
mechanism how sumoylation might enhance condensation. Although our data cannot yet 
demonstrate that paused Pol II is present within stress-induced NELF condensates, the strong 
increase of NELF and SUMO2/3 occupancy near downregulated gene promoters upon heat 
shock, which both correlate with enhanced Pol II pausing at these genes suggest a mechanistic 
link175, 353, 367, 368. Together with these published findings175, 353, 367, 368, our data suggest a model 
that involves the stress-induced sequestration of promoter-proximally paused Pol II through 
NELF condensates at downregulated genes.  
 
Model for stress-induced transcriptional downregulation 
After promoter release, NELF binds together with DSIF to the early Pol II elongation complex 
within the promoter-proximal region. In cooperation with DSIF, NELF mediates Pol II pausing 
through the stabilization of a nonproductive DNA-RNA hybrid conformation and prevents 
escape from the paused state76, 158. Under conditions of cellular homeostasis at steady state, 
paused Pol II is readily released into productive elongation. During proteotoxic stress, however, 
Pol II becomes stably paused at downregulated gene promoters through the accumulation of 
NELF175. We suggest that a phase separation mechanism can account for the increased 
residence time of NELF at downregulated gene promoters. Our data implies that two 
 







mechanisms promote the formation of NELF condensates. In the following I present a model, 
which proposes that the accumulation of dephosphorylated NELF under heat stress might 
inevitably trigger polysumoylation. 
During stress, the available pool of active P-TEFb is reduced through an increased sequestration 
within the 7SK snRNP complex (Fig. 4.5i). Consequently, this results in the accumulation of 
dephosphorylated NELF (Fig. 4.5h). In the non-phosphorylated state, NELF has a stronger 
tendency to self-interact (Fig. 4.5c-g) so that the fractional increase of the dephosphorylated 
form might be sufficient to overcome the saturation threshold. Alternatively, it is an intriguing 
possibility that other disordered domains of the paused elongation complex such as the  
Pol II CTD could provide a localized scaffold for the subcritical condensation of 
dephosphorylated NELF (see also Section 3.2.2). Such a model assumes that weak NELF-
scaffold interactions can locally increase the NELF concentration over saturation and implies 
that condensation is spatially limited to the range of this interaction. Independent of the precise 
mechanism, both possibilities could lead to the accumulation of NELF around the paused 
elongation complex. Similar to other transcriptional condensates211, such clusters might initially 
consist only of a limited number (≤100) of molecules, representing a potential reason why they 
are not visible using diffraction-limited microscopy techniques.  
Growth of stress-induced NELF condensates over the optical detection limit additionally 
requires the functional sumoylation machinery (Fig. 4.6). The NELF subunits NELFA, NELFC 
and NELFE become (poly-)sumoylated upon stress (Fig. 4.6a), mediated by the SUMO E3-
ligase ZNF451 (Fig. 4.6c). How might the E3-ligase reach its substrate NELF within the 
nucleus? Under normal conditions ZNF451 resides in PML bodies369, which partially 
disassemble upon heat stress370, 371. ZNF451 itself is polysumoylated295, 369 (Fig. 4.6e) and 
phase-separated NELF droplets interact with SUMO2/3 in a chain length-dependent manner, 
presumably through a putative SIM motif within the NELFE tentacle (Fig. 4.6d). Thus,  
a plausible mechanism could be that small clusters of dephosphorylated NELF that formed due 
to P-TEFb inactivation can trap ZNF451 through SUMO-SIM interactions. Within this 
condensate, large NELF concentrations might promote high catalytic efficiency372. Based on 
our previous results (Fig. 4.4b-c), it is likely that covalent polysumoylation further enhances 
NELF self-association through the presence of additional SUMO-SIM interactions. This would 
in turn lead to increased recruitment of the E3-ligase, creating a positive feedback loop that 
 







guarantees a rapid response. Growing condensates on the same and neighboring genes might 
coalesce to form larger assemblies. High NELF concentrations might assure stable Pol II 
pausing under stress conditions. At the same time, the phase boundary of the condensate 
increases the residence time of NELF within the promoter-proximal region and might constitute 
a selective barrier that restricts the access of elongation factors (Fig. 4.6c).  
The model highlights the functional synergism between P-TEFb sequestration and ZNF451 
mediated sumoylation for NELF condensation and stress-induced stabilization of Pol II 
pausing. According to the model, P-TEFb inactivation on its own could lead to formation of 
small clusters with few molecules that cannot grow further, while available ZNF451 can only 
be trapped efficiently through high local NELF concentrations that do not build up in the 
presence of active P-TEFb. This could allow signal integration from multiple orthogonal stress-
triggered pathways. Such a co-incidence detection mechanism would increase the robustness 
against intracellular fluctuations and noise and could ensure that a pervasive transcriptional 
response, resulting in the downregulation at the majority of genes becomes only elicited upon 
receiving multiple cues. 
 
The combination of heat shock experiments in human cells with orthogonal in vitro phase 
separation assays in this study has expanded our understanding about the mechanisms that 
might underlie the genome-wide transcriptional downregulation upon stress. It revealed the 
mechanistic basis of stress-induced condensation of NELF through an intricate interplay 
between P-TEFb sequestration and sumoylation. These findings can guide future investigations 
that may provide corroborative evidence. Imaging-based approaches shall be used in order to 
confirm that Pol II is present within NELF condensates and that condensates are associated with 
downregulated genes. Furthermore, it will be important to understand to which extent NELF 
condensation promotes stable Pol II pausing. For this, integrative multiomic approaches will be 
required that facilitate the accurate estimation of Pol II pause duration on a genome-wide 
scale162. However, this question is inherently difficult to answer as the deletion of protein 
regions that affect condensation might at the same time also influence NELF association with 
Pol II. In vitro pausing assays76 in combination with in vivo imaging approaches used in this 
study might help to elucidate appropriate regions. One such region could be the putative 
SUMO-interacting motif within the NELFE tentacle. If this motif is required for E3-ligase 
 







recruitment, its removal should attenuate stress-induced NELF condensation in vivo.  
It is located in a flexible loop region within the RRM domain, which refolds and might become 
inaccessible upon RNA binding373, 374. RNA binding is not required for Pol II pausing and pause 
release76, 87, and it is currently unclear in which conditions NELFE associates with RNA in 
vivo152, 156. Future PAR-CLIP experiments, which allow the identification of RNA binding sites 
transcriptome-wide375, may provide insights on how RNA binding contributes to NELF 
function.  
The interplay of the NELF tentacles with other disordered domains within the paused 
elongation complex, such as the Pol II CTD, remains an interesting aspect that should be 
explored in the future. Early biochemical studies showed that Pol II with CTD that was pre-
phosphorylated by P-TEFb is resistant to NELF-DSIF-induced pausing in an in vitro 
transcription assay, because CTD phosphorylation impairs the association of NELF with 
Pol II148. These results suggest that the Pol II CTD can interact in a phosphorylation state-
specific manner with NELF148. In this regard, it is plausible that multivalent interactions 
between the disordered NELF tentacles and the Pol II CTD contribute to NELF-Pol II 
association. In vitro droplet assays that probe co-recruitment of differentially phosphorylated 
Pol II CTD constitute an ideal experimental set-up to help to answer this question in the future.  
Although we find that heat stress leads to increased P-TEFb sequestration in the inactive 7SK 
complex, the underlying signaling mechanism is not yet clear. It could potentially involve the 
kinase p38α that becomes activated upon heat stress376 and translocates from the cytoplasm to 
down-regulated gene promoters in the nucleus175, post-translational modification of CDK9377 
and/or other complex members378, or post-transcriptional modification of the 7SK snRNA379. 
Similarly, the signaling pathways that regulate the availability of the SUMO E3-ligase ZNF451 
are not known and should be investigated in the future.  
Finally, it will be important to understand how NELF-dependent downregulation is coordinated 
with HSF1-driven transcriptional upregulation of pro-survival genes176, 177. Stress-induced 
transcriptional activation at the Drosophila HSP70 locus leads to the formation of  
a ‘transcription compartment’ that concentrates Pol II together with other positive elongation 
factors, retains them for multiple rounds of transcription and is dependent on poly(ADP-ribose) 
polymerase activity185, 188. In retrospect, these data suggest the control of stress-induced 
transcriptional activation at the Drosophila HSP70 locus through an analogous phase separation 
 







mechanism. Interestingly, heat shock factor HSF1 is known to directly recruit P-TEFb to these 
compartments182, representing a potential way as to how the active kinase can still be delivered 
efficiently to activated loci despite globally decreasing levels (Fig. 4.5i). The coordination of 
stress-induced activation and inactivation as well as the differential allocation of factors should 
be examined using multi-color imaging of surrogate proteins combined with assays that probe 
their partitioning into reconstituted phases in vitro. 
Together with the results presented here, these experimental endeavors will allow us to gain  
a holistic understanding about the fundamental mechanisms that govern the coordinated 
redistribution of the transcriptional machinery upon stress in the near future. 
 
 







5 Conclusion and outlook 
 
 
Research over the last few years has brought a sea change in our understanding of the 
spatiotemporal organization of eukaryotic gene transcription (reviewed in191, 347). Classical 
textbook models describe for example gene activation as the sequential recruitment of single 
Pol II enzymes to the target gene promoter. In contrast, recent experiments provided compelling 
evidence that gene activation rather involves the transient formation of multiprotein assemblies, 
which may contain about 80 Pol II enzymes211. These findings could be rationalized through an 
increasing molecular mechanistic understanding of the intermolecular interactions that may 
stabilize such extremely large multiprotein assemblies. Liquid-liquid phase separation that is 
based on weak multivalent interactions between disordered protein domains has emerged as a 
fundamental organizational principle to concentrate proteins in living cells225, 231, 235.  
In this thesis, I provide evidence that phase separation mechanisms control key aspects of 
transcriptional regulation in eukaryotic cells. In all eukaryotes, gene transcription is highly 
regulated at the step of initiation, mediated through the recruitment of the Pol II machinery107. 
Based on the results presented in Chapter 3, it appears that the ability of the disordered Pol II 
CTD to engage in weak multivalent interactions in a phosphorylation state-specific manner 
underlies Pol II accumulation at activated gene promoters through a phase separation 
mechanism. In higher eukaryotes, gene transcription is additionally regulated during early 
elongation by promoter-proximal pausing73. Because accumulation of paused Pol II 
simultaneously blocks new initiation, this allows for rapid gene downregulation during cellular 
stress responses. Heat shock leads to the recruitment of the pausing factor NELF to 
downregulated gene promoters175 and is accompanied by its IDR-dependent concentration in 
phase-separated condensates that may sequester paused Pol II (Chapter 4). Together with other 
recently published studies135, 212, 333, 334, 340, 345, 346, 380, and in contrast to current textbook models, 
the findings presented here indicate that many factors involved in gene transcription may 
function in condensates, and that these large multiprotein assemblies are stabilized by dynamic, 
weak and multivalent rather than stable lock-and-key interactions.  
 
 







Future research should strive to provide a more complete picture of the interactions that underlie 
condensate formation, examine their constituent proteins, and characterize the dynamic 
interplay of different transcriptional condensates. Below I highlight certain aspects, which 
might in particular merit further investigation. 
 
5.1 Uncovering the molecular details of CTD-activator 
interactions in promoter condensates 
 
Upon gene activation, initiation-competent Pol II with an unphosphorylated CTD assembles 
together with transcriptional (co-)activators in ‘promoter condensates’347. So far, all 
experimental efforts were focused on the interaction of CTD with only very few different 
transactivation domains134, 135, 343, 381. The human proteome, however, comprises over 1,600 
different transcription factors113, with many of them containing disordered transactivation 
domains227. Future research should thus strive for a more comprehensive picture of CTD-
activator interactions: It is likely that not all activators interact equally well with 
unphosphorylated CTD382; rather, different types of activation domains might exist that 
preferentially recruit distinct promoter condensate components. Based on activation domain 
sequence motifs together with their binding preference at enhancer or promoter regions112, 339, 
it may be possible to obtain different transcription factor classes that can then be tested 
experimentally in phase separation assays for their ability to interact with the Pol II CTD.  
Although disordered domains such as the CTD and activation domains continuously sample a 
heterogeneous population of different conformations, it is possible that transient secondary 
structure elements exist383-385 and may become stabilized upon activator-CTD interaction386, 387. 
To which extent residual secondary structure elements form within the condensed phase of 
liquid droplets and may contribute to the interaction specificity is debated139, 311, 388-391. NMR 
spectroscopy can be used to investigate the structure of the CTD in the dispersed phase, and 
probe for potential structural differences in the condensed phase. This may then provide the 
starting point to analyze the molecular basis of heterotypic interactions between the CTD and 
different activation domain classes in the future. 
 







5.2 Refining the components of gene-body condensates  
Upon CTD phosphorylation, Pol II escapes from promoter condensates and a launched convoy 
of polymerases enters the gene body220. Nuclear condensates that associate with transcribing 
Pol II with a hyperphosphorylated CTD and nascent RNA should be better investigated in the 
future. Such condensates are collectively termed ‘gene-body condensates’347. Among these are 
splicing speckles ‒ phase-separated condensates that contain high concentrations of splicing 
factors with arginine-serine (RS)-rich low-complexity domains ‒ that are known to associate 
with sites of active transcription348, 351. It was suggested347 and shown346 that 
hyperphosphorylated CTD can engage in multivalent interactions with such splicing factor 
condensates. Beyond splicing speckles, other such nuclear domains exist: Similar phase-
separated protein assemblies called paraspeckles form in a transcription-dependent manner at 
active loci392-394. Paraspeckles are mostly composed of RNA-binding proteins and their 
formation is strongly dependent on RNA, which is known to promote phase separation by 
enhancing their intermolecular interactions303, 358. Although the function of paraspeckles is not 
entirely understood, they have been suggested to be important for 3’-end processing of the 
nascent RNA395. Indeed, cleavage factor I (CFI), a key component of  
the 3’-end processing machinery composed of CPSF5 and CPSF6 (or the shorter isoform 
CPSF7)396, 397, is known to be concentrated within paraspeckles394, 398, 399. Analogous to splicing 
speckles, paraspeckles might thus correspond to condensates that provide a concentrated 
pool of 3’-end processing factors.   
Although the precise molecular basis is not well understood, it is clear that an intricate network 
of multiple binary and multivalent protein-protein and protein-RNA interactions underlies 
mRNA 3’-end processing in eukaryotes330, 400, 401. Intriguingly, CPSF6 possesses a long 
disordered C-terminus that encompasses a proline-rich region and a RS-like domain397, similar 
to splicing factors. Whether CPSF6 condensates can potentially associate with 
hyperphosphorylated CTD to couple 3’-end processing and transcription, analogous to splicing 
factors, merits further investigation. Support for such a model comes from the analysis of a 
prion protein that compartmentalizes 3’-end processing factors in liquid-like condensates to 
promote polyadenylation efficiency in Arabidopsis thaliana402.  
 
 







5.3 Understanding the dynamics of transcriptional condensates 
The organization of transcription is dynamic and transcriptional condensates can be extremely 
transient structures191, 347. For example, promoter condensates with Pol II and Mediator form 
and disassemble within few seconds at most genes208, 211, 212. The all-or-nothing nature of 
cooperative liquid-liquid phase separation can provide the molecular basis for such fast (dis-) 
assembly kinetics. Whether condensation of Pol II at gene promoters underlies the hitherto 
enigmatic phenomenon of transcriptional bursting217-219, 343, remains to be explored in future 
experiments. It will also be important to elucidate the events that precede condensation: 
Whether condensates form only after sustained enhancer-promoter proximity in between121, 341 
or whether they are pre-formed at enhancers that only transiently contact the target promoter212, 
warrants further investigation. 
The cellular response to stress intriguingly demonstrates the dynamics that can underlie 
genome-wide transcriptional reorganization. To mediate broad transcriptional downregulation 
upon heat shock, the rapid condensation of negative elongation factor NELF near repressed 
gene promoters may sequester and stabilize promoter-proximal Pol II in ‘pausing condensates’. 
It has been proposed that paused Pol II may correspond to a transition intermediate between 
promoter and gene-body condensates347. Stabilization of the transition state through high NELF 
concentrations could thus assure stable pausing during stress conditions. NELF binding 
to Pol II is abolished upon P-TEFb mediated CTD hyperphosphorylation148, suggesting that 
only promoter-proximal Pol II is amendable to NELF sequestration. Which additional factors 
and whether also promoter condensate components are present within pausing condensates 
necessitates thorough future investigation. Future work should also explore how the formation 
of pausing condensates at downregulated genes influences the localization of gene-body 
condensates351. How such transcriptional re-organization is triggered on a molecular level and 
how it affects or is affected by the three-dimensional organization of the genome403, 404 will 
require additional dedicated research.  
Together, these endeavors will bring us yet one step closer to deciphering the ‘molecular 
grammar’ that underlies condensate formation, and will ultimately allow us to attain an 
improved understanding of the organization of eukaryotic gene transcription, the fundamental 
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7.1 Supplementary Note 
Calculation of diffusion coefficients 
The observed free diffusion coefficients obtained from fitting the spaSPT data with the Spot-
On model (Brownian motion) were 3.74 +/- 0.178 m2/s, 2.97 +/- 0.0912 m2/s and 2.34 +/- 
0.049 m2/s for the 25R, 52R and 70R versions of Halo-Rpb1, respectively (mean +/- standard 
error). Given that the molecular weight of e.g. 25R is lower, one would expect the diffusion 
coefficient to be higher. To estimate whether this large difference could be explained by size 
alone or whether it might be due to reduced multivalent interactions, we consider the Stokes-






where 𝑘𝐵 is Boltzmann’s constant, 𝑇 is the absolute temperature, 𝜂 is the viscosity of the liquid  









The Stokes-Einstein equation assumes the particle to be a sphere and accordingly the radius is 
















where 𝑁𝐴 is Avogadro’s constant and 𝑀𝑊 is the molecular weight in atomic mass units 










Thus using 25R and 52R as the example, the ratio between the diffusion coefficients of 25R 





















According to UniProt (P24928) the molecular weight of wild-type Rpb1 is 217.2 kDa (52R). 
The molecular weight of the HaloTag is 33.6 kDa. Thus, the molecular weight of Halo-Rpb1-
52R is ~250.8 kDa, the molecular weight of Halo-Rpb1-25R is ~230.9 kDa and the molecular 







































It becomes clear that size/mass difference alone cannot explain the large difference between the 
diffusion coefficients that we observe in cells. To be comprehensive, below we list the Stokes-
Einstein expected and observed diffusion coefficient ratios for all the combinations: 
 
Comparison Stokes-Einstein expectation Observed ratio 
25R vs. 52R 0.973 0.794 
25R vs. 70R 0.964 0.626 
52R vs. 70R 0.991 0.789 
 
For all three combinations, the observed ratio cannot be explained by the change in size/mass. 
Instead this indicates a higher propensity of the full-length CTD to engage in intermolecular 
interactions. Moreover, in the above calculations we have just considered the change in the 
mass of Rpb1. In reality, Rpb1 is likely diffusing as part of the Pol II holocomplex, thus the 
relative difference due to the smaller CTD (e.g. ~20 kDa between 25R and 52R) is actually 
much smaller than the calculations using only Rpb1 would suggest and thus the expected 
difference in diffusion coefficients due to mass/size would be even much closer to 1. We 
conclude that the mass/size difference between the 25R, 52R and 70R Pol II enzymes cannot 










7.2 Supplementary Figures 
 
 
Figure 7.1 | Characterization of Halo-RPB1 cell lines.  
a, Confocal image of RPB1-25R (left), RPB1-52R (middle) and RPB1-70R (right) cell lines showing the nuclear 
localization of Halo-RPB1. Before fixation the cells were labeled for 30 min with HALO-TMR ligand (500 nM 
final concentration). Scale bars correspond to 5 µm. b, Western blot analysis of the Halo-RPB1-25R, -52R and  
-70R expression level for the different cell lines. c, FACS analysis to evaluate Halo-RPB1 expression levels of the 
different cell lines. d, Growth curve analysis of the Halo-tagged Pol II cell lines. The growth rate of the three cell 
lines is overall similar albeit the RPB1-25R (red) and RPB1-70R (grey) cell lines grew slightly slower than the 
U2OS WT (purple) and RPB1-52R (blue) cell lines. Once treated with alpha-amanitin, the WT cells (black) die 
while the growth rate of the other lines is unaffected. Growth curves show mean across n = 6 independent samples 
and error bars show the standard deviation. Growth curves of a representative experiment performed independently 
five times are shown. e, Doubling time analysis of the Halo-tagged Pol II cell lines. The three cell lines have 













Figure 7.2 | Pol II dynamics determined by spaSPT and FRAP. 
a, Overview of the 2-state model used in fitting the displacement data from spaSPT (Spot-On)293. Diffusion is 
modeled as Brownian and arising from a bound/immobile population and a freely diffusing population assuming 
no state transitions at the short time-scale of observation. A correction is applied to the free population to correct 
for “defocalization”: since the 2D imaging only captures a ~700 nm axial slice of the nucleus, the free population 
rapidly moves out of focus at later time points. b, Cumulative distribution functions (CDF) for displacements. The 
CDF of displacements for the representative time-lag Δτ = 22.5 ms is shown for Halo-RPB1-25R, Halo-RPB1-
52R and Halo-RPB1-70R. The data shown is merged from three independent replicates (n = 29, 30, 26 cells in 
total for Halo-RPB1-25R, -52R, -70R, respectively). c, Model fit to displacement histograms. Raw displacements 
from spaSPT data for six different time-lags are shown for Halo-RPB1-25R, Halo-RPB1-52R and Halo-RPB1-
70R. Model-fitting from a two-state (bound vs. free) model is overlaid, from which the diffusion constants and 
subpopulation sizes were calculated. The data shown is merged from three independent replicates (n = 29, 30, 26 










Figure 7.2 | Pol II dynamics determined by spaSPT and FRAP. (Figure caption continued from previous page.) 
d-f, FRAP data of Halo-RPB1-25R (d), Halo-RPB1-52R (e) and Halo-RPB1-70R (f) were fitted to a reaction 
dominant two-state model214, 292. We performed 50 iterations using 50% of the data in each to estimate the error 




Figure 7.3 | Effect of flavopiridol treatment on RNA Pol II dynamics. 
a, Cumulative distribution functions (CDF) for displacements. The CDF of displacements for the representative 
time-lags Δτ = 22.5 ms and Δτ = 30.0 ms are shown for Halo-RPB1-25R, Halo-RPB1-52R and Halo-RPB1-70R 
after treatment with flavopiridol. The data shown is merged from three independent replicates. b, Model fit to 
displacement histograms. Raw displacements from spaSPT data for six different time-lags are shown for Halo-
RPB1-25R, Halo-RPB1-52R and Halo-RPB1-70R. Model-fitting from a two-state (bound vs. free) model is 
overlaid, from which the diffusion constants and subpopulation sizes were calculated. The data shown is merged 
from three independent replicates (n = 13, 15, 28 cells in total for Halo-RPB1-25R, -52R, -70R, respectively). c, 
Bound fractions of Halo-RPB1-25R, -52R and -70R after flavopiridol treatment. The bound fraction was inferred 
from two-state model-fitting to the spaSPT displacement data using Spot-On293. Each of three independent 
replicates was fitted separately and bar graphs show the mean and standard error. d, Diffusion coefficients of the 
free population of Halo-RPB1-25R, -52R and -70R. Free diffusion coefficients were inferred from two-state 
model-fitting to the spaSPT displacement data using Spot-On293. Each of three independent replicates was fitted 
separately and bar graphs show the mean and standard error. e, FRAP data of Halo-RPB1-25R (red), Halo- 
RPB1-52R (blue) and Halo-RPB1-70R (grey) after flavopiridol treatment. The data were fitted to a reaction 
dominant two-state model214, 292. FRAP curves represent the mean across n = 5 independent measurements for each 
cell line and error bars show the standard error. We performed 50 iterations using 50% of the data in each to 
estimate the error (standard deviation of the subsampling) on the bound fraction. For comparison purposes, the 
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